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Abstract
In the last few years, there has been a growing concern in the occurrence of 
pharmaceutically active compounds in the aquatic environment. Just in Europe, more 
than 3000 prescription and non-prescription drugs are used by human and animals and 
more than 80 drugs have been detected in municipal wastewater treatment plant effluent, 
surface water, groundwater, and in a few isolated cases, in drinking water, some at 
alarmingly high concentrations. Although no known human health effects have been 
associated with exposure to drinking water containing trace concentrations of drug 
residues, there is concrete evidence that these drug residues could cause numerous 
adverse health effects on aquatic life, even at very low concentrations.
Municipal wastewater treatment plant effluents have been identified as the major 
source o f drug residues in surface waters. Conventional wastewater treatment systems 
cannot effectively remove pharmaceutically active compounds. The suitability of distinct 
wastewater treatment processes for the elimination of drug residues has not been studied. 
Freezing has been used successfully to treat various wastewaters. Application of freezing 
technology to purify water is based on the principle that when water freezes, ice crystals 
grow of pure water and impurities are rejected from the ice structure and become 
concentrated in the unfrozen liquid. Without addition of any chemicals, contaminants in a 
large volume of dilute wastewater can be effectively removed by freeze concentration. 
Objectives o f this study are: 1) literature review of occurrence o f pharmaceutically active 
compounds, treatment technologies and analytical methods; and 2) experimental study: 
evaluate the potential o f the freeze concentration process for the removal of selected 
pharmaceutically active compounds, the effect of initial concentration of drug residues.
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freezing temperature and degree o f  freezing on the removal efficiency o f  
pharmaceutically active compounds.
Five drugs aspirin, ibuprofen, gemfibrozil, metoprolol and sulfamethoxazole were 
selected to investigate the removal efficiency of freeze concentration. Gas 
chromatograph-mass spectrometry and total organic carbon were used to quantify the 
drug concentrations in water samples. After first freezing cycle, ibuprofen and 
gemfibrozil were concentrated 2-3 times compared to the feed water and the 
concentration factors reached 12 after second freezing cycle. The total removal efficiency 
of the selected pharmaceutically active compounds was about 80% after one stage freeze 
concentration. Results indicated that aspirin degraded during the treatment; therefore, the 
concentration o f aspirin was difficult to measure. Analysis of sample total organic carbon 
concentration indicated that about 84% and 92% removal efficiency was achieved for 
ibuprofen and gemfibrozil one stage freeze concentration. Approximately 99% impurity 
removal efficiency and around 60% volume reduction was observed in refrozen ice 
obtained from the first freezing.
This research results indicated freeze concentration was effective and not 
sensitive to the natural of target pharmaceutically active compounds in the feed water. In 
addition, the analytical methodology for the determination of drug residues in complex 
environmental matrices is still evolving and it may takes years before the universally 
accepted methods are developed. The gas chromatograph-mass spectrometry method 
used by many researchers requires complex sample preparation, which could influence 
the accuracy o f the analysis.
- 2 -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Acknowledgements
I wish to express my sincere appreciation to Dr. Wa Gao. Her guidance and 
support were essential to the completion of this thesis. I would like to thank Dr. timed 
Panu and Dr. Tong Yu for their efforts as examiners of this thesis. Special thanks go to 
Mr Ain Raitsakas, Miss Jiali Wen and Miss Susanne Walford in instrumentation lab as 
well as Debbie Leach in chemistry department. Their inspiring teaching and helpful 
suggestions opened me the door to practice researches. I would like to thank all of 
professors in environmental engineering for their help in my two-year studies.
I thank all my friends at Lakehead University for their friendship, moral support 
and technical discussion during the past two years.
Most importantly, however, I want to thank my parents for their patience, 
understanding and encouragement on my graduate studies.
-3  -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Contents
CHAPTER 1 INTRODUCTION.............................................................................................1
CHAPTER 2 PHARMACEUTICALLY ACTIVE COMPOUNDS................................5
2 .1 A  V ariety  of PhA C s ................................................................................................................. 5
2.1.1 Group Pain Relievers, Analgesics, Antiphlogistics, Anti-inflammatories, and
Non-steroidal Drugs..................................................................................................6
2.1.1.1 A nalgesics...................................................................................................................... 6
2.1.1.2 Antiphlogistic Pharmaceuticals...............................................................................7
2.1.1.3 Non-steroidal Anti-inflammatory D ru gs.............................................................. 7
2.1.2 Group C Cardiovascular System ............................................................................. 8
2.1.2.1 Beta B lockers................................................................................................................ 8
2.1.2.2 Lipid-lowering D ru gs.................................................................................................8
2.1.3 Group JAntibiotics ...................................   P
2.1.4 Group N  Nervous System .......................................................................................... 9
2.2 P r o p e r tie s  o f  P h a r m a c e u t ic a ls ....................................................................................... 10
2.2.1 Pain Relievers, Antiphlogistics, Analgesics, Anti-inflammatories, and
Non-steroidal Drugs................................................................................................10
2.2.2 Group P-blockers, Lipid - lowering Agents..........................................................10
2.2.3 Antibiotics.................................................................................................................11
2.2.4 Antidepressants........................................................................................................ 12
2.3 PhA C s Consum ption  by  Hu m a n .........................................................................................13
2.3.1 Non-steroidal Anti-inflammatory Drugs (NSAlDs)...........................................15
4 -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
2.3.2 Betablockers and Lipid Regulators...............................................   15
2.3.3 Antibiotics................................................................................................................. 16
2.3.4 Antiepileptics.............................................................................................................17
2.4 V eterinary U se of PhAC s and  Food A d d it iv e s .........................................................18
CHAPTER 3 FATE OF PHARMACEUTICALLY ACTIVE COMPOUNDS IN
THE ENVIRONMENT..........................................................................   20
3.1 Exposure Ro u t e s ..................................................................................................................... 20
3.1.1 Fate before Entering the Environment................................................................. 20
3.1.2 Environmental Fate o f  PhACs............................................................................... 22
3.2 Occurrence of PhA C s in Wastewater Treatment Plant  Effluents.............. 24
3.2.1 Occurrence o f  Antiphlogistics in STP Effluents................................................... 31
3.2.2 Occurrence o f  Betablockers and Lipid-Lowing Agents in STP Effluents 31
3.2.3 Occurrence o f  Antibiotics in STP Effluents..........................................................32
3.2.4 Occurrence o f  Carbamazepine in STP Effluents................................................. 33
3.3 Occurrence of PhA C s in Surface Wa t e r .................................................................... 33
3.3.1 Trace o f  Pain Killers in Rivers or Lakes............................................................... 34
3.3.2 Trail o f  Cardiovascular Drugs in Surface Water................................................ 34
3.3.3 Occurrence o f  Antibiotics and Antiepieptics in Surface Water...........................35
3.4 Occurrence of PhA C s in Groundw ater ...................................................................... 35
3.4.1 Anti-inflammatories and Lipid-lowering Drugs................. ................................36
3.4.2 Antibiotics................................................................................................................. 36
3.5 O c c u r r e n c e  o f  PhA C s in T r e a te d  D rink ing  W a te r ................................................ 37
3.5.1 Antiphlogistics........................................................................................................37
-5  -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3.5.2 Others.......................................................................................................................38
CHAPTER 4 EFFECT OF RESIDUAL PHARMACEUTICALLY ACTIVE 
COMPOUNDS ON THE ENVIRONMENT..............................................39
4.1 E f f e c t s  o f  N S A ID s o n  t h e  A q u a t ic  E n v ir o n m e n t ............................................... 39
4.2 E f f e c t s  o f  B e t a b l o c k e r s  f o r  A q u a t ic  O r g a n i s m s .......................................................39
4.3 S id e  E f f e c t  o f  A n t ib io t ic s  o n  t h e  E n v ir o n m e n t ............................................................. 40
4.3.1 Toxicity o f  Antibiotics............................................................................................. 40
4.3.2 Promotion o f  Antibiotic Resistance........................................................................41
4.3.3 Genotoxic Effects o f  Antibiotics............................................................................. 42
CHAPTER 5 TREATMENT TECHNOLOGIES FOR REMOVING 
PHARMARCEUTICALLY ACTIVE COMPOUNDS IN WATER 
AND W ASTEW ATER....................................................................................44
5.1 W a s t e w a t e r  T e c h n o l o g y ..............................................................................................................44
5.1.1 Conventional Municipal Treatment System ..........................................................44
5.1.2 Removal Efficiency in Conventional Treatment Systems.................................... 45
5.1.2.1 Primary Treatment........................................................................................... 46
5.1.2.2 Secondary Treatment.......................................................................................46
1) Biological Degradation........................................................................................47
2) Sorption onto Sludge (Excess Sludge Removal)..............................................50
5.1.3 Advanced Treatment Systems..................................................................................52
5.1.3.1 Membrane Bio-Reactors................................................................................. 52
5.1.3.2 Others................................................................................................................. 55
5.2 D r in k in g  W a t e r  T e c h n o l o g y ...................................................................................................... 55
- 6 -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
5.2.1 Conventional Surface Water Treatment System .................................................. 55
5.2.2 Conventional Groundwater Treatment P lant.......................................................56




2) Chlorine Dioxide (CIO2) ......................................................................................62
5.2.4 Advanced Treatment................................................................................................64
5.2.4.1 Ozonation........................................................................................................ .64
5.2.4.2 Advanced Oxidation Processes.......................................................................66
5.2.4.3 Adsorption on Activated Carbon................................................................... 69
5.2.4.4 Membrane Filtration........................................................................................72
1) Microfitration /Ultrafiltration............................................................................. 72
2) Nanofiltration........................................................................................................ 73
3) Reverse Osmosis...................................................................................................75
CHAPTER 6 FREEZE CONCENTRATION....................................................................78
6.1 Freezing of W a t e r ................................................................................................................. 78
6.2 Impurity Separation during  Freezing ........................................................................... 79
6.2.1 Rejection o f  Inorganic Impurities in a Simple Solution.......................................80
6.2.2 Rejection o f  Organic Impurities in a Simple Solution.........................................82
6.2.3 Rejection o f  Impurities in a Complex solution......................................................84
6.3 A pplication of Freeze Concentration in Water and  Wastewater 
Purificatio n ......................................................................................................................................88
7 -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CH A PTER  7 A N A L Y T IC A L  M E T H O D S................................................................................. 96
7.1 Extraction Processes.........................................................................................................97
7.2 Gas Chromatography-M ass Spectrometry (GC-M S)..........................................99
7.2.1 Description................................................................................................................99
7.2.2 Application in Detecting PhACs.......................................................................... 100
7.3 H igh Performance Liquid Chromatography (HPLC)......................................... I06
CHAPTER 8 MATERIALS AND METHODS.................................................................I ll
8.1 M a te r ia l s ............................................................................................................................... i n
8.1.1 Drugs Selectedfor Experimentation....................................................................I l l
8.1.2 Water Sample Preparation...................................................................................113
8.2 Sample An a l y sis .................................................................................................................. 113
8.2.1 pH ............................................................................................................................. 113
8.2.2 Conductivity............................................................................................................114
8.2.3 Total Organic Carbon............................................................................................114
8.2.4 Gas Chromatography-Mass Spectrometry.........................................................114
8.2.4.1 Sample Preparation.......................................................................................115
1) Solid phase extraction................................................................................................. 116
2) Derivatization..................................................................................................... 116
3) GC-MS Operation...............................................................................................117
8.3 Experimental Procedures (Unidirectional D ownward  Freezing) ...........11?
CHAPTER 9 RESULTS AND DISCUSSIONS................................................................120
9.1 GC-MS Re su l t s ................................................................................................................... 120
-8
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9.1.1 Acetylsalicylic Acid Responses o f  GC-MS..........................................................120
9.1.2 Ibuprofen Responses o f  GC-MS........................................................................... 124
9.1.3 Gemfibrozil Responses o f  GC-M S.......................................................................129
9.1.4 Detection Limits o f  GC-MS...................................................................................134
9.2 Freeze Concentration Results................................................................................. I40
9.2.1 Ibuprofen................................................................................................................. 140
9.2.1.1 Single-stage Freezing of Ibuprofen............................................................. 141
1) Effect o f Initial Drug Concentration in Feed Water on Impurity Removal on 
Single-Stage Freezing............................................................................................ 141
2) Effect o f Freezing Temperature on Ibuprofen single-stage Freeze 
Concentration...........................................................................................................147
9.2.1.2 Second-Stage Freeze Concentration of Ibuprofen..................................... 149
1) Effect o f Initial Drug Concentration in Feed Water on Impurity Removal on 
Second-Stage Freezing........................................................................................... 149
2) Freezing Temperature Effect on Second-Stage Freeze Concentration 152
9.2.2 Gemfibrozil.............................................................................................................153
9.2.2.1 Effect of Initial Drug Concentration in Feed Water on Impurity Removal 
on Single-stage Freeze Concentration............................................................153
9.2.2.2 Effect o f Initial Drug Concentration in Feed Water on Impurity Removal 
on Second-Stage Freeze Concentration.........................................................156
9.2.3 Comparison o f  Ibuprofen and Gemfibrozil.........................................................157
9.2.3.1 Single Stage Freeze Concentration.............................................................. 157
9.2.3.2 Two Stages Freeze Concentration............................................................... 158
9 -
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
9.2.4 Association o f  Drug Concentration with Total Organic Carbon (TOC) 159
9.2.4.1 Drug Concentration versus TO C ..................................................................160
9.2.4.2 TOC of Frozen Ibuprofen, Gemfibrozil and Mixed Drugs....................... 162
CHAPTER 10 SUMMARY AND CONCLUSIONS........................................................170
REFERENCES......................................................................................................................... 172
- 10-
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List of Figures
Figure 2-1 Schematic structure of sulfonamides and quinolones...................................... 17
Figure 3-1 Two phase o f drug metabolism; all drugs under go both phases; conjugation
reactions can be reversed (Kujawa-Roeleveld et al., 2006).........................21
Figure 3-2 Metabolism of pharmaceutical compounds; Solid lines transformation into a
more water soluble compound; Dotted lines indicate a reactivation o f the 
phase 11 metabolites into a less water soluble compound.
(Halling-Sorsensen et al., 1998).....................................................................  21
Figure 3-3 Scheme for the main fates of pharmaceuticals in the environment after
application (STP: sewage treatment plant) (Temes, 1998)..........................23
Figure 5-1 A flow scheme of conventional municipal treatment systems....................... 44
Figure 5-2 Absorption and adsorption mechanisms of PhACs on the sludge (Tonalide;
personal care products, a synthetic polycyclic musk; Norfloxancin:
abtibiotic) (Kujawa-Roeleveld et al., 2007)...................................................51
Figure 5-3 Typical schematic for membrane bioreactor systems......................................52
Figure 5-4 Schematic flow diagram of conventional surface water treatment plant in
North America....................................................................................................56
Figure 5-5 Schematic flow diagram of conventional groundwater treatment p lan t 57
Figure 5-6 Structures o f the P-blockers studied by Pinksron and Sedlak (2004)............60
Figure 5-7 Reactions between propranalol and chlorine....................................................60
Figure 5-8 Chemical structures o f reactive PhACs and sites of proposed C102 attack.
(Huber et al., 2005)...........................................................................................63
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 6-1 Relationship between solubility and efficiency o f freeze concentration. The
numbers in the graph represent ten different dyes (Yang et al., 1992)........86
Figure 6-2 Visual comparison of ice cylinder color and clarity (Martel et al., 2002)... 87
Figure 6-3 Two methods for freeze concentration (Miyawaki et ah, 2005)................... 89
Figure 6-4 Freeze concentration/incineration flow diagram (Niro Ltd., 1999)..............93
Figure 7-1 Scheme o f typical GC-MS instruments. (Internet-14, 2007).........................99
Figure 7-2 Examples o f derivatization pathways for GC-MS analysi of NSAIDs.......102
Figure 7-3 Scheme o f typical HPLC instruments (Internet-16, 2007)...........................106
Figure 8-1 Unidirectional downward freezing equipment...............................................118
Figure 9-1 Full-scan chromatogram plot of Ippm A.S.A. standard.............................. 121
Figure 9-2 Derivatization o f A.S.A.....................................................................................121
Figure 9-3 Chromatogram plots of typical A.S.A. external calibration standards and
unfrozen liquid from two-stage freezing.......................................................122
Figure 9-4 A.S.A standard curves from GC-MS responses.............................................123
Figure 9-5 Full-scan chromatogram plot of Ippm ibuprofen standard.......................... 125
Figure 9-6 Derivatization o f ibuprofen ........................................................................ 125
Figure 9-7 Chromatogram plots o f typical IBP external calibration standards............ 126
Figure 9-8 IBP standard curves from GC-MS responses.................................................126
Figure 9-9 GC-MS responses o f IBP samples.................................................................. 127
Figure 9-10 GC-MS full spectrum of 0.2 ppm GEM external standard......................... 129
Figure 9-11 Derivatization of GEM.....................................................................................130
Figure 9-12 Chromatogram plots o f typical GEM external calibration standards 130
Figure 9-13 Gemfibrozil standard curves from GC-MS responses.................................131
II
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 9-14 GC-MS responses of gemfibrozil feed water and samples after 1st stage
fi-eeze concentration........................................................................................ 132
Figure 9-15 GC-MS responses of gemfibrozil samples after 2nd stage freeze
concentration.................................................................................................... 133
Figure 9-16 Chromatograph plots o f 10 ng/L ibuprofen and gemfibrozil mixed external
standard..............................................................................  135
Figure 9-17 Full spectrum of 20 mg/L ibuprofen and gemfibrozil mixed external
standard.............................................................................................................135
Figure 9-18 Chromatograph plots of ca. 250±8.2 ng/L individual ibuprofen and
gemfibrozil as well as two drugs mixed external standards....................... 136
Figure 9-19 Comparison of GC-MS responses for individual ibuprofen, gemfibrozil and 
two drugs mixed standards at the same concentration o f 250±8.2 ng/L.. 137 
Figure 9-20 Response changes for 250 ±3.1 ng/L individual ibuprofen and gemfibrozil 
using fixed GC-MS compared to the old instrument used in the early
studies................................................................................................................ 138
Figure 9-21 Inconsistent GC-MS responses for 10 ng/L individual ibuprofen and
gemfibrozil solutions obtained.......................................................................139
Figure 9-22 A typical SIM spectrum of drug-mixed standard added 10 ppm 2,3-D... 140
Figure 9-23 pH change in unfrozen liquid after single-stage freeze concentration for
different ibuprofen concentrations in feed w ater........................................ 141
Figure 9-24 Comparison of pH between blank and ibuprofen feed water......................142
Figure 9-25 Comparison of conductivity between blank and ibuprofen feed water.... 143
111
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 9-26 Concentration ratio and conductivity ratio against ibuprofen concentrations
in feed water (-7°C)..........................................................................................144
Figure 9-27 CL/ CO after single-stage freezing against ibuprofen concentrations in feed
water (-15°C).................................................................................................   145
Figure 9-28 Effect o f freezing temperature on single-stage freeze concentration of
ibuprofen solution............................................................................................148
Figure 9-29 Effect o f feed water concentration on ibuprofen 2nd-stage freeze
concentration (-7°C).........................................................................................150
Figure 9-30 Effect o f feed water concentration on ibuprofen 2nd-stage freeze
concentration (-15°C)...................................................................................... 151
Figure 9-31 Effect o f freezing temperature on ibuprofen two-stage freeze concentration
............................................................................................................................ 152
Figure 9-32 Comparison o f pH between distilled water and gemfibrozil feed water.. 153
Figure 9-33 Comparison of conductivity between distilled water and gemfibrozil feed
w ater.................................................................................................................. 154
Figure 9-34 Effect o f gemfibrozil concentrations in feed water on 1st stage freeze
concentration (-15°C)...................................................................................... 155
Figure 9-35 Effect o f feed water concentration on gemfibrozil 2nd stage freeze
concentration (-15°C)...................................................................................... 156
Figure 9-36 Comparison o f different drugs in single-stage freezing (-15°C).................157
Figure 9-37 Comparison of different drugs in two stages freezing (-15°C)................... 158
Figure 9-38 Schematic o f two-step cascade freeze concentration of high concentration
drug solution..................................................................................................... 160
IV
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Figure 9-39 TOC vs. drug concentration............................................................................ 161
Figure 9-40 Freeze concentration results o f 4.98 mg/L ibuprofen single solution 163
Figure 9-41 Final products of two stages freeze concentration o f 4.98 mg/L ibuprofen
single solution..................................................................................................164
Figure 9-42 Actual volume changes during ibuprofen freeze concentration experiment
 166
Figure 9-43 Freeze concentration results o f 5.03 mg/L gemfibrozil single solution... 167
Figure 9-44 Final products of two stage freeze concentration of 5.03 mg/L gemfibrozil
single solution..................................................................................................168
V
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
List of Tables
Table 2-1 Main groups of human pharmaceuticals (WHO, 2006).....................................6
Table 2-2 Results o f the closed bottle test (Al-Ahmad et ah, 1999)...............................  11
Table 2-3 Annual consumption (tons) of different classes o f prescribed drugs for
different countries.................................................................................................14
Table 2-4 Annual consumption (kg) of different classes of veterinary drugs in Denmark
and the U.S............................................................................................................18
Table 3-1 Occurrence o f PhACs in the aquatic environment........................................... 26
Table 5-1 Mean removal of selected pharmaceuticals by the MBR and conventional
activated sludge (CAS) processes (Radjenovic et ah, 2007)......................... 53
Table 6-1 Different behavior of various inorganic solutes in a simple solution 81
Table 6-2 Removal efficiency of freeze concentration for different wastewaters (Lorain
et ah, 2000).......................................................................................................... 86
Table 6-3 The differences o f suspension crystallization processes and progressive
freeze concentration (Wynn, 1992).................................................................. 90
Table 6-4 Estimates o f the total operating costs for the various systems at the Asian
plant (Niro Ltd., 1999)........................................................................................94
Table 7-1 LOQ for different matrices (Temes et ah 1998)............................................  102
Table 7-2 LC-based methods used for the quantitative determination of NSAIDs in
water samples (Farré et al. 2007)...................................................................  110
Table 8-1 List of the selected drugs....................................................................................112
Table 9-1 Calculation results o f one ibuprofen freezing ru n ...........................................128
Table 9-2 Calculation results o f one gemfibrozil freezing run ........................................134
VI
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Table 9-3 Concentration ratios of ibuprofen at each freezing stage ..................... 165
Table 9-4 Removal efficiency of freeze concentration to gemfibrozil at each freezing 
stage.................................................................................................................... 169
VII
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 1 INTRODUCTION
In the past few years, there has been a growing concern in the occurrence of 
pharmaceutically active compounds (PhACs) in the aquatic environment (Daughton and 
Temes 1999, Kiimmerer 2001, Heberer et al. 2002 and Snyder et al. 2005). Various 
prescription and non-prescription human and veterinary dmgs such as painkillers, 
antibiotics, antidepressants, lipid regulators have been detected in municipal wastewater 
treatment plant effluent, surface water, groundwater, and in a few isolated cases, in 
drinking water, some at alarmingly high concentrations (Khan and Ongerth 2004, 
EU-POSEIDON 2004 and Sedlak et al. 2005). Although no known human health effects 
have been associated with exposure to drinking water containing trace concentrations of 
dmg residues, there is concrete evidence that these drug residues could cause numerous 
adverse health effects on aquatic life, even at very low concentrations (EU-POSEIDON 
2004 and Nghiem et al. 2006). For example in the case of antibiotics, the possibility of 
inducing resistance in bacterial strains (Hectoen et al 1995, Migiore et al. 1996 and 
Gilliver et al. 1999), which could pass to humans via environmental exposure, is still 
under debate (Pascoe et al. 2003). In addition, the phenomena of pharmaceutical 
bioaccumulation have been found in fish of effluent-dominated stream by Brooks et al. 
(2005). Antidepressants such as the select serotonin reuptake inhibitors fluoxetine and 
setraline and their metabolites norfluoxetine and desmethylsetraline were detected at 
levels greater than 0.1 ng/g in all tissues examined from fish residing in a municipal 
effluent-dominated stream.
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Human-use PhACs enter raw sewage via urine and feces and by improper 
disposal. Because o f their specific properties including high chemical stability, low 
biodegradability, high water solubility, and low sorption coefficients (Zwiener 2007), 
municipal wastewater treatment effluents have been identified as the major source of 
drug residues in surface waters (Temes et al. 2002, Miao 2003, Boyd et al. 2003 and 
Snyder et al. 2005). Additionally, although the concentrations o f veterinary dmg residues, 
found in aquatic environment, are generally in the range from a few nanograms to 
micrograms per liter (Kolpin et al 2002 and Calamari et al. 2003), it is really a 
beyond-neglect inflow into the environment.
In Europe alone, more than 3000 compounds are used as human and veterinary 
pharmaceuticals today (Zuccato et al. 2000) and a wide variety o f new dmgs with 
specific chemical and biological properties but often unknown (eco)toxicological effects 
are produced (Pent et al. 2006) and day by day released in unmatched and increasing 
quantities.
The presence of a number o f PhACs in sewage treatment plant effluents has been 
confirmed in Germany (Temes 1998 and Hirsch et al. 1999), the Netherlands (Belfroid et 
al. 1999), Switzerland (Golet et al. 2001), United Kingdom (Johnson et al. 2001), France, 
Greece, Sweden, Italy (Andreozzi et al. 2003), Spain (Calamari et al. 2004), the United 
States (Huggett et al. 2003 and Yang et al. 2004), Canada (Metcalfe et al. 2003), Brazil 
(Stumpf et al. 1999), and Australia (Braga et al. 2005). Obviously, the current wastewater 
treatment systems can not effectively remove PhACs residues. Also because o f this 
situation, a sea of PhACs like antiphogistics, lipid regulators, neutral dmgs and 
betablockers, antibiotics might be discharged into receiving waters and pollute source
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
water for drinking water supplies. Therefore, more enhanced technologies are crucial for 
the future.
Research on the suitability of wastewater treatment methods for the elimination of 
drug residues has just started, however, numerous uncertain and knowledge gaps persist 
(EU-POSEIDON 2004, Sedlak et al. 2005 and Castiglioni et al. 2006). The potential of 
freeze concentration process for removal of drug residue in wastewater has not been 
investigated.
Objectives o f this study are: 1) to review occurrence o f PhACs in the aquatic 
environment; 2) to summarize analytical methods for detection o f PhACs in aquatic 
environment; 3) to investigate removal efficiency of drug residues by currently treatment 
technologies; 4) to evaluate the potential o f the freeze concentration process for the 
removal of selected PhACs; 5) to examine different factors influencing freeze 
concentration: a) freezing temperature, b) feed water drug concentration, and c) type of 
pharmaceuticals.
Baker (1966, 1967, 1969, 1970) and Halde (1979) reported that the effectiveness 
of the freeze concentration depends on a few of main factors as follow, freezing rate, 
impurity concentration, mixing intensity and ice washing. The freezing rate is important 
because it affects ice crystal growth and the subsequent rejection of impurities. Usually, a 
slow freezing rate is more effective than a fast freezing rate. Mixing is important because 
it sweeps away the accumulation of impurities ahead of the freezing front. For this very 
reason, a solution containing a high concentration of impurities is more difficult to purify 
than the same solution containing a lower concentration of impurities. Ice washing is 
necessary because it can obtain the concentrated liquid from growing ice front surface
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and achieve complete impurities recovery. In this research, all o f experiments were run 
with mixing and with ice washing by distilled water o f constant volume. Because we 
consider the differences in experimental conditions and the nature of detected impurities 
(drug residues) compared to that of literature, this study focuses examining the effects of 
freezing rate (freezing temperature) and impurities concentration (initial concentration of 
drug residues). In addition, we also investigate the effects of type of pharmaceuticals. 
Although the experimental results of Baker (1967) and Yang et al. (1990) indicated the 
non-selectivity of freeze concentration for organic impurities, characteristics of various 
pharmaceuticals are very different and literature (Gross, 1967) showed different behavior 
of impurities during freezing. Therefore, we selected different drugs to examine the 
effects of different types o f pharmaceuticals.
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Chapter 2 PHARMACEUTICALLY ACTIVE 
COMPOUNDS
Pharmaceutically active compounds (PhACs) are a group of compounds 
consisting o f prescription drugs, over-the-counter medications, drugs used exclusively in 
hospital and veterinary drugs (Sedlak et al. 2005). PhACs in the environment are 
introduced primarily through excretion from humans or animals and the subsequent 
transport in sewage (Heberer et al. 2002). A large amount o f pharmaceuticals are 
consumed by both humans and animals. For example, around 3000 different human 
medicines including analgesics and anti-inflammatory pharmaceuticals, contraceptives, 
antibiotics, beta-blockers, lipid regulators, neuroactive compounds and many others are 
used in Europe (Halling-Sorensen et al. 1998). Pharmaceuticals used in veterinary 
medicine include antibiotics, anti-inflammatory drugs and food additives.
2.1 A Variety of PhACs
Pharmaceuticals comprise a broad arrangement o f chemical structures answering 
a wide array o f medical needs. Because different groups have different preferences for 
the foundation of classifications, it is complex to classify pharmaceuticals. Generally, 
pharmaceuticals can be classified in different ways such as method of production, 
pharmaceutical criteria and material used. Pharmaceutical criteria can further be divided 
into three types: chemical group, e.g. alkaloids; pharmacologically, i.e. the way they 
work in the body; and according to their therapeutic uses.
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According to a recent report from WHO (2006), human pharmaceutical 
substances can be classified to fourteen main groups (Table 2-1) based on the Anatomical 
Therapeutic Chemical (ATC) classification of pharmaceuticals. In this literature review, 
we will focus on four groups of them covering various drugs such as pain relievers, 
antiphlogistics, analgesics, anti-inflammatories, non-steroidal drugs, beta blockers, 
lipid-regulator drugs, antibiotics and antiepileptics.
Table 2-1 Main groups o f human pharmaceuticals (WHO, 2006)
NO. ATC group
A Alimentary tract and metabolism
B Blood and blood forming organs
C Cardiovascular system
D Dermatologicals
G Genito urinary system and sex hormones
H Systematic hormonal preparations
J Anti-infectives for systematic use
L Antineoplastic and immunomodulating agents
M Musculo-skeletal system
N Nervous system




2.1.1 Group Pain Relievers, Analgesics, Antiphlogistics, Anti-inflammatories, and 
Non-steroidal Drugs
2.1.1.1 Analgesics
An analgesic (colloquially known as a painkiller) is any member of the diverse 
group of drugs used to relieve pain and to achieve analgesia. Analgesic drugs include 
paracetamol (acetaminophen), the nonsteroidal anti-inflammatory drugs (NSAIDs) such
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
as the salicylates, narcotic drugs such as morphine, synthetic drugs with narcotic 
properties such as tramadol, and various others. Some other classes o f drugs not normally 
considered analgesics are used to treat neuropathic pain syndromes; these include 
tricyclic antidepressants and anticonvulsants (Internet-1 2007 ).
2.1.1.2 Antiphlogistic Pharmaceuticals
Antiphlogistic drugs and pain killers are agents, which are applied in medical 
therapy for relieving pains, fevers and against inflammatory caused by various diseases. 
They are substances used in many non-prescription drugs in the primary health sector 
(lnteraet-2 2007).
2.1.1.3 Non-steroidal Anti-inflammatory Drugs
Non-steroidal anti-inflammatory drugs, usually abbreviated as NSAlDs, are drugs 
with analgesic, antipyretic and anti-inflammatory effects - they reduce pain, fever and 
inflammation. The term "nonsteroidal" is used to distinguish these drugs from steroids, 
which (amongst a broad range o f other effects) have a similar eicosanoid-depressing, 
anti-inflammatory action. NSAlDs are sometimes also referred to as non-steroidal 
anti-inflammatory agents/analgesics (NSAlAs). The most prominent members o f this 
group of drugs are aspirin and ibuprofen. Paracetamol (acetaminophen) has negligible 
anti-inflammatory activity, and is strictly speaking not an NSAID. Beginning in 1829, 
with the isolation of salicylic acid from the folk remedy willow bark, N S A lD s  have 
become an important part o f the pharmaceutical treatment o f pain (at low doses) and 
inflammation (at higher doses). Part of the popularity of NSAlDs is that, unlike opioids, 
they do not produce sedation, respiratory depression, or addiction. NSAlDs, however, are
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not without their own problems. Certain NSAlDs, including ibuprofen and aspirin, have 
become accepted as relatively safe and are available over-the-counter without 
prescription (Internet-3 2007).
2.1.2 Group C Cardiovascular System
2.1.2.1 Beta Blockers
Beta blockers (P-blockers) are a class of drugs used in the highest quantities 
within ATC group C used for various indications, but particularly for the management of 
cardiac arrhythmias and cardioprotection after myocardial infarction. Beta blockers are 
pharmaceuticals designed to block the p,-receptor from stimulating the higher heart rate 
and the cardiac output in humans with mainly cardiovascular diseases, like hypertension 
and angina pectoris, but also some other diseases like migraine, thyrotoxicoses and the 
control of tremors. Some beta blockers have a high first pass metabolism, while others 
are excreted unchanged in the urine (lntemet-4 2007). Most of the generic names for beta 
blockers end with "o/o/"(e.g. timolol, esmolol, carteolol, nadolol, propranolol, 
propranolol, betaxolol, penbutolol, metoprolol, acebutolol, atenolol, metoprolol, pindolol, 
bisoprolol).
2.1.2.2 Lipid-lowering Drugs
Lipid-lowering drugs reduce serum cholesterol levels by inhibiting a key enzyme 
involved in the biosynthesis o f cholesterol; examples: l)Resins cholestyramine (Cholybar, 
Questran) colestipol (Colestid); 2) HMG Co A Reductase Inhibitors lovastatin (Mevacor) 
pravastatin (Pravochol) simvastatin (Zocor); 3) Fibric Acid Derivatives gemfibrozil
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(Lobid) clofibrate (Atromid-S); 4) Miscellaneous nicotinic acid (Niacin) probucol 
(Lorelco).
2.1.3 Group J Antibiotics
An antibiotic is a chemical compound that inhibits or abolishes the growth of 
microorganisms, such as bacteria, fungi, or protozoans. The original meaning of 
antibiotic includes any agent with biological activity against living organisms; however, 
the term is commonly used to refer to substances with anti-bacterial, anti-fungal, or 
anti-parasitical activity. The first antibiotic compounds used in modem medicine were 
produced and isolated from living organisms, for example, the penicillin class produced 
by fungi in the genus Pénicillium, or streptomycin from bacteria of the genus 
Streptomyces. With the advent o f organic chemistry many antibiotics are now also 
obtained by chemical synthesis, such as the sulfa drugs. Many antibiotics are relatively 
small molecules with a molecular weight less than 2000 Da (Internet-5, 2007).
2.1.4Group N Nervous System
Sedatives, tranquilizers, depressants, anxiolytics, soporifics, sleeping pills, 
downers, or sedativehypnotics these are different names for substances, which depress 
the central nervous system (CNS), resulting in calmness, relaxation, reduction of anxiety, 
sleepiness, slowed breathing, slurred speech, staggering gait, poor judgment, and slow, 
uncertain reflexes. At high doses or when they are abused, many of these drags can cause 
unconsciousness and death (Intemet-6, 2007). Carbamazepine is a representive of group 
N. It is an anticonvulsant and mood stabilizing drag, used primarily in the treatment of
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
epilepsy and bipolar disorder. It is also used to treat schizophrenia and trigeminal 
neuralgia (Intemet-7, 2007).
2.2 Properties of Pharmaceuticals
Pharmaceuticals are compounds characterised by complex chemical structures. 
Most pharmaceuticals are charged and hydrophilic. Many pharmaceuticals have multiple 
ionisable functional groups. The hydrophobic reactions dominate partitioning neutral 
organic compounds to sediments and suspended solids (limited sorption properties) are 
relatively unimportant for most of the pharmaceuticals. Many pharmaceutical are chiral 
and often administered as racemic mixtures (Williams 2005). Properties of a few 
pharmaceutical groups relevant for their behaviour in environment are given below.
2.2.1 Pain Relievers, Antiphlogistics, Analgesics, Anti-inflammatories, and 
Non-steroidal Drugs
Zwiener and Frimmel (2000) found a high degree of degradation for ibuprofen in 
the oxic biofilm reactor, which was attributed to adaptation of the biofilm to the residue. 
Two metabolites could be identified based on their mass spectra and comparison with 
literature data, viz. hydroxyibuprofen and carboxyibuprofen. Moreover, salicilic acid is 
found to be easily biodegradable.
2.2.2 Group p-blockers, Lipid - lowering Agents
High solubility (metoprolol >1000ppm) or moderate solubility (atenolol, 
propranolol lO-lOOOppm) and low logKow (<3) correspond to a high affinity of
10
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p-blockers to water. The presence of beta blockers in the gaseous compartment is 
neglectable due to its low vapour pressure.
2.2.3 Antibiotics
Al-Ahmad et al. (1999) investigated biodegradability of some clinically important 
antibiotics, Cefotiam, Ciprofloxacin, Meropenem, Penicillin G, and Sulfamethoxazole, in 
the closed bottle test (CBT). These drugs possessed different chemical structures and 
mode o f action (= antibiotic spectra). None of the investigated antibiotics were readily 
biodegradable (Error! Reference source not found.).
Table 2-2 Results o f the closed bottle test (Al-Ahmad et al., 1999)
TpctPn t t' Biodégradation Biodégradation
Test Compound Supplied By i est concentration ^Aer 28 Days After 40 Days
     (%) (%)
Cefotiam dihydrochloride Takeda Pharma GmbH 4.8 7 10
Ciprofloxacin Bayer MG, Lever Kusen 3.5 0 0
Meropenem gm ^^ rün en th al.G m b H  ? ?
P én icilline Zen^a-Grünenthal.OmbH ^7 36
Stolberg
S ' " ' - ' " - » " '  °
Low biodégradation rates were also reported in soils. Adaptation of 
microorganisms was not concluded. Penicillin seems to be easier biodegradable than the 
rest of tested antibiotic compounds. These finding were in agreement with reported poor 
biodegradability in soils. On the other hand this could have been caused by adsorption 
resulting in poor bioavailability. Authors concluded that biodégradation of antibiotics in 
sewage treatment plants (STPs) might not be a reliable expectation for the removal of 
antibiotic substances. The CBT was a screening test using low bacterial density. In tests 
with higher bacterial density (biodégradation tests) or a higher degree of simulating an
11
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
STP, higher biodegradability and nonbiotic elimination processes like adsorption, 
hydrolysis, or partial degradation o f active moieties may take place in a higher extension, 
but not necessarily.
2.2.4 Antidepressants
In a study by Black (2004), three selective serotonin reuptake inhibitors (SSRI’s): 
paroxetine, sertraline and fluvoxamine, were tested for biodegradability using activated 
sludge inoculum from a wastewater treatment plant. No degradation was observed during 
a test period o f 28 days. It was concluded that none of the compounds could be labelled 
readily biodegradable in wastewater treatment plants. Cunningham et al. 2004 found in a 
preliminary biodégradation study with sewage biomass a rapid depletion of paroxetine 
from solution over the first day of the studies followed by no further depletion despite 
culture acclimations and enrichments. In extensive aerobic biodegradability studies no 
depletion of paroxetine was observed in the period after sorption had reached 
equilibrium.
The antidepressants are not volatile from water or they have a very slow rate of 
volatilisation as Henry constants are low, K h < 1.3T0'’ atm m  ̂ -mole'*. They have rather 
little mobility or are immobile in soils and will most likely sorb to soils and sludge. It is 
expected that the compounds tend to bioaccumulate as logKow values are around 3 and 
higher. In a study performed by Brooks et al., 2003, the fluoxetine, sertraline and the 
metabolites norfluoxetine and desmethylsertraline were detected at levels greater than 0.1 
ng/g in all tissues examined from fish residing in a municipal effluent-dominated stream.
12
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2.3 PhACs Consumption by Human
Table 2-3 summarizes the annual consumption of various common-use PhACs in 
different countries. Up to one hundred tons of individual pharmaceuticals were sold in 
Germany, England, Switzerland and Japan and other countries. The consumption pattern 
of pharmaceuticals for the different countries is not identical and some pharmaceuticals 
may be forbidden or replaced by related pharmaceuticals. However, a few 
pharmaceuticals are regularly documented within the most frequently applied range: the 
class o f NSAlDs including acetylsalicylic acid, paracetamol, ibuprofen, naproxen and 
diclofenac, the oral antidiabetic metformin and the antiepileptic carbamazepine. The 
quantity o f each pharmaceutical consumed ranged from several tons to about one 
thousand tons in each country.
Additionally, North Americans have become one of the world’s greatest 
producers and consumers o f pharmaceuticals. In 2005, North America accounted for 47% 
of global pharmaceutical sales (Robinson 2006). The US top 200 prescriptions were 
prescribed more than two billion times within the United States in 2003 (Jjemba 2006). In 
Canada, approximately 9,100 products and 1,870 active ingredients are available on the 
market. Canadians spent more than $18 billion in 2005 alone on pharmaceutical products 
(IMS Health 2005).
It is worthy to say that the number of pharmaceuticals and their availability to the 
general population will continue to increase dramatically with modernization and 
scientific advancement, especially, since many drugs can be purchased without 
prescription. For instance, according to a recent IMS report (IMS Health 2007), in the 12 
month period from 2005 through to December 2006, a 5% growth in drug sales had
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Analgesics, abtuoyretics and anti-inflammatory
Acetylsalicylic acid 902.27(1) 862.60(1) 836.26(1) 78.45(1) 0.21(7) 20.4(9) 403(1) 43.80(3)
Salicylic acid 89.70(12) 76.98(17) 71.67(17) 9.57(11) 5.30(6)
Paracetamol 654.42(2) 641.86(2) 621.65(2) 35.08(2) 0.24(6) 295.9(1) 390.9(1) 95.20(1)
Naproxen 4.63(16) 22.8(7) 35.07(12) 22-33(6) 1.70(12)
Ibuprofen 105(1) 259.85(5) 300.09(5) 344.89(5) 6.7(13) 0.03(19) 14.2(13) 162.2(3) 1.9(15) 17.982(1) 99(4) 25.00(4)
Diclofenac 75(3) 81.79(16) 82.20(14) 85.80(14) 6,14(15) 26.12(16) 3.883(3) 4.50(7)
f}-Blocker
Atenolol 28.98(13) 22.07(4) 3.20(9)
Metorolol 50(4) 67.66(18) 79.15(16) 92.97(11) 2.44(20) 3.20(9)
Antilipidemic
Gemfibrozil 6(8) 20(10) 0.399(18)
Bezafibrate 30(5) 4.47(17) 7.60(8) 0.757(15)
Neuroactive
Carbamazepine 80(2) 86.92(13) 87.71(13) 87.60(12) 6.33(14) 9.97(18) 40.35(8) 107-162(2) 4.40(8)
Diazepam 0.21(8) 0.051(21)
Antiacidic
Ranitidine 85.41(15) 89.29(12) 85.81(13) 33.7(5) 36.32(10) 26.67(3) 1.60(13)
Cimetidine 35.65(11) 0.063(20)
Diuretics





Metformin 368.01(4) 433.46(4) 516.91(3) 26.38(3) 90.9(2) 205.8(2) 51.40(2)
lopromide 64.93(19) 63:26(19) 64.06(19) 6.90(5)
For every country a top 20 sold-list is taken into account. Data in bracket represent the position in the 
“ Temes (1998) '  Sattelberger (1999).
Huschek et al. (2004). '  Stuer-Lauridsen et al. (2000).
‘ Khan and Ongerth (2004).
ranking list within a country.
'  Jones et al. (2002).
® Calamari et al. (2003). 
Tauxe-Wuersch et al. (2005)
' Nakada et al. (2006)
‘ ©IMS Health Incorporated or its affiliates.
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occurred through retail pharmacies in the 13 key markets closing at US$388.28 billion, in 
which North America posted a 7% sales growth at $211.52 billion in sales in the 12 
months to December, 2006; that growth was slightly higher than that of in Europe, which 
has a 3% constant exchange growth (IMS Health 2007).
2.3.1 Non-steroidal Anti-inflammatory Drugs (NSAlDs)
NSAlDs such as acetylsalicylic acid (aspirin) and ibuprofen are an important 
group in pharmaceuticals. Their widespread application in high doses makes up the 
largest tonnage of one group of pharmaceuticals (Daughton and Temes 1999, 
Sattelberger 1999, Huschek et al. 2004, Tauxe-Wuersch et al. 2005 and Nakada et al., 
2006). For example, the sale amount of aspirin constantly lies on top o f the sold-list in 
France as well as in Germany between 1999 and 2001, with annual sales of up to 800 
tons (Buser et al. 1999 and Huschek et al. 2004). Furthermore, from 1998 to 2004, 
paracetamol came forth frequently predominance among all sold parmaceuticals in 
Australia (Temes 1998), England (Jones et al. 2002) and Switzerland (IMS Health 2004), 
of whose consumption are almost beyond hundreds of tons. NSAlDs are even available 
without prescription.
2.3.2 Betablockers and Lipid Regulators
y?-blockers including nadolol, bisoprolol atenolol, metoprolol and propranolol are 
important therapies for the treatment of angina, glaucoma, heart failure, high blood 
pressure and other related conditions, and have been widely employed in cosmopolitan 
sites. Different countries seem to have different predilection for use of /9-blockers, for 
instance, metorolol was employed comprehensively in Germany (Huschek et al. 2004),
15
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
while it seems atenolol was preferred in England (Jones et al. 2002) and Italy (Calamari 
et al. 2003).
Lipid regulators were also consumed largely at tens o f tons yearly deals in 
different countries. Gemfibrozil is a representive of a lipid regulator and was consumed 
20 tons in 1998 by Australian (Khan and Ongerth 2004).
2.3.3 Antibiotics
Sulfonamides and (fluoro)quinolones, among the most powerful antibiotics, are 
nowadays used extensively to treat a wide variety of diseases (Daughton and Temes 1999 
and Sacher et al. 2001). The original antibacterial sulfonamides (sometimes called simply 
sulfa drugs) are synthetic antimicrobial agents that contain the sulfonamide group (Figure 
2-1). The quinolones are a family of broad-spectrum (an antibiotic with activity against a 
wide range of disease-causing bacteria) antibiotics. The parent o f the group is nalidixic 
acid (Figure 2-1). The majority of quinolones in clinical use belong to the subset of 
fluoroquinolones, which have a fluoro group (Figure 2-1) attached the central ring system, 
typically at the 6-position.
Bacteriostatic sulphonamide (sulpha) antibiotics such as sulphamethoxazole, 
sulphathiazole and sulphadiazine etc., are used in the treatment o f infections in livestock 
and to a lesser extend in the treatment of human infection such as bronchitis and urinary 
tract infection. On the other hand, antibiotics belonging to the quinolones, including 
fluoroquinolones, pipemidic acid, ofloxacin, norfloxacin, ciprofloxacin, lomefloxacin, 
enrofloxacin, difloxacin, sarafloxacin, and tosufloxacin, are applied to treat various 
bacterial infections such as bronchitis, gonorrhea, skin infections, and urinary tract 
infections etc. in many different parts of the body. Over 50 million pounds of antibiotics
16
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are produced annually in the US, with approximately 60% for human use and 40% for 
animal agriculture (Levy 1998).
HO
Nalidixic Add
Figure 2-1 Schematic structure of sulfonamides and quinolones
2.3.4 Antiepileptics
For the other low production pharmaceuticals, they are usually prescribed as 
prescription and their consumption depend on the different applied conditions (e.g., 
different countries). For example, the antiepileptic carbamazepine is an established drug 
for the control o f grand mal and psychomotor epilepsy and is also effective in the 
treatment of trigeminal neuralgia. Furthermore, it is used in bipolar depression (Clara et 
al. 2004). In 1997, the consumption of carbamazepine in Austria amounted to 6 tons 
(Sattelberger 1999). However, in Canada, approximately 28 tons of carbamazepine was 
sold as prescriptions in 2001 (IMS Health in Canada 2001).
17
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2.4 Veterinary Use of PhACs and Food Additives
A variety o f pharmaceuticals, including antimicrobial agents, anthelminthics, 
insecticides, vitamins, digestive medicines, and vaccines, have been utilized in animal 
husbandry. Most frequently used are antimicrobial agents, followed by antiparasitic drugs 
consisting of anthelmintics and insecticides.
Table 2-4 Annual consumption (kg) o f different classes of veterinary drugs in Denmark 
and the U.S.
 ̂Halling-Sorensen et al., 1997 




Growth promoters (livestock production pigs)
Single substances 









Virginiamycin 2,590 108 215
Therapeutics applied in livestock production
Antibiotics 49,687
Therapeutics applied in poultry industry
Coccidiostatics 16,165
Antibiotics feed additive 2,491
Fish farms, feed additive
Single substances
Branzil (Trimetoprim Sulfamethizol) 3,356
Oxolinic acid and Inoxyl 208
Oxytetracycline 82
Sulfa contaning substances (therapeutics) 182
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According to the exiguous literature about trade circumstances o f these veterinary 
pharmaceuticals, it is not hard to image a mass o f pharmaceuticals being employed in 
animal husbandry in worldwide medication market. As shown in Table 2-4, every year, 
pharmaceuticals o f a few kilogram to tens o f tons were used in animals as growth 
promoters, therapeutics and feed additive in Denmark (Halling-Sorensen et al. 1997) and 
the U.S. (Sedlak et al. 2005).
19
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Chapter 3 FATE OF PHARMACEUTICALLY ACTIVE 
COMPOUNDS IN THE ENVIRONMENT
3.1 Exposure Routes
There are two stages of drugs enterint the environment. First is the reaction in the 
received and another one is environmental fate o f PhACs. These stages are introduced as 
followed sections.
3.1.1 Fate before Entering the Environment
After applied, all pharmaceuticals will pass through a series of reactions in the 
receiving body before entering the environment. Figure 3-1 and Figure 3-2 show an 
overview of the metabolisation phases of a parent compound. Before being retrieved 
from the body with the urine and exposed to the environment, most pharmaceutical 
compounds such as ibuprofen are metabolized to two phases of metabolites through 
specialized enzymatic systems. Phase I metabolism usually precedes Phase II, though not 
necessarily. During these reactions, polar bodies are either introduced or unmasked, 
which results in (more) polar metabolites of the original chemicals. Phase I reactions 
usually consist o f oxidation, reduction or hydrolysis, and the products are often more 
reactive and sometimes more toxic than the parent drug (Halling-Sorsensen et al. 1998).
20
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Phase I P h a se  II
Conjugation reactions involving 
Addition of functional groups 
(acetyl, sulfate, glucuronic acid, 
glutathione or some aminoacids} 
Increasing polarity and excretability
Introduction of new functional groups 
Or modification/unmasking 
existing functional group 
(oxidation, hydroxylation, reduction, 
hydrolysis)
Figure 3-1 Two phase o f drug metabolism; all drugs under go both phases; conjugation 




Figure 3-2 Metabolism of pharmaceutical compounds; Solid lines transformation into a 
more water soluble compound; Dotted lines indicate a reactivation o f the 
phase II metabolites into a less water soluble compound. (Halling-Sorsensen 
et al., 1998)
If the metabolites of phase I reactions are sufficiently polar, they may be readily 
excreted at this point. However, many phase I products are not eliminated rapidly and 
undergo a subsequent reaction in which an endogenous substrate combines with the 
newly incorporated functional group to form a highly polar conjugate (Kujawa-Roeleveld 
et al. 2006). Phase II reactions involve conjugation (e.g., with glucuronic acid, sulfonates 
(commonly known as sulfation), glutathione or amino acids), which normally results in 
inactive compounds and involve the interactions o f the polar functional groups of phase I
21
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metabolites (Intemet-8, 2007). Both phase I and phase II reactions change the physical 
chemical behavior o f the substance because metabolisation always renders the 
metabolites more water soluble than the parent compounds (Halling-Sorsensen et al. 
1997). For example, Berger et al. (1986) showed that chloramphenicol glucoronide and 
N-4-acetylated sulphadimidine, phase II metabolites, were converted to chloramphenicol 
and sulphadimidine respectively in samples o f liquid manure, and thus reactivated into 
the parent compounds. Therefore, often it is not only the parent compound, which should 
be the subject of a risk assessment but also the main metabolites.
3.1.2 Environmental Fate of PhACs
Due to the increasing consumption of pharmaceuticals in daily life, more parent 
and metabolized drugs will enter the environment via the municipal sewage systems at 
the end o f their application cycles. Although PhACs can enter the environment by many 
routes, municipal wastewater treatment plant effluents have been identified as a main 
source because conventional wastewater treatment system cannot effectively remove 
residual PhACs (McQuillan et al. 2002, Alder et al. 2003, Clara et al. 2004 and 
Castiglioni et al. 2006). Chen et al. (2006) detected a widespread of residual 
pharmaceuticals in wastewater treatment effluents and in the water supply systems in 
Canada.
There are differences between the fates of veterinary and human drugs after urinal 
or fecal excretion. As shown in Figure 3-3, in general, excreted human pharmaceuticals 
can be partly removed since passing through a sewage treatment plant prior to entering 
rivers or streams (surface water). However, the route of veterinary pharmaceutical
22
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products to the environment is predominantly via manure deployed to soils, which 
ultimately results in ground water contamination (Stumpf et al. 1999).
Additionally, after rainfall incidents, abundant human or veterinary 
pharmaceutials can enter surface waters by run-off from fields treated with digested 
sludge or livestock slurries respectively, which can lead to surface water pollution. 
Richardson et al. (1985) suggested industrial wastewater may be another possible source 
for the contamination o f surface waters, but are surely not responsible for their ubiquitous
occurrence.
Human drugs Veterinary drugs 
Feed additives
excretion disposai excretion
—  (run-off) (liquid) manurewastesewage
(leakages)
Landfill site
STP (digested sludge)' soil
Surface water Ground water
Drinking w a te T ^
Figure 3-3 Scheme for the main fates of pharmaceuticals in the environment after 
application (STP: sewage treatment plant) (Temes, 1998)
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The application of digested sludge from municipal sewage treatment plants on 
agricultural areas possibly causes the contamination o f soils and ground water. Transport 
to groundwater is of relevance for all compounds with low sorption efficiency and high 
water solubility. Furthermore, groundwater can be affected by bankfiltration or artificial 
recharge of loaded surface waters, by leaks from sewer systems in urban areas, and, 
occasionally, by residues from production (Hall and Medmenham 1992). Holm et al. 
(1995) also found that drugs disposed together with domestic waste can reach landfill 
sites which could lead to ground water contamination by leaching.
Medicinal residues derived from human application have a unique pathway for 
the contamination of soils and ground water that may be the disposal of raw sewage or 
STP effluents by spray and board irrigation in agricultural areas. Veterinary 
pharmaceuticals used in animal feeding operations may be released to the environment 
with animal wastes through overflow or leakage from storage structures or land 
application (Kolpin et al. 2002).
3.2 Occurrence of PhACs in Wastewater Treatment Plant Effluents
As discussed in section 3.1, the majority of pharmaceutical compounds after 
ingestion and subsequent excretion, in the form of the original compound or as 
metabolites with STP effluents, enter aquatic systems. Moreover, many of the conjugates 
of PhACs can be converted back into active parent compounds by enzymes present in 
wastewater (Rodriguez et al. 2003 and Sedlak et al. 2005). The high application and the 
high levels of excretion of intact drugs as well as their persistence against biodégradation 
are the major reasons for PhACs’ occurrence in the environment (Van der Heide and 
Hueck-Van der Plas 1984, Richardson and Bowron 1985).
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Table 3-1 gives an overview of published literatures describing occurrences of 
residue PhACs in the aquatic environment. About 30 initial commom-use 
pharmaceuticals have been alphabetically listed in the table. These PhACs include 
NSAlDs, P-blockers, hormones and antibiotics, and all those commonly employed in 
human therapy and animal husbandry. The first column gives the name of PhACs or 
residues and the corresponding therapeutic types are shown in the second column. The 
concentrations o f observed PhACs in the aquatic environment and sampling sites are 
illustrated in columns 3 and 4, respectively. The final column supplies the matching 
authors and issued date to each pharmaceutical. According to the table, most PhACs were 
detected in pg/L-level in sewage, for example, the concentrations of ibuprofen was found 
up to 20 pg/L and 4 pg/L, respectively, in STP influents and effluents in Finland. In 
contrast to wastewater or treated wastewater, the concentrations o f residue PhACs ranged 
at the ng/L-level in surface water and ground water. The literature on aspect of the 
occurrence o f veterinary drug residues is limited, only two data have been found, 
therefore, veterinary drugs will not be further the subject of this study.
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Table 3-1 Occurrence o f PhACs in the aquatic environment
PhACs Therapeutic use Concentration detected 
in the aquatic environment Source or receiving body Reference
Human Therapy
Aspirin Analgesic (Pain killer) ~ lp g /L STP effluents Richardson and Bowron, 1985
<150-15 lOng/L Effluent from sedimentation tank Stumpf et al., 1996
500-3000ng/L STP influents in Tokyo Nakada et al., 2006
50-200 ng/L Secondary effluents
Atenolol p-B locker 190 ng/L STP effluents in Italy Castiglioni et al., 2005
30ng/L STP influents in Sweden Bendz et al., 2005
160ng/L STP effluents in Sweden
160-1100 ng/L STP effluents in Canada Nikolai et al., 2006
Bleom ycin Antinoplastic agent 11-19 ng/L STP effluent (radioimmunno assay) Aheme et al., 1990
<5-17 ng/L River water
5-13 ng/L Potable water
Caffeine Psychomotor stimulants ~  1 Pg/L STP effluents Richardson and Bowron, 1985
> 1 pg/L Potable water
16-292 pg/L STP effluents Rogers et al., 1986
1.7-8.1 pg/L STP effluents in Western Canada Verenitch et al., 2006
29-53 ng/L River water
Carbamazepine Antiepileptic 0.25pg/L River and stream water in German Temes, 1998
2.1 pg/L STP effluents in German Temes, 1998
< 900ng/L Groundwater in German Sacher et al., 2001
1.7 pg/L STP effluents in Calgary, Canada Metcalfe et al., 2002
0.7 pg/L STP effluents in Canada Metcalfe et al., 2003
Ciprofloxacin Antibiotic 118 ng/L STP effluents in Canada Chen et al., 2006
850-2000ng/L Hospital effluents in N ew  M exico Brown et al., 2006
200-1000ng/L STP effluents in N ew  M exico
Clofibrate Liquid lowering agent ~  40 ng/L River water Richardson and Bowron, 1985
Clofibric acid < 0 .5 -1750  ng/L River water Berlin Heberer, 1995
< 0.5-220 ng/L River water Europe
< 5 -1 8 0  ng/L River water Stumpf et al., 1996
<50-1560 ng/L Effluent from sedimentation tank
< 20 ng/L River water Stumpf et al., 1999
<25 ng/L STP effluents in U.S. Drewes et al., 2002
50 ng/L Surface water o f  lake Wannsee Heberer et al., 2002

































Table 3.1 (Continued) Occurrence of PhACs in the aquatic environment
PhACs Therapeutic use Concentration
In the aquatic environment Source or receiving body Reference
Cyclophosphamide Antinoplastic agent 146ng/L Treated hospital effluent from STP Steger-Hartmarm et al., 1996
(chemotherapy) (Estimated 1-lOpg/L)
Dextropropoxyphene Analgesic agent ~1 pg/L River water Richardson and Bowron, 1985
Diazepam Anxiolytic agent <1 pg/L STP effluents Waggott, 1981
-1 0  ng/L River water
-1 0  ng/L Potable water
Diclorfenac Analgesic agent Up to 2 pg/L Effluent from sedimentation tank Stumpf et al., 1996
15-304 ng/L River Rhine
38-489 ng/L Different rivers
<590ng/L Groundwater in German Sacher et al., 2001
15-80 ng/L STP effluents in U.S. Drewes et al., 2002
50 ng/L Surface water o f  lake Wannsee Heberer et al., 2002
<20-568 ng/L STP downstream river water in U. K. Ashton et al., 2004
0.68-5.45pg/L STP effluents in Sweden Bendz et al., 2005
<10-200 ng/L STP effluents in U.S. Sedlak et al., 2005
32-448 ng/L STP effluents in Western Canada Verenitch et al., 2006
Erythromycin Antibiotic -Ip g /L River water Watts et al., 1983
<50-366 ng/L STP downstream rivers water in U. K. Ashton et al., 2004
4.5-15.9 ng/L River water Zuccato et al., 2005
Estrogen Hormone Measurable concentration Treated sewage water for irrigation Shore et al., 1992
0.2 -0.5 nmol/L Raw sewage water, Tei Aviv, Israel Shore et al., 1993
Estrogen/estradiol and Hormones 10 pmol/day Daily excreate with urine from Fostis, 1987
estrone pregnant women
10-500 ng/L STP influents in Tokyo Nakada et al., 2006
<1-100 ng/L STP secondary effluents
Ethinylestradiol Hormone < 0.2 ng/L Surface water Kalbfus, 1995
0.3-0.6 ng/L Effluent from sedimentation tank
2-15 ng/L River water Ahem e and Briggs, 1989
1-3 ng/L Reservoir
< 5 ng/L Drinking water
Gemfibrozil Lipid regulator <10-1235 ng/L STP effluents in U.S. Drewes et al., 2002
<10- 4600 ng/L STP effluents in U.S. Sedlak et al., 2005
0.84-4.76pg/L STP effluents in Sweden Bendz et al., 2005




































In the aquatic environment Source or receiving body
Reference
80-478 ng/L STP effluents in Canada Verenitch et al., 2006
13.7 ng/L Surface water in Canada Lissemore et al., 2006
23ng/L Surface water in Canada Chen et al., 2006
Ibuprofen Analgesic agent Up to I2pg/L Effluent sedimentation tank Stumpf et al., 1996
< 5-41 ng/L River Rhine
17-139 ng/L Different river water samples
1.5-7.8 ng/L River or lake water Buser et al., 1999
1-5 pg/L STP effluents in Switzerland
5-3380 ng/L STP effluents in U.S. Drewes et al., 2002
<10-2300 ng/L STP effluents in U.S. Sedlak et al., 2005
<0.02-5 pg/L STP downstream rivers water in U. K. Ashton et al., 2004
9.7-19.7 pg/L STP influents in Finland Lindqvist et al., 2005
<3.9pg/L STP effluents in Finland
0.05-7.11 pg/L STP effluents in Sweden Bendz et al., 2005
1-4.6 pg/L STP effluents in Switzerland Tauxe-Wuersch et al., 2005
2.2-6.7pg/L STP effluents in Western Canada Verenitch et al., 2006
< 24.6pg/L STP effluents in Canada M etcalfe et al., 2003
Ifosfamide Antinoplastic agent 24 ng/L Treated hospital effluent from SPT Steger-Hartmann et al., 1996
(chemotherapy) (estimated 1-10  ng/L)
Indometacin Analgetic agent <5-26 ng/L River Rhine Stumpf et al., 1996
17-121 ng/L Different rivers
Methaqualone Hypnotics -  Ipg/L STP effluents Richardson and Bowron, 1985
Methotrexate Antinoplastic agent -  Ipg/L STP effluents Ahem e and English, 1985
(chemotherapy) <6.25 ng/L River water
<6.25 ng/L Potable water
Metoprolol Beta-blocker 730 ng/L STP effluents in Germany Tem es, 1998
<10-160 ng/L STP effluents in U.S. Sedlak et al., 2005
160ng/L STP influents in Sweden Bendz et al., 2005
190 ng/L STP effluents in Sweden
170-520 ng/L STP effluents in Canada Nikolai et al., 2006
Morphinan structure Narcotic analgesic < 1 pg/L River water Richardson and Bowron, 1985
Naproxen Analgesic, 16-292pg/L STP effluents Rogers et al., 1986
anti-inflammitory 70 ng/L River and stream water in German Tem es, 1998

































Table 3.1 (Continued) Occurrence of PhACs in the aquatic environment
PhACs Therapeutic use Concentration
In the aquatic environment Source or receiving body Reference
< 3 3 .9  pg/L STP effluents in Canada Metcalfe et al., 2003
-1 0 0  ng/L STP effluent in German Temes et al., 2003
100-3200 ng/L STP effluents in U.S. Sedlak et al., 2005
<6.8pg/L STP effluents in Canada Lishman et al., 2006
Norethisterone Hormone 8-20 ng/L Effluent from sedimentation tank Aheme and Briggs, 1989
< 17 ng/L River water
< 10 ng/L Reservoir
< 10 ng/L Drinking water
Norfloxacin Antibiotic 50ng/L STP effluents in Canada Chen et al., 2006
Oral contraceptive Hormone < 0.2 pg/L River water Aheme and English, 1985
< 0.1 pg/L STP effluents
Ofloxacin Antibiotic 330-5 lOng/L STP effluents in France Andreozzi et al., 2003
290-580ng/L STP effluents in Italy
460 ng/L STP effluents in Greece
94ng/L STP effluents in Canada Chen et al., 2006
4900-35,500ng/L Hospital effluents in N ew  M exico Brown et al., 2006
llO-lOOOng/L STP effluents in N ew  M exico
Penicilloyl groups Antibiotic > 25 ng/L River water Richardson and Bowron, 1985
> 10 ng/L Potable water
Propranolo Beta-blocker 170 ng/L STP effluents in Germany Temes, 1998
30 ng/L STP effluents in U.K. Paxeus et al., 2004
50ng/L STP influents in Sweden Bendz et al., 2005
30ng/L STP effluents in Sweden
60ng/L STP effluents in U.S. Fono and Sedlak, 2005
20-92 ng/L STP effluents in Canada Nikolai et al., 2006
Sulphamethoxazole Antibiotic -  Ipg/L River water Watts et al., 1983
300-1500 STP effluents in Germany Hartig et al., 1999
<410ng/L Groundwater in German Sacher et al., 2001
<50 ng/L STP downstream river water in U. K. Ashton et al., 2004
<30-2000 ng/L STP effluents in U.S. Sedlak et al., 2005
50-90 ng/L STP effluents in Sweden Bendz et al., 2005
243ng/L STP effluents in Canada Chen et al., 2006
400-2 lOOng/L Hospital effluents in N ew  M exico Brown et al., 2006














Table 3.1 (Continued) Occurrence of PhACs in the aquatic environment
PhACs Therapeutic use Concentration
In the aquatic environment
Source or receiving body Reference
310-1000ng/L STP effluents in N ew  M exico
Tetracycline Antibiotic ~  Ipg/L River water Watts et al., 1983
Theophylline Psycomotor stimulant ~  Ipg/L River water Watts et al., 1983
Testosterone Hormone 0.8-1.1 nmol/L Raw sewage water, Tel A viv, Israel Shore et al., 1983
Animal Husbandry
Ivermectin Antiparacitic agent >60% Excreated with feces the 3 first days Chiu et al., 1990
after injection (dose 0.3 mg/kg o f  cattle
body weight)
2% Concentration in urine (see above)
















3.2.1 Occurrence of Antiphlogistics in STP Effluents
Researches in the water industry have had concerns about the occurence of 
PhACs residues in STP effluents since the early 1970’s. Hignite and Azamoff (1977) 
reported loads o f antiphlogistics such as salicylic acid up to 28.7 kg/d in the effluents of 
the municipal sewage treatment plant of Kansas City (USA). Later, Waggott (1981), 
Watts et al. (1983) and Richardson and Bowron (1985) noticed that the same drug was 
present in the aquatic environment at concentrations up to approximately Ipg/L in the 
U.K.
Rogers et al. (1986) identified the two antiphlogistics ibuprofen and naproxen in 
untreated sewage on Iona Island, British Columbia, Canada. Up to now, antiphlogistics 
such as ibuprofen, naproxen, mefenamic and diclofenac, and the rest frequently utilized 
acidic pharmaceuticals are constantly protagonists in alL statements relative to PhACs in 
wastewater (Drewes et al. 2002, Lee et al. 2005, Lindqvist et al. 2005, Tauxe-Wuersch et 
al. 2005, Chen et al. 2006). The concentrations of these anti-inflammatory drugs in 
wastewater fluctuate between ng/L and pg/L, of which naproxen was found to be the 
most abundant compound. In Canada, concentrations o f naproxen and ibuprofen were 
found up to 33.9 pg/L and 24.6 pg/L in STP effluents (Metcalfe et al., 2003).
3.2.2 Occurrence of Betablockers and Lipid-Lowing Agents in STP Effluents
Mean concentrations of ,9-blockers were in the pg/L-range in many wastewater 
treatment plant effluents (Huggett et al. 2003, Paxeus 2004, Fono and Sedlak 2005, 
Castiglioni et al. 2006, Roberts and Thomas 2006, Nikolai et al. 2006). For example, 
metoprolol had concentrations below 2pg/L in different countries like Germany, the U.S.
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and Canada have been reported by several researchers (Temes 1998, Huggett et al. 2003, 
Nikolai et al. 2006). In Europe, atenolol concentrations varied in a wide ng/L range 
(Paxeus 2004, Roberts and Thomas 2006, Nikolai et al. 2006), with median 
concentrations o f 190 ng/L in Italy (Castiglioni et al. 2006). Concentrations of 
propranolol have been kept with the lower median concentrations (20-92 ng/L) in Canada 
(Nikolai et al. 2006) compared to the other two ^-blockers (atenolol and metoprolol) 
obseiwed in the U.S. and the U.K. S IP  effluents {ca. 30ng/L) (Fono and Sedlak 2005 and 
Paxeus 2004) and 170 ng/L in German STP effluents (Ternes 1998).
Lipid regulator gemfibrozil and clofibric acid (a metabolite of the lipid regulator 
clofibrate) occurred in high concentration in wastewater treatment plant effluents 
(Drewes et al. 2002, Lee et al. 2003, Chen et al. 2006). Gemfibrozil was found at 
concentrations around 5pg/L was detected in a STP effluent in Sweden (Bendz et al. 
2005). In addition, Hignite and Azamoff (1977) found clofibric acid of up to 3 kg/d in the 
STP effluents in U.S.
3.2.3 Occurrence of Antibiotics in STP Effluents
Among a variety of pharmaceuticals, antibiotics are o f particular environmental 
concern. The occurrences of antibiotics have been revealed in several European countries, 
such as Switzerland (Golet et al. 2002), France, Italy, Sweden, Greece (Andreozzi et al. 
2003) as well as in Canada (Chen et al. 2006).
Several studies have reported the occurrence of antibiotics with the quinolone 
group in hospital effluents (Guiliani et al. 1996, Guardabassi et al. 1998, Hartmann et al. 
1998, Alder et al., 2003). Brown et al. (2005) found ciprofloxacin and ofloxacin with 
concentrations over hundreds of part per billion (ppb) in hospital effluents and
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wastewater treatment plants in New Mexico. High concentrations o f ofloxacin have been 
found in the effluents from sewage treatment plants in different countries, such as France 
(330-5 lOng/L), Italy (290-580ng/L), Greece (460ng/L) (Andreozzi et al., 2003), and 
Canada (max. 506ng/L) (Chen et al. 2006).
Widespread use o f bacteriostatic sulphonamide (sulpha) antibiotics in factory 
farming without proper withdraw periods led to the accumulation of sulphaonamides in 
wastewater treatment plant influents (Brown et al. 2006, Chen et al. 2006) and futher 
more washed out with wastewater treatment plant effluents due to the incomplete 
elimination during wastewater treatment processes. For instance, sulfamethoxazole was 
detected in the effluents of wastewater treatment plants in Germay (Hartig et al. 1999) 
and Switzerland (Golet et al. 2002) as well as several European countries (Andreozzi et al. 
2003) and Canada (Chen et al. 2006).
3.2.4 Occurrence of Carbamazepine in STP Effluents
Many researchers described the resistance of antiepileptic carbamazepine to 
treatments in the STPs (Metcalfe et al. 2003, Joss et al. 2005, Carballa et al. 2005) thus 
resulted in its frequent occurrence in wastewater treatment plant effluents (Temes 1998, 
Oilers et al. 2001; Heberer 2002, Metcalfe et al., 2003). Also, its concentrations are 
usually up to the pg/L-level in sewage treatment plant effluents.
3.3 Occurrence of PhACs in Surface Water
All concentrations o f PhACs found in sewage treatment plant effluents indicated a 
potential contamination of surface water. Over 80 PhACs have been detected in surface 
waters by investigations carried out in Austria (Hohenblum 2002), Brazil (Stumpf et al.
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1999), Denmark (ENDS 2000), the U.K. (Richardson and Bowron 1985), Germany 
(Temes 1998), Italy (Zuccato et al. 2005), the Netherlands (Mons et al. 2000), Canada, 
Croatia, Greece, Spain, Switzerland and the U.S. (Heberer 2002).
3.3.1 Trace of Pain Killers in Rivers or Lakes
Because o f the sufficiently large applications and the appropriate physicochemical 
properties (i.e. nondegradability, polarity), analgesics have reached detectable 
concentrations in the environment. If  this type of compound is mobile in the aquatic 
environment, they may then become detectable in rivers and lakes in very much the same 
way as other environmental contaminants. An analgesic agent such as ibuprofen, 
diclofenac and naproxen etc. were found in concentrations in excess of O.lpg/L 
distinguished in various lakes or rivers in Switzerland (Buser et al. 1999) and in 18 
Brazilian rivers and streams (Stumpf et al. 1999) as well as in surface waters in the U.S. 
(Boyd et al. 2003). Additionally, Ashton et al. (2004) and Bound and Voulvoulis (2006) 
consistently found ibuprofen at the highest concentrations (up to 3pg/L) in U.K. rivers 
that were downstream to the sewage treatment plant.
3.3.2 Trail of Cardiovascular Drugs in Surface Water
Several studies showed that y9-blockers could be located in surface water and 
indicate incomplete degradability in sewage treatment plants (Stolker et al. 2004, Wiegel 
et al. 2004, Thomas and Hilton 2004, Ashton et al. 2004, Bendz et al. 2005, Fono and 
Sedlak 2005, Castiglioni et al. 2006, Roberts and Thoma 2006). Bendz et al. (2005) 
reported a high degree of persistence of propranolol and metoprolol to biological 
degradation in the aquatic environment.
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The lipid lowering agent clofibric acid and gemfibrozil were detected in rivers, 
lakes, and in the open sea (Buser et al. 1998 and Rabiet et al. 2006). Clofibric acid was 
perceived to have a similar concentration of a hundred-level nanogram per liter in North 
American (Boyd et al. 2003) and in European surface waters (Stan et al. 1994, Stumpf et 
al. 1996, Temes 1998, Daughton and Temes 1999).
3.3.3 Occurrence of Antibiotics and Antiepieptics in Surface Water
Wastewater treatment processes achieve variable and often incomplete removal of 
antibiotics, resulting in the discharge o f antibiotics into surface waters. Watts et al. (1983) 
described the presence of several antibiotics (erythromycin, sulphamethoxazole, 
tetracyclines and theophlline) with mg/L-level concentration in river water samples near 
a fish farm. From 1999 to 2001, tetracyclines and sulfonamides were detected in samples 
from nine sites in the U.S. in concentrations ranging from 70 ng/L to >15pg/L (Lindsey 
et al. 2001).
Antiepieptic carbamazepine displayed its high-ng/L (>100ppb) concentrations in 
surface waters in Germany (Zuehlke et al., 2004) and in northern Italy (Loos et al. 2007).
3.4 Occurrence of PhACs in Groundwater
As discussed in section 3.1.2, groundwater can be contaminated by digested 
sludge from municipal sewage treatment plants and by leaks from sewer systems in urban 
areas and occasionally, residues from production. Owing to their polar stmcture, several 
PhACs are not significantly adsorbed in the subsoils (Heberer 1995; Heberer and Stan, 
1997, Heberer et al. 2001); thus they may reach the groundwaters. Sacher et al. (2001) 
analysed samples from 105 groundwater wells in Baden-Württemberg, Germany and
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located traces o f PhACs including analgesics (phenazone, propyphenazone), p-blockers 
(metoprolol, bisoprolol, sotalol), the antiepileptic carbamazeppine and some antibiotics 
like the sulfonamides sulfamethoxazol in more than one-third o f the samples.
3.4.1 Anti-inflammatories and Lipid-lowering Drugs
Analgesics, like phenazone-type pharmaceuticals, as well as their metabolites 
(Reddersen et al. 2002) and paracetamol (Rabiet et al. 2006) were discovered at 
trace-level concentrations in groundwater samples from Germany and France, 
respectively.
Contamination o f groundwater by clofibric acid (a lipid regulator) was 
investigated in Spain and Germany (Galceran et al. 1989, Stan and Linkerhâger 1994, 
Heberer and Stan 1996). These papers showed that samples, taken from different districts 
of Berlin, all contained clofibric acid with concentration levels ranging up to 165 ng/L.
3.4.2 Antibiotics
Investigations related to antibiotics in the past decade have resulted in 
publications documenting their presence in the groundwater. For example, sulfonamides 
have the potential to enter groimdwater rapidly (Stuer-Laurdsen et al. 2000) and have 
been detected in groundwater in Germany (Sacher et al., 2001), because they are water 
soluble, demonstrate low chelating ability and have a low binding constant for soil 
(Thurman and Lindsey 2000). Studies in the U.S. have identified antibiotics 
(sulfonamides and trimethoprim) in groundwater down-gradient from a landfill 
containing hospital waste (Eckel et al. 1993).
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In addition, tetracylines have been shown to be strong chelators (Blanchflower et 
al. 1997) and sorb to soils strongly (Thurman and Lindsey 2000), therefore, it was 
hypothesized by Lindsey et al. (2001) that although tetracylines might be detected in 
surface water, they may not occur in groundwater. However, Thurman and Hostetler 
(1999) as well as Meyer et al. (2000) tracked tetracylines in groundwater samples 
collected near waste and wastewater lagoons (>1 pg/L,) and liquid hog lagoon samples (5 
to 700pg/L), respectively.
3.5 Occurrence of PhACs in Treated Drinking Water
Because of the difficulties associated with measuring trace concentrations of 
PhACs, it is extremely difficult to detect PhACs in most water supplies. Nevertheless, 
concentrations o f PhACs in the range of several hundreds of ng/L have been reported in 
the drinking water of several large European cities. These cities include Berlin (Heberer 
and Stan 1997, Heberer et al. 1998, Heberer 2002 and Redderson et al. 2002), Prague 
(Mdller et al. 2002), or Milano (Zuccato et al. 2000). Additionally, trace-concmtration 
PhACs were also found in treated drinking water of Southern California, U.S. (Loraine 
and Pettigrove 2006).
3.5.1 Antiphlogistics
Reddersen et al. (2002) detected NSAIDs such as phenazone (400ng/L) and 
propiphenazone (120ng/L) in drinking water. Although the concentrations of phenazone 
and propiphenazone in drinking water seem harmless to human health over a lifetime 
consumption o f drinking water according to the recommended concentration level 3pg/L 
by the German Federal Environmental Protection Agency (Reddersen et al. 2002), other
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data are needed to prove the potential human health risk due to increasing PhACs 
residues in aquatic environment. Loraine and Pettigrove (2006) conducted an 
investigation about the occurrence of thirteen polar PhACs in finished drinking water in 
Southern California, and found ibuprofen and its metabolite at low-pg/L levels.
3.5.2 Others
Anitiotic sulfonamides have been detected in Berlin drinking water wells for 
which almost all o f the groundwater was bank-filtered surface water (Hartig and Jekel
2001), and in water supply wells in a Nebraska bank filtration site (Heberer et al. 2001).
From 1992 to 1994, Heberer and Stan (1999) found clofibric acid in Berlin tap 
water at a concentration of 270 ng/L. Later, Heberer et al. (2002) reported discovery o f 
carbamazepine and primidone at concentrations as high as lOOng/L in the water-supply 
wells in Berlin.
In 2004, antiepileptic carbamazepine at a high concentration of 258ng/L was 
found in finished water in the U.S. by Stackelberg et al. (2004) using high performance 
liquid chromatography-mass spectrometry (HPLC-MS).
Based on discussions in this chapter, it has been known that through two stages, 
reactions in received bodies and environmental fate, the occurrence o f PhACs in water 
systems presented in high concentration ranges from hundreds of nanogram per liter to a 
few of microgram per liter. What effects on the environment have these drug residues of 
high concentrations? This topic will be introduced as the followed chapter.
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Chapter 4 EFFECT OF RESIDUAL 
PHARMACEUTICALLY ACTIVE COMPOUNDS ON 
THE ENVIRONMENT
With the increasing concentration of residual pharmaceuticals in water, scientists 
are beginning to realize that the health of aquatic organisms might be adversely affected 
(Sonnenschein and Soto 1998, Stumpter 1998) if they were continually exposed to 
residual pharmaceuticals became most of pharmaceutical are biologically active.
4.1 Effects of NSAIDs on the Aquatic Environment
The anti-fungal activity o f ibuprofen was found to be enhanced with lowered pH, 
especially at values below pH 7 by Sanyal et al. (1993) as well as Elvers and Wright 
(1995). They also pointed out Staphylococcus aureus (a spherical bacterium frequently 
living on the skin or in the nose of a healthy a living beings) was susceptible to ibuprofen 
when its concentrations were greater then 150 pg/mL at initial pH 7. When pH decreased 
to 6, Staphylococcus aureus was significantly prevented growth.
4.2 Effects of Betablockers for Aquatic Organisms
Ecotoxicological studies show that aquatic organisms are sensitive to P-blockers 
(Huggett et al. 2002, Villegas-Navarro et al. 2003, Ferrari et al. 2004, Fent et al. 2006). 
Escher et al. (2005, 2006) demonstrated that most P-blockers had a specific toxicity 
towards green algae (JDesmodesmus subspicatus).
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For most mammals including human beings, p-receptors are located in many 
peripheral regions including the heart and lungs. In the heart, P-receptor blockade causes 
a decrease in heart rate and contractile strength (Insel 1991).
4.3 Side Effect of Antibiotics on the Environment
Intensive use of antibiotics in human and veterinary medicine and in industrial 
farming (food additives) has led to a significant increase in antimicrobial resistance, with 
important consequences on public health (Hartmann et al. 1998, ASM 2002). Just due to 
such diversified influences as disruption of aquatic ecology, promotion of antibiotic 
resistance and potential genotoxicity, antibiotics have exceptional concerns from water 
reaseachers compared to other PhACs in the environment (Daughton and Temes 1999).
4.3.1 Toxicity of Antibiotics
The immediate concern o f antibiotics is the potential toxicity o f these compounds 
to aquatic organisms and humans through drinking water (ASM 2002). Harrass et al. 
(1985) reported that growth of six blue-green algae species were prevented by 
streptomycin (the first antibiotic remedy for tuberculosis) at concentrations level of 0.09 
to 0.86 mg/L. Additionally, a motile single celled green algae {Chlamydomonas 
reinhardtii) growth was prevented at streptomycin concentrations of 0.66 mg/L. Algae 
growth in sub-lethal concentrations of streptomycin was slowed or delayed, and the 
maximum density attained by several species was decreased.
Macri et al. (1988) and Migliore et al. (1997) showed that the acute toxicity of 
several agricultural antibiotics to daphnia magna (the most popular live food for 
aquarium fishes) or artemia salina (a brine shrimp), for example, furazolidone, an
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antibiotic largely used in medicated fish feed, has significant toxicity on daphnia magna 
and the mosquito {culex pipiens) larvae. In this regard, recent work by Golet et al. (2002) 
used acute ecotoxicity data to develop a risk assessment for total fluoroquinolone 
concentrations in wastewater treatment plants for Pseudomonas putida, a common 
wastewater treatment plant bacterium, and in surface water with regard to fish, daphnia, 
and algae. The predicted no-effect concentration (PNEC) of total fluoroquinolones for 
wastewater treatment plant organisms was found to be 8 pg/L while the PNEC for surface 
water species was 3 pg/L.
4.3.2 Promotion of Antibiotic Resistance
There is growing concern that releases of antibiotics to the environment 
contribute to the emergence of strains of disease-causing bacteria that are resistant to 
even higher doses of these drugs and makes treatment of infections more difficult (ASM
2002). Leff et al. (1993) detected resistance to kanamycin (an aminoglycoside antibiotic 
used to treat a wide variety of infections) and neomycin (an aminoglycoside antibiotic 
used topically in the treatment of skin and mucous membrane infections, wounds, and 
bums) in the bacterial assemblage of a coastal plain stream of South Carolina in U.S. by 
growth of colonies on media containing antibiotics. Attrassi et al. (1993) reported that 
resistance of bacterial flora to some antibiotics from water and mussels sampled at three 
marine sites located in Morocco, especially, resistance to penicillin and ampicillin, two 
P-lactam antibiotics used in the treatment of bacterial infections. Guardabassi et al. (1998) 
foimd that sewers downstream from a hospital displayed an increased prevalence of 
bacteria resistant to oxytetracycline (a tetracycline used to treat many infections common 
and rare), while sewers downstream from a pharmaceutical plant showed an increased
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prevalence o f bacteria resistant to multiple drugs, including sulfamethoxazole. These 
results lend credence to the concern that antibiotic-resistant bacteria might develop from 
long-term environmental exposure to relatively low concentrations of antibiotics (Brown 
et al. 2005).
4.3.3 Genotoxic Effects of Antibiotics
Genotoxic substances are often mutagenic and carcinogenic, and are therefore, 
potentially suspect in the development of antibiotic-resistant organisms. Giuliana et al. 
(1994 and 1996) showed genotoxic activity in 13% of the 800 analyzed unconcentrated 
wastewater samples from a hospital. Fluoroquinolone antibiotics exhibited genotoxic 
effects for the genetically modified bacterial strain. Salmonella typhimurium, at 
concentrations as low as 5pg/L for norfloxacin and 25pg/L for ciprofloxacin (Hartmann 
et al. 1998).
It should be pointed out that although the concentration of these drug residues 
mentioned above in the aquatic environment is too low to pose an acute risk in an 
individual manner, it is unknown whether the combination of drugs that share a common 
mechanism of action can exhibit synergistic effects (Tyler et al. 1998). Due to that 
possibility, the last two decades have witnessed extensive efforts to identify the 
occurrence, fate and effects o f pharmaceuticals in water analysis as discussed in 
Chapter3.
As discussions above, although no know human health effects have been 
associated with exposure to drinking water containing trace concentrations of drug 
residues; there is concrete evidence that these residual drugs could cause numerous 
adverse health effects on aquatic life, even at very low concentrations. Therefore, it is
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necessary to pay attention on the behaviors of PhACs in wastewater/water treatment 
processes. The efficiency o f currently treatment technologies for removing drug residues 
in wastewater/water is summarized in Chapter 5.
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Chapter 5 TREATMENT TECHNOLOGIES FOR 
REMOVING PHARMARCEUTICALLY ACTIVE 
COMPOUNDS IN WATER AND WASTEWATER
There are limited reports available regarding treatment technologies for removing 
PhACs from water systems. In this project, a literature review was done aimed at PhACs 
removal efficiency of current treatment techniques.
5.1 Wastewater Technology
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Figure 5-1 A flow scheme of conventional municipal treatment systems
Sewage treatment is a multi-stage process to renovate wastewater before it 
reenters a body o f water, or applied to the land or reused. Generally, conventional 
wastewater treatment process includes five steps; preliminary, primary, secondary, 
advanced treatment and sludge treatment, as shown in Figure 5-1. Preliminary treatment, 
used to screen out, grind up, or separate debris, is the first step in wastewater treatment
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plants. Primary process is the second step in reduction and separation of greases and 
settleable solids from wastewater. Wastewater is held in settling tank or clarifiers for 
several hours allowing the particles to settle to the bottom and the greases to float to the 
top. The solids drawn off the bottom and skimmed off the top receive further treatment as 
sludge. The clarified wastewater flows on to secondary wastewater treatment, which 
usually is a biological treatment process to substantially degrade the biological content of 
the sewage such as human waste, food waste, soaps and detergent. After secondary 
treatment, the effluent may be discharged, depending on the discharge limits. In some 
cases, advanced treatment is required to remove nutrients or further reduction of organic 
and solid content in an effluent. Advanced treatment may also involve physical-chemical 
separation techniques such as adsorption, flocculation/precipitation, membranes for 
advanced filtration, ion exchange, and reverse osmosis. In various combinations, these 
processes can achieve any desired degree o f pollution control. As wastewater is purified 
to higher and higher degrees by such advanced treatment processes, the treated effluents 
can be reused for urban, landscape, and agricultural irrigation, industrial cooling and 
processing, recreational uses and ground water recharge, and even indirect augmentation 
of drinking water supplies.
Sludges accumulated in the wastewater treatment process must be treated and 
disposed o f in a safe and effective manner. The goals of sludge treatment are to stabilize 
the sludge, reduce odors, and reduce volume, kill disease causing organisms.
5.1.2 Removal Efficiency in Conventional Treatment Systems
Results from occurrence surveys (Sedlak et al. 2005, Clara et al. 2005 and Nakada 
et al. 2006) indicated that PhACs can be more or less removed in each single treatment
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process during sewage treatment plant. Among them, primary and secondary treatment 
processes as well as sludge treatment play roles in the removal of PhACs.
5.1.2.1 Primary Treatment
During primary treatment processes, sedimentation is used to reduce pollutants in 
wastewater. Due to the limitation o f the hydrophilicity o f PhACs, the removal efficiency 
of PhACs o f various groups is low or zero by primary treatment, even with the best 
conditions (e.g., high temperature) (Carballa et al. 2004, 2005). For example, ibuprofen 
no significant elimination of ibuprofen was found during primary treatment in a full scale 
STP by Carballa et al. (2004).
5.1.2.2 Secondary Treatment
So far, worldwide sewage treatment plants mostly adopted biological methods to 
achieve the removal o f organic matter from municipal water, of which the activated 
sludge treatment is the commonly used biological technique.
The activated sludge system is a wastewater treatment method in which the 
carbonaceous organic matter of wastewater provides an energy source for the production 
of new cells for a mixed population of microorganisms in an aquatic aerobic environment. 
The microbes convert carbon into cell tissue and oxidized end products that include 
carbon dioxide and water. In addition, a limited number of microorganisms may exist in 
activated sludge that obtains energy by oxidizing ammonia nitrogen to nitrate nitrogen in 
the process known as nitrification.
Bacteria constitute the majority of microorganisms present in activated sludge. 
Bacteria that require organic compounds for their supply of carbon and energy
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(heterotrophic bacteria) predominate, whereas bacteria that use inorganic compounds for 
cell growth (autotrophic bacteria) occur in proportion to concentrations of carbon and 
nitrogen. Both aerobic and anaerobic bacteria may exist in the activated sludge, but the 
predominant species are facultative, able to live in either the presence o f or lack of 
dissolved oxygen.
The success o f an activated sludge process is dependent upon establishing a 
mixed community o f microorganisms that will remove and consume organic waste 
material, that will aggregate and adhere in a process known as bioflocculation, and that 
will settle in such a manner to produce a concentrated sludge (return activated sludge, or 
RAS) for recycling. Therefore, biological degradation and sorption onto the excess 
sludge are the core mechanisms of removal of PhACs during wastewater secondary 
treatment of the activated sludge process.
1) Biological Degradation
Joss et al. (2006) simultaneously ran three batch experiments using activated 
sewage sludge originating from nutrient-eliminating municipal wastewater treatment 
plants to study the biological degradation of 25 PhACs at typical concentration levels of 
3pg/L. The three batch experiments were 1) the control batch without sludge, 2) an 
experiment with diluted sludge, and 3) an experiment with diluted sludge and substrate 
(addition of primary effluent). Comparing the results of three batch experiments, the 
control experiments run without biologically active sludge did not achieve any removal 
of all selected PhACs; however, an exponential decrease of the concentration over time 
can be seen for all the compounds in the batch experiments with sludge.
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According to the comparison of results from batch experiments (Joss et al. 2006), 
the removal o f PhACs during activated sludge treatment is due to their interaction with 
the sludge. Additionally, pseudo first order kinetic demonstrated by Temes et al. (2004) 
in the EU-POSEIDON project can describe the biological degradation of PhACs as 
follows.
^  = k * ,-S S -C , (5.1)
Where:
Ci = soluble substance concentration o f the compound i inside the reactor
[pg/L]
ki,bioi = kinetic constant for pseudo first order degradation [L/(gSS-d)]
SS = suspended solids concentration [gSS/L]
Since suspended solids concentration (SS) are usually assumed to be constant for 
short-term batch observations, the term “pseudo” is added to the definition; and the direct 
proportionality of the transformation rate to the soluble substance concentration (C i)  is 
visually addressed as the “first order”. The expression of the reaction rate constant kî bioi 
in per suspended solids concentration implied that it not only depends on the 
degradability o f each specific compound but also on the dilute sludge composition.
Combining their experimental data and using Eq. (5.1), Joss et al. (2006) draw 
conclusions similar to those of previous researchers, for example, Metcalfe et al. (2003), 
EU-POSEIDON (2004), Clara et al. (2005), Joss et al. (2005), Lindqvist et al. (2005), 
Tauxe-Wuersch et al. (2005) and Chen et al. (2006). Namely, the observed biological 
removal varies strongly from compound to compound, with no evident correlation to the
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compound structure. Moreover, PhACs can be divided into three classes according to 
their persistence in state of typical reactor configurations: no substantial removal (ki,bioi 
<0.1 L/(gSS-d)); partial removal (0.1< ki,bioi <10 L/(gSS-d)); transformation by greater 
than 90% (kĵ bioi >10 L/(gSS-d)). For example, NSAID ibuprofen achieved notable 
removal rates o f more than 90% and resulted in low-effluent concentrations at sludge age 
longer than 5 days, corresponding to a high kjbioi (>10 L/(gSS-d)); antibiotics 
roxithromycin and sulfamethoxazole were seen partial and high variation removal o f 0 to 
90% at sludge ages longer than 5 days, corresponding to a ki,bioi of 0.1 to 10 L/(gSS-d); 
whereas no remarkable biological transformation occurred for the antiepileptic 
carbamazepine, corresponding to a low ki bioi (<0.1 L/(gSS-d)).
Maurer et al. (2007) studied degradation rates o f four p-blockers sotalol, atenolol, 
metoprolol and propranolol in sewage treatment plants. The pseudo-first-order 
degradation rate constants kĵ bioi in Eq. (5.1) were estimated to be 0.29, 0.69, 0.58 and 0.39 
L/(gSS-d) for the four p-blockers mentioned above, respectively. The kj,bioi values o f 0.1 
to 10 L/(gSS'd) means the four p-blockers are incompletely degraded during sewage 
treatment.
As for partially degradation o f PhACs such as P-blockers and antibiotics, Temes 
et al. (2004) explained that there are probably accuracy limitation for the experiments due 
to unaccounted influencing factors such as sludge loading and specific sludge 
composition. However, low kibioi value (<0.1 L/(gSS-d)) lead to no significant 
degradation o f PhACs like carbamazepine. Moreover, it could be clarified by the 
following sludge characteristics: (i) Biodiversity of the active biomass due to either 
differences in each species of micropollutants such as sludge age (Ternes et al., 2005) or
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the expressed enzymatic activity (Clara et al., 2005), (ii) Portion o f active biomass within 
the total suspended solids (Temes et al., 2005 and Joss et al., 2006), (iii) Floe size of the 
sludge for PhACs being well degraded (Joss et al., 2004 and 2005).
As a result, characteristic ki_bioi value for each species o f PhACs illustrates that 
biological degradation in municipal wastewater treatment contributes only to a limited 
extent to the overall load reduction of PhACs.
2) Sorption onto Sludge (Excess Sludge Removal)
During activated sludge treatment processes, sorption onto sludge is another one 
processing path for the removal o f PhACs by derivating the compounds out o f the water 
into activated sludge.
Temes et al. (2004) assumed that the concentration of PhACs sorbed onto sludge 
(Ci,sorbed) is proportional to the concentration of PhACs in solution (C,,soluble) for a 
compound i in equilibrium conditions as shown below.
î,sorbed ^d,i î,so\uble (^'2)
Where:
Ci,sorbed = concentration o f the compound i sorbed onto sludge [pg/kg] 
kd,i = sorption coefficient o f the compound i [L/kg]
Ci,soluble -  soluble concentration o f the compound i [pg/L]
According to equation (5.2), the sorption coefficient (kd,i) is decided primarily by 
characteristics o f the PhACs and of the sludge, therefore, the value of kd,i can represent 
sorption behavior o f PhACs. Only those PhACs with high kd,i (>200 L/kg) values such as
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analgesic (diclofenac) and antibiotic (norfloxacin), showed a relevant process o f sorption 
for PhACs elimination in EU-POSEIDON (2004).
In the studies o f riddance of P-blockers in sewage treatment plants by Maurer et al. 
(2007), the kd,i values of four observed P-blockers sotalol, atenolol, metoprolol and 
propranolol were determined as less than 320 L/kg, it is seen that these P-blockers cannot 
significantly contribute to the overall elimination.
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Figure 5-2 Absorption and adsorption mechanisms of PhACs on the sludge (Tonalide: 
personal care products, a synthetic polycyclic musk; Norfloxancin: 
abtibiotic) (Kujawa-Roeleveld et al., 2007)
All sorption experiments of PhACs involve two mechanisms absorption and 
adsorption (EU-POSEIDON 2004) as shown in Figure 5-2. When PhACs are mixed with 
sludge, the aliphatic and aromatic groups of the compound such as diclofenac came about 
hydrophobic interactions with the lipophilic cell membrane of the micro-organisms and 
the lipid fractions of the sludge and during this process, absorption played an important 
role to the sorption of PhACs onto sludge. On the other hand, for those charged 
molecules such as the fluoroquinolone antibiotics ciprofloxacin and norfloxacin, this can 
be attributed to specific sorption mechanism adsorption that seems to occur mainly due to 
the effects of electrostatic interactions between the positively charged amino group and 
the negatively charged surfaces of the suspended solids where the micro-organisms make 
up the main fraction. By this observation, the sorption onto suspended solids is not an
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effective mechanism for removal of PhACs except for hydrophobic and positively 
charged compounds (EU-POSEIDON 2004).
5.1.3 Advanced Treatment Systems
5.1.3.1 Membrane Bio-Reactors
The Membrane Bio-reactor (MBR) process is an emerging advanced wastewater 
treatment technology that has been successfully applied at an ever increasing number of 
locations around the world. In addition to their steady increase in number, MBR 











Mixed liquor recycle for denitrification Waste Sludge
Figure 5-3 Typical schematic for membrane bioreactor systems 
(lntem et-9,2007)
The MBR process is a suspended growth activated sludge system that utilizes 
microporous membranes for solid/liquid separation in lieu of secondary clarifiers. The 
typical arrangement shown in Figure 5-3 includes submerged membranes in the aerated 
portion o f the bioreactor, an anoxic zone and internal mixed liquor recycles. As a further
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alternative to Figure 5-3, some plants have used pressure membranes (rather than 
submerged membranes) external to the bioreactor.
Table 5-1 Mean removal of selected pharmaceuticals by the MBR and conventional 
activated sludge (CAS) processes (Radjenovic et al., 2007)
Compound Elimination (%) in:
MBR® CAS""
Analgesics and anti-inflammatory drugs
Naproxen 99 J  (1.52) 85.1 (11.4)
Ketoprofen 91.9(6.55) 51.5(22.9)
Ibuprofen 99.8 (0.386) 82.5 (15.8)
D iclofènæ 87.4(14.1) 50.1 (20.1)
Indomethacin 46.6 (23.2) 23.4 (22.3)
Acetaminophen 99.6 (0.299) 98.4 (1.72)
Mefenaraic acid 74.8(20.1) 29.4 (32.3)
Propyphenazone 64.6(13.3) 42.7 (19.0)
Anti-ulcer agents
Ranitidine 95.0 (3.74) 42.2 (47.0)
Psychiatric drugs
Paroxetine 89.7 (6.69) 90.6 (4.74)
Antiepilqjtic drugs
C aitam azepine N o  elimination^ N o  elimination
Antibiotics
Ofloxacin 94.0 (6.51) 23.8 (23.5)
Sulfam ethoxazole 60.5 (33.9) 55.6 (35.4)
Erythromycin 67.3 (16.1) 23.8 (29.2)
B-blockers
Atenolol 65.5 (36.2) N o  elimination
Metoprolol 58.7 (72.8) N o elimination
Diuretics
Hydrochlorothiazide 66.3 (7.79) 76.3 (6.85)
Hypogfycaemic agents
Glibenclamide 47.3 (20.1) 44.5 (19.1)
Lipid regulator and cholesterol lowering statin drugs
Gemfibrozil 89.6 (23.3) 38.8 (16.9)
Bezaftbrate 95.8 (8.66) 48.4 (33.8)
Clofibric acid 71.8(30.9) 27.7 (46.9)
Pravastatin 90.8 (13.2) 61.8(23.6)
Values are averages, with relative standard deviations (%) in
parentheses, for n - 10“ or n -8 * ’ sam ples
‘̂ Compounds w ere classified as “no elimination” i f  elimination was
less than 10%
53
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Compared to conventional activated sludge treatment, MBR is one novel 
approach to eliminate PhACs from wastewater and offers advantages such as long solids 
retention time (Clara et al., 2005) and low sludge load (Petrpvic et al., 2003).
Radjenovic et al. (2007) observed the behavior of several pharmaceutical products 
in different therapeutic categories (NSAIDs, antiepileptics and antibiotics, etc.) during 
wastewater treatment in a laboratory-scale MBR, and compared the results with those in a 
conventional activated sludge process. Through a two-month operation of the MBR, for 
most of the PhACs investigated, MBR treatment achieved ahigh and steady performance 
(removal rates >80%) compared to the conventional system (Table 5-1).
According to the experimental results of Radjenovic et al. (2007), such 
biodegradable PhACs as ketoprofen, diclofenac, bezafibrate, and gemfibrozil removal by 
the MBR system was very high and uniform (>90%) because o f the smaller flock size of 
the sludge, which enhances mass transfer by diffusion and therefore increases elimination. 
Additionally, large amount of active biomass in suspended solids originating from MBR 
also improved the removal of this kind of PhACs.
In particular, Radjenovic et al. (2007) pointed out that substantially greater 
attenuation o f diclofenac by the MBR was achieved with average removal efficiency of 
87%, more than 50% in conventional activated sludge treatment. That is attributed to the 
longer solids retention time and greater adsorption potential of the MBR sludge compared 
to conventional activated sludge process. Unfortunately, antiepileptic carbamazepine was 
the most persistent drug and it passed untransformed through both the MBR and 
conventional systems. Other authors (Metcalfe et al. 2003, Clara et al. 2004, Joss et al. 
2005) have reported similar results.
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Although there are few papers reporting on the behavior of PhACs during MBR 
treatment, a fact that a complete removal could never be achieved by MBR even under 
optimum adaptation conditions for the rapid primary degradable PhACs was proven by 
many researchers (Kimura et al. 2004, Clara et al. 2005, Bernhard et al. 2006).
5.1.3.2 Others
There are many other advanced treatment techniques for treated wastewater such 
as membrane filtration, ozonation, advanced oxidation processes (AOPs) and disinfection. 
Because these techniques are also commonly used in drinking water treatment processes, 
the details about them will be discussed in the followed section.
5.2 Drinking Water Technology
5.2.1 Conventional Surface Water Treatment System
Water treatment originally focused on improving the aesthetic qualities of 
drinking water (EPA 2000). As early as 4000 B.C., water treatment methods such as 
filtering through charcoal and boiling were recommended by ancient Sanskrit and Greek 
writings to improve the taste and odor. Starting at the early 1800s, slow sand filtration 
was beginning to be used regularly in Europe, till to today; sort o f filtration technologies 
have already been widely employed in worldwide water treatment plants. Behind the 
earliest water treatments, the turbidity concerns of people accelerated to the development 
of coagulation/flocculation techniques. Egyptians reportedly used the chemical alum to 
achieve coagulation at 1500 B.C. (EPA 2000).
In 1908 chlorine was used for the first time as a primary disinfectant o f drinking
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water in Jersey City, New Jersey, the disinfection has become an indispensable in 
drinking water treatment processes, and the correlate technologies bloomed in water 
industries. According to a 1995 EPA survey, approximately 64 percent of community 
drinking water systems disinfect their water with chlorine. Almost all of the remaining 
surface water systems, and some of the remaining groundwater systems, use another type 
of disinfectant, such as ozone or chloramine.
Through the several-century growth, a classic flow diagram of a conventional 
surface water treatment plant was formed as shown in Figure 5-4. The basic treatment 
system includes screening, coagulation/flocculation, sedimentation, and filtration and 
post-disinfection is a traditionally used process.
PUMP
ConwBirtmnfal Surface Water Trejtinent 
(the U.S. and Canada)
Figure 5-4 Schematic flow diagram of conventional surface water treatment plant in 
North America
5.2.2 Conventional Groundwater Treatment Plant
Contrasted to surface water, groundwaters usually have higher quality with 
respect to turbidity and microbiological contaminants such that disinfection may be the 
only required treatment, in some states disinfection may be even eliminated. 
Circumstances favoring this situation are that the aquifer has no direct connection to 
surface water and the well has been properly constructed so the aquifer cannot be
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contaminated at the well site (Letterman 2004). However, with the rapid development of 
kinds of industries such as mining and pharmacy, etc., much groundwater in 
cosmopolitan cities has been polluted to some extents by inorganic and organic 
substances. As a result, flocculation was frequently employed in the conventional 
groundwater treatment plant as shown in Figure 5-5.
Groundwater 
Well 
3- - - - - - - - - SEDIMENTATIONFLO C CU LA TIO N FILTRATION DISIN FECTIO N
r - a -
HIGH SERV ICE 
PU M P
Conventional Groundwater Treatment
Figure 5-5 Schematic flow diagram of conventional groundwater treatment plant
5.2.3 Removal Efficiency in Conventional Drinking Water Systems
In conventional drinking water treatment process, the main removal mechanisms 
of PhACs involved are the coagulation/flocculation and disinfection.
5.2.3.1 Coagulation/Flocculation
Generally, such chemicals as metal salts or organic compounds are added into the 
wastewater to promote the agglomeration of suspended solids and colloids, thereby 
enhancing the removal of these particles; these processes are called 
coagulation-flocculation. A flotation process can be used as an alternative technique to 
separate finely suspended particles by their adhesion to the surface o f rising bubbles, and 
has proved to be efficient for the removal o f fat and other contaminants such as oils and 
biomolecules from water (Zouzoulis and Avranas 2000). By carrying out laboratory
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coagulation/flocculation studies (jar test), conventional coagulation/flocculation 
processes can accomplish minimal removal o f some kinds of PhACs. These PhACs 
include analgesics diclofenac (Temes et al. 2002) and naproxen (Boyd et al. 2003) with 
the exception o f partial elimination (40-50%) o f antibiotics (Adams et al. 2002). The low 
aqueous solubility and hydrophobic nature of the aforementioned PhACs and being 




Chlorine is a strong oxidant used primarily as a disinfectant in drinking water 
treatment. While Sedlak et al. (2005) analyzed the removal efficiency of some kinds of 
pg/L-concentration PhACs including NSAIDs, ^-blockers and antibiotics in many water 
treatment plants from the U.S.; they found elimination of certain PhACs such as 
diclofenac, ibuprofen, and propranol during chlorine disinfection of water effluent, 
especially when the water has been nitrified prior to disinfection. However, verification 
from the laboratory experiments through sampling before and after wastewater 
disinfection did not show any clear evidence for removal of these compounds. Therefore, 
ftirther works is needed to prove the removal of the compounds during disinfection with 
chloramines.
When 0.5 and 6.0 mg/L of free chlorine (CI2) was applied to treated drinking 
water samples spiked with various pharmaceuticals (up to a concentration of Ipg/L) in 
laboratory tests, chlorine was found most effective to oxidize NSAIDs pyrazole
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derivatives phenazone, dimethylaminophmazone and prpyphenazone with a 30 minutes 
eontact time (Temes et al., 2005). A complete oxidation o f these compounds was 
achieved by a chlorine (CI2) dose of 0.5 mg/L were about 90%, 60% and 40%, 
respeetively. The other selected pharmaceuticals, including caffeine, carbamazepine, 
diazepam, clofibric acid, ibuprofen and bezafibrate, were refractory to oxidation by 
chlorine.
Pinksron and Sedlak (2004) studied transformation o f four P-bloekers (atenolol, 
metoprolol, propranolol and nadolol) during chlorine disinfection. The P-blockers all 
exhibited a strong dependence of reactivity on pH. All four o f the compounds exhibited 
an increase in reaetion rates below pH 7. Except nadolol, three compounds (atenolol, 
metoprolol and propranolol) also showed an increased reaction rate above pH 8. The 
relative reactivity o f these blockers was depended on their structure or function groups 
containing, for example, the p-blocker that does not exhibit an increase in reaetivity at pH 
values above 8 (i.e., nadolol) contains a tert-huXy\ group (See Figure 5-6).
The difference in reactivity associated with this slight change in molecular 
structure is most likely attributable to the presence of an a-hydrogen (Figure 5-7) in 
atenolol, metoprolol, and propranolol (Pinksron and Sedlak, 2004). Chloramines that 
have hydrogen on the carbon a  to the amine (Figure 5-7) have been shown to undergo a 
base-catalyzed decomposition reaction in which the hydrogen is abstracted and an imide 
(a functional group consisting of two carbonyl groups bound to a primary amine or 
ammonia) is formed. The imide then hydrolyzes, causing cleavage of the bond between 
the nitrogen and earbon and removal of the a-carbon and its substituents. An example of 
how this reaction would occur for propranolol can be seen in Figure 5-7.
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The carbon atom  adjacent to a carbonyl group is  ca lled  the a-carbon. 
T he h ydrogen  atom  adjtæent to  an a-carbon is  ca lled  the a-hydogeu .
Figure 5-7 Reactions between propranalol and chlorine
Moreover, effects of pH and chlorine dosage on the extent o f acidic compound 
naproxen elimination were investigated by Boyd et al. (2005). In experiments, synthetic 
waters containing elevated concentrations of naproxen were oxidized by free chlorine at 
naproxen: chlorine molar ratios o f 0.02 to 3.1 and pH values o f 5 to 9. Firstly, results 
indicated that reactions between naproxen and chlorine were rapid and the reactions
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approached completion with 30 seconds for the experimental conditions. Results also 
demonstrate that naproxen was more readily transformed by contact with chlorine at pH 
5.0, 99.7% of naproxen was removed after 15 minutes reaction. At neutral pH 7.0, about 
99.2% of naproxen was eliminated in comparison to elevated pH 9.0, only 61.5% 
removal o f naproxen was achieved at pH 9.0.
The extent o f reaction of naproxen at pH 5.0 and 7.0 was attributed to the 
reactivity o f free chlorine in this pH range. At low pH conditions, aqueous chlorine exists 
primarily as hypochlorous acid (HOCl), which favors the oxidation reaction with 
naproxen. Further, naproxen is a weak acid with pKa o f 4.4 (Cantabrana et al. 1995) and 
experimental conditions favored the anionic form of naproxen. As a consequence, at 
elevated pH 9.0, the predominant form of chlorine is hypochlorite ion (OCF) (Fair et al., 
1948) and the reaction between the two anionic forms is less efficient compared to the 
low pH experiments. Because the formation o f specific reaction products can vary 
depending on the characteristics of the water and treatment operation conditions, so far it 
is not clear how to identify the intermediated and chemical reaction end products. 
Additionally, the reaction kinetic of naproxen chlorination for arranging o f water and 
wastewater treatment conditions is hard to understand. But, according to the study of 
Boyd et al. (2005), low pH conditions are likely to favor oxidation of naproxen by 
chlorination in water treatment systems.
Secondly, the experimental findings of Boyd et al.’s (2005) indicated that the rate 
and extent of reaction between naproxen and chlorine increased with greater chlorine 
dosages and a naproxen to chlorine molar ratio less than 3:1 is needed to remove 
naproxen from the aqueous phase in their batch experiments.
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Overall, only a few PhACs tend to be transformed during chlorine disinfection 
(Glassmeyer and Shoemaker 2005 and Gibs et al. 2007). More research is needed to 
identify the specific intermediate and end transformation products and the characterizing 
mechanisms o f PhACs’ chlorination reactions for a range of water treatment conditions 
as well as natural aquatic environments such as pH and TOC (Temes et al., 2005; Boyd et 
al., 2005). Furthermore, just as discussed previously, the examples of naproxen and 
P-blockers implied that the removal efficiency of PhACs by chlorination is not only 
relied on aquatic environments (e.g. pH), but also depends on the nature (e.g. structure 
and pKa) o f target PhACs. That means these conditions limit the applications of 
chlorination on removing the majority PhACs.
2) Chlorine Dioxide (CIO2)
Since chlorine dioxide lowers potential of forming disinfection by products such 
as trihalomehtanes (THMs), it is an alternative to chlorine for disinfection of relatively 
high quality water including drinking water.
In order to predict the oxidation of PhACs under the given conditions, Temes et al. 
(2005) carried out the deprotonated species of diclofenac, 17a-Ethinylestradiol, 
sulfamethoxazole as well as the neutral species of roxithromycin exhibit a high reactivity 
to chlorine dioxide. Most the remaining PhACs such as bezafibrate, carbamazepine, 
diazepam, ibuprofen, and iopromide, etc. did not react at an appreciable rate with 
chlorine dioxide.
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Figure 5-8 Chemical structures of reactive PhACs and sites o f proposed CIO2 attack.
(Huber et ah, 2005)
Huber et ah (2005) carried out a series of oxidation experiments of PhACs during 
water treatment including drinking water, surface water and groundwater treatment with 
chlorine dioxide and obtained similar results as Temes et ah (2005). Chlorine dioxide 
was only effective to oxidize certain PhACs such as sulfonamide and macrolide 
antibiotics, and estrogens. In their work, diclofenac, 17a-Ethinylestradiol (EE2), 
sulfamethoxazole and roxithromycin showed an appreciable reactivity and exhibited 
relativly high reactivity at pH>7. Because CIO2 reacts very selectively with certain 
functional groups with high electron densities such as phenoxide ions and neutral tertiary 
amines (Hoigné and Bader 1994), the reactivity o f the protonated forms of these
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functional groups is usually many orders o f magnitude lower. Therefore, the 
pH-dependent reactivity o f EE2 and roxithromycin, which exhibit a phenolic and a 
tertiary amino group, respectively, can be explained by the protonation state of their 
reactive functional groups. The pH dependency of the reactions also implies that CIO2 
attack actually takes place at the phenolic moiety o f EE2 and at the tertiary amino group 
of roxithromycin (Figure 5-8). The reactions of diclofenac and sulfamthoxazole with 
CIO2 may be contributed by the aniline group (C6H5-NH2) they containing. Moreover, the 
deprotonation o f the acidic nitrogen of the sulfonamide moiety enhances the reactivity of 
sulfamehtoxazole considerably.
Due to these specially pivotal function groups reacted with CIO2 in PhACs, fewer 
compounds are efficiently removed during water treatment with chlorine dioxide 
compared to ozone with the exception of a little of PhACs stated previously.
5.2.4 Advanced Treatment
5.2.4.1 Ozonation
Ozonation as an advanced treatment technique is an interesting and representative 
chemical oxidation option. Ozonation of the treated wastewater has confirmed being a 
feasible polishing step for biologically treated wastewater with the potential of 
eliminating a wide variety o f PhACs (Themes et al. 2003, 2005). It is worthy to say that 
there is no indication that the by products of ozonation of PhACs are toxic (Temes et al. 
2005).
In drinking water treatment, ozonation showed high efficiency in oxidizing 
PhACs (Zwiener et al. 2000; Themes et al. 2002 and Huber et al. 2003). Huber et al.
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(2005) using ozone ( O 3 )  treated municipal wastewater effluents in a pilot-scale plant. 
Selected pharmaceuticals macrolide and sulfonamide antibiotics, estrogens, and the 
diclofenac, naproxen, and indomethacin were spiked in the wastewater at realistic levels 
ranging from 0.5 to 5pg/L. The oxidization efficiencies of these drugs were more than 
90% for O 3  doses greater than 2mg/L in all effluents. Compare to CIO2, ozone exhibited 
higher removal ability o f PhACs. Ozone reacts with the same functional groups as CIO2, 
however, ozone also reacts with C=C double bonds and activated benzene rings. With 
respect to ozone, it has also to be taken into account that hydroxyl radicals formed due to 
ozone decay, can oxidize refractive PhACs to a substantial extent.
Unfortunately, ozonation were broadly applied in water treatment processes based 
on highly reactive radicals like phenol ring and the sulfur atom (Andreozzi et al. 2005 
and Zwiener 2007), especially the hydroxyl radical (OH) (Vogna et al. 2004). During 
ozonation, micropollutants can be oxidized either by O 3  directly or by hydroxyl radicals 
(OH), which are formed as a consequence o f O 3  decay. The two oxidants vary strongly in 
their reactivity. O 3  attacks very selectively certain functional groups, whereas OH is a 
nonselective oxidant that reacts very fast with a large number o f moieties. Consequently, 
most OH is scavenged by the water matrix in wastewater (von Gunten 2003). Therefore, 
the oxidation of compounds that react slowly with O 3  is always less efficient than for 
compounds that react fast with O 3 ,  even if  the rate constants for the reaction with OH are 
nearly diffusion-controlled. This characteristic led to the presence in treated water of 
those compounds lacking susceptible functional groups such as ifosfamide, even at high 
ozone dosage (2.1 mg/L) (McDowell et al. 2005). Otherwise, the oxidation reactions of 
certain PhACs were controlled by aquatic conditions. For example, the solubility of
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diclofenac is very limited at low pH, on the other hand, it could form foam at pH greater 
than 6. These prevented the investigation of ozonation in a broader range (Vogna et al. 
2004).
5.2.4.2 Advanced Oxidation Processes
Advanced oxidation process (AOP) is considered as a good choice in order to 
treat the hazardous non-biodegradable pollutants including pharmaceuticals in water and 
wastewater (Andreozzi et al. 1999, Oppenlander 2003 and Pérez-Estrada et al. 2005). The 
AOPs are characterized by a variety of radical reactions that involve combinations of 
chemical agents (e.g., ozone ( O 3 ) ,  hydrogen peroxide ( H 2 O 2 ) ,  transition metals, and metal 
oxides) and auxiliary energy sources (e.g., ultraviolet-visible (UV-Vis) radiation, 
electronic current, y-radiation, and ultrasound). Examples of AOPs include O 3 / H 2 O 2 ,  O 3 /  
UV, O 3 / H 2 O 2 /  UV, H 2 O 2 /  UV, Fenton (Fe^+/H202).
Hydroxyl radicals (OH) which are produced in AOP process are very reactive and 
play an important role in the mineralization of the pharmaceutical compounds in the final 
stage (Pérez-Estrada et al., 2005). However, other radical and active oxygen species such 
as superoxide radical anions (O j - ) ,  hydroperoxyl radicals {HOI),  triplet oxygen COl),  
and organic peroxyl radicals ( i? -  O -  O* ) are also involved (Oppenlander, 2003).
Zwiener and Frimmel (2000) reported that ozonation (1 mg/L applied ozone) 
alone was not sufficient to convert 2 pg/L ibuprofen (NSAID) in distilled water, resulting 
in only 12% conversion in 10 min. However, increasing the ozone dose and adding 
hydrogen peroxide ( O 3 / H 2 O 2  AOP) greately improved the ibuprofen conversion. They 
also investigated the effect o f water matrix on the degraditon of ibuprofen using a river
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water sample. The presence of hydroxyl radical scavenger, bicarbonate ion and natural 
DOC, in the river water significantly reduced the extent of ibuprofen conversion by 
O 3 / H 2 O 2  AOP, implying the importance o f hydroxyl radical reaction. In the river water, 
they noted that the treatment with 5.0 mg/L applied ozone and 1.8 mg/L hydrogen 
peroxide was sufficient to convert 2 pg/L ibuprofen in 10 min at pH 7.5 and 10 °C 
(Zwiener and Frimmel, 2000).
Andreozzi et al. (2004) investigated H2O2/UV and Ti02 photo-catalysis for the 
decontamination of an aqueous pharmaceutica mixture containing ofloxacin, as well as 
five other drugs, namely diclofenac, propranolol, clofibric acid, sulfamethoxazole and 
carbamazepine. It was shown that H2O2/UV treatment ([H202]o=5-10 mM, a low-pressure 
Hg lamp, at 254 nm, 2.51 x 10'^ Einstein s ') was sufficient for the complete conversion of 
propranolol (p-blocker) and ofloxacin (antibiotic) at pH 7.4 and 25°C, whereas Ti02/hv 
process was less effective.
Degradation o f clofibric acid (lipid regulator) by ozone can be enhanced by 
adding hydrogen peroxide (i.e., O 3 / H 2 O 2  AOP) (Zwiener and Frimmel, 2000) or elevating 
pH (Andreozzi et al. 2003). These two approaches indicate the importance of hydroxyl 
radical reactions for the degradation of this drug metabolite.
Vogna et al. (2004) reported the degradation of carbamazepine by H2O2/UV AOP. 
Carbamazepine could be converted rapidly by H2O2/UV treatment; about 4.7 mg/L 
carbamazepine was completely converted within 4 min of treatment with 170 mg/L H2O2 
and UV irradiation at 254 nm using a 17 W low-pressure Hg lamp (2.7x10'^ Einstein s ') 
at pH 5.0 (Vogna et al. 2004). Recently, the carbamazepine degradation by Ti02 
photocatalysis was investigated in a series o f study (Doll and Frimmel 2004, 2005). Doll
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and Frimmel (2004) showed that as compared with other persistent pharmaceuticals 
including clofibric acid, iomeprol, iopromide, carbamazepine could be rapidly degraded 
by TiOz/hv process. More than 90% of initial carbamazepine (4.2 mg/L) was converted in 
nine minutes by treatment using 100 mg/L (TiOz) (P25) and a 1000 -W  xenon short-arc 
lamp as a source o f simulated solar UV rays (1.35x10'' Einstein m^ s '', X< 400 nm) at pH 
6.5 (Doll and Frimmel 2005). A successful pilot-scale investigation of the continuous 
treatment of carbamazepine by the TiOz/hv process was reported using a cross-flow 
microfiltration to retain catalyst (Doll and Frimmel 2005). The degradation of 
carbamazepine was strongly inhibited in the presence of natural organic matter (NOM) in 
a lake water sample by competing for hydroxyl radicals, as well as by deactivating TiOz 
catalyst surface by adsorption (Doll and Frimmel 2005).
The advantages o f AOPs processes include complete mineralization o f PhACs, 
production o f less harmful and more biodegradable by-products, and ability to handle 
fluctuating flow rates and compositions (Zhou and Smith 2001). However, the 
performance o f AOP is affected by the presence of other water and wastewater 
constituents, such as NOM, dissolved and suspended solids, and alkalinity, as well as by 
water pH and temperature (Oppenlander 2003). For example, suspended solids and color 
can hinder photochemical reactions by light scattering and absorption and may impair the 
performance o f photochemical AOPs, such as O 3 /  UV, HzOz/ UV, photo -  Fenton, and 
TiOz/hv processes. Carbonate, bicarbonate, and chloride ions, as well as some natural 
organic compounds are known to act as radical scavengers. These compounds compete 
with target pollutants for hydroxyl radiacals; therefore, their presence increases oxidant 
demands and lowers the treatment efficiency. In addition, the costs of materials and
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equipment, as well as energy requirements and efficiency must be taken into account 
when assessing the overall performance of AOPs (Legrini et al. 1993 and Oppenlander
2003)
S.2.4.3 Adsorption on Activated Carbon
Activated carbon is a well-known process for removing various organic 
contaminants and organic carbon in general. Activated carbon is either applied as a 
powdered feed or in a granular form in packed bed filters. Granular activated carbon 
(GAC) is used at many water treatment plants in the U.S. and Canada (EPA 2000). The 
GAC can be employed as a replacement for anthracite media in conventional filters, thus 
providing both adsorption and filtration. Alternatively, GAC can be applied 
post-conventional filtration as an adsorbent bed (Moore et al. 2001, 2003). Estimated two 
thirds of all surface water treatment plants in the U.S. and Canada have the capability to 
feed powdered activated carbon (PAC) intermittently (EPA 2000). One of the more 
common submissions o f PAC is for controlling tastes and odors such as geosmin and 
methylisobomeol (MIB) (Knappe et al. 1998). Recently, researchers have developed 
tailored activated carbons for improving geosmin and MIB removal (Nowack et al. 2004, 
Rangel-Mendez and Cannon 2005), and the work herein has appraised how this activated 
carbon also enhances the removal of PhACs. Studies about activated carbon efficiency 
for PhACs removal were performed both in lab scale experiments (Temes et al. 2002, 
2005 and Westerhoff et al. 2005) and full-scale utilities (Snyder et al. 2007).
Temes et al. (2002, 2005) carried out adsorption of PhACs on GAC and on PAC 
in pilot-scale experiments. According to their experimental results, the octanol-water 
partition coefficient (Kow) has proved useful for predicting removal efficiency.
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Antiepileptic compounds (e.g. carbamazepine, diazepam) with rather high Kow values 
(lO "̂* to 10^'') are very easily adsorbable (<0.2 mg/L AC for 99% removal). Additionally, 
medium absorbability was observed for charged PhACs or compounds with lower Kow 
values ( 10 '^^ to 10^^) such as ibuprofen, roxythromycin, sulfamenthoxazole and 
iopromide and showed a behavior similar to that o f atrazine. Adsorption of charged 
PhACs on activated carbon is much lower than would be expected from the Kow values of 
the protonated PhACs. This is also reflected by the low breakthrough volumes of 
clofibric acid in an activated carbon filter (17 m^/kg activated carbon) compared with 
carbamazepine (70 m^/kg activated carbon).
The study of Westrhoff et al.’s (2005) further demonstrate the affinity between 
Kow values and the percentage adsorption of PhACs on activated carbon. Relatively 
higher removal, between 75 and 100%, has been observed in batch experiments with 5 
mg/L activated carbon and four hours o f contact time for PhACs with Kow values higher 
than 10  ̂ (e.g. carbamazepine). Exceptions from this correlation include N-heterocyclic 
compounds (e.g. pentoxifylline and trimethoprim); because o f specific interactions o f the 
protonated compounds with activated carbon, removal efficiencies are higher for these 
PhACs than might be expected from their Kow values. In contrast, those functional groups 
like carboxyl groups in PhACs much lowered the counterpart (e.g. clofibric acid, 
ibuprofen and diclofenac) adsorption efficiency on activated carbon, because in water 
they are to some extent dissociated and, therefore, negatively charged.
Snyder et al. (2007) evaluated activated carbon at bench-scale using rapid small 
scale column tests and at two full-scale utilities. In their study, both PAC and GAC were 
capable o f removing nearly all compounds evaluated by greater than 90%. However,
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activated carbon efficacy is greatly reduced by the presence o f natural organic matter 
which competes for binding sites and can block pores within the activated carbon 
structure. PAC offers the advantage of providing fresh carbon continuously since it is fed 
as a new product and is not recycled through the treatment process. Since PAC is added 
to the plant dynamically as a feed “chemical”, it can be used seasonally when risk of 
trace organics may be greater (e.g., low-flow events). The ability of PAC to remove 
organic contaminants depends upon PAC dose and contact time, as well as the molecular 
structure and behavior of the contaminant of interest. GAC also was found to be 
highly-effective; however, water soluble contaminants can breakthrough the GAC much 
more rapidly than strongly bound hydrophobic contaminants. In two full-scale GAC 
applications evaluated, vastly different results were observed (Snyder et al. 2007). At a 
drinking water facility with on-site and regular regeneration, removal of trace organics 
occurring in source water was efficiently improved. In contrast, a facility with relatively 
high levels o f TOC using GAC without regular replacement/regeneration provided very 
little removal. These data collectively show that activated carbon in both powdered and 
granular forms has great potential for the removal of trace organic contaminants; however, 
PAC dose and GAC regeneration/replacement will be critical for excellent removal 
(Snyder et al. 2007).
Generally, activated carbon is a powerful process to remove most PhACs. 
Whereas adsorption on activated carbon depends on the non-polar character of uncharged 
compounds which do not have functional groups or N-heterocyclic structural groups, a 
number o f PhACs such as iodinated contrast media iopromide and the antibiotic 
sulfamethoxazole showed insufficient affinity to activated carbon as mentioned
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previously. In addition to the molecular structures of PhACs, activated carbon dosage or 
regeneration and the react time as well as the treated water conditions also influence to 
some extent the adsorption ability of activated carbon for PhACs. Additionally, due to the 
introduction o f carbon, the disposal of spent carbon may lead to some practice problems 
such as complicated operation and extra post treatment costs.
S.2.4.4 Membrane Filtration
Implementation o f membranes in water treatment is steadly increasing. It is 
well-known that pressure-driven membranes are capable of removing microbial 
constituents without increasing disinfection by-products, thereby allowing compliance 
with the rules promulgated in response to the 1986 Surface Water Treatment Rule 
Amendments (Adham et al. 2005). Based on the pore size o f membrance, there are four 
main membrane types from larger size microfiltration following by ultrafiltration and 
nanofiltration to smaller pore size reverse osmosis. Recently, data have become available 
which demonstrate that membrane technology can be highly effective for the removal of 
PhACs (Kiso et al. 2001, Van der Bruggen et al. 2001, Drewes et al. 2002, Yoon et al. 
2002, Schafer et al. 2003, Nghiem et al. 2005 and 2006).
1) Microfîtration /Ultrafiltration
Among multitude types of membrane filtration, microfiltration/ultrafiltration 
(MF/UF) systems are strongly recommended for reducing micro-pollutants when there 
are space limitations and/or variable feed water quality. However, microfiltration (Sedlak 
et al. 2005, Snyer et al. 2007) and ultrafiltration (Snyer et al. 2007,Yoon et al. 2007)
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membranes have little value for the direct removal o f the vast majority o f PhACs by 
sieving.
2) Nanofiltration
Nanofiltration (NF) is an important technology for water reuse. Complete or near 
complete removal of a wide range of contaminants in secondary effluents can be 
achieved with NF membranes (Van der Bruggen et al. 2003). As a result, the rejection 
ability to PhACs have attracted many researchers (Kiso et al. 2001, 2002, Nghiem et al. 
2004, 2005, Yoon et al. 2007).
Kiso et al. (200, 2002) tested strong hydrophobic PhACs including aromatic 
pesticides, non-phenylic pesticides, and alkyl phthalates by nanofiltration (NF) 
membranes and concluded that PhACs rejection was correlated significantly with 
molecular width and size in addition to compound hydrophobicity. They observed that 
rejection of non-dissociated PhACs were insensitive to feed water pH and removal 
increased linearly with the molecular weight and molecular width. The rejection 
efficiency, however, also correlates with the concentration of PhACs, which necessitates 
more effort at lower concentrations.
Nghiem et al. (2004, 2005) investigated the retention mechanisms of four classes 
PhACs antibiotics (sulfamethoxazole), antiepileptic (carbamazepine) and 
anti-inflammatory (ibuprofen) by NF membranes. Laboratory scale experiments were 
carried out with two well characterized NF membranes, with the goal of relating 
pharmaceutical retention behavior to membrane characteristics, physicochemical 
properties of the pharmaceutical molecules, and solution chemistry. Results show that 
retention o f PhACs by a tight NF membrane is dominated by steric (size) exclusion.
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whereas both electrostatic repulsion and steric exclusion govern the retention o f ionizable 
PhACs by a loose NF membrane. In the latter case, spéciation o f PhACs may lead to a 
dramatic change in retention as a function of pH, with much greater retention observed 
for ionized, negatively charged PhACs. For uncharged pharmaceutical species, intrinsic 
physicochemical properties of the pharmaceutical molecules can substantially affect their 
retention. In its neutral form, ibuprofen adsorbs considerably to the membrane because of 
its relatively high hydrophobicity. Similarly, polarity (represented by the dipole moment) 
can influence the separation of molecules that are cylindrical in shape because they can 
be directed to approach the membrane pores head-on due to attractive interaction between 
the molecule polar centers and fixed charged groups on the membrane surface. This 
phenomenon is probably inherent for high dipole moment organic compounds, and the 
governing retention mechanism remains steric in nature.
Yoon et al. (2007) evaluated initial interactions between 27 PhACs and NF 
membranes having different compounds in various waters using a dead-end stirred-cell 
filtration system. Eight o f 27 PhACs showed 100% recovery based on the mass balance 
for NF membrane tests. Among the compounds showing less than 100% recovery, the 
compounds (androstenedione, oxybenzone, progesterone, testosterone, triclosan) having 
Kow of greater than 10^^ exhibited typically less than 40% recovery except gemfibrozil 
and ibuprofen. However, the other compounds (Kow < 10^^) showed higher recovery 
(>75%). For the compounds, a general trend appears to exist with higher mass recovery at 
lower Kow- These results indicate that observed retention for the relatively hydrophobic 
compounds based on their Kow was significantly governed by adsorption.
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Overall, nanafiltration are really powerful processes to remove PhACs. However, 
the removal efficiency o f PhACs is relative to many factors such as the character of 
PhACs (i.e., Kow, hydrophobicity and molecule size) and membranes (i.e., density). 
Further, for negatively charged PhACs rejection efficiencies were higher than for 
antiepileptics, because antiepileptics belonging to neutral pharmaceutical compounds 
tend to be adsorbed on the membrane materials (Zwiener, 2007). Consequently, these 
relative factors limited the application of nanofiltration membranes for removal o f the 
majority PhACs.
3) Reverse Osmosis
In contrast to MF/UF and NF, reverse osmosis (RO) membranes were capable of 
removing almost all PhACs (e.g. NSAIDs, beta-blockers and lipid regulators) (Sedlak et 
al., 2005).
Kimura et al. (2003) explored the rejection of PhACs by RO membranes as a 
function of their physicochemical properties and initial feed water concentration. 
Experimental results indicated that negatively charged compounds could be rejected very 
effectively (i.e., >90%) regardless o f other physicochemical properties o f the tested 
compounds due to electrostatic exclusion. No time-dependency was observed for 
rejection o f charged compounds. In contrast, rejection of non-charged compounds was 
generally lower (<90% except for one case) and influenced mainly by the molecular size 
of the compounds. Kimura et al. (2003) also observed clear time-dependency for 
rejection o f non-charged compounds, attributable to compound adsorption on the 
membrane. It was demonstrated that feed water concentration influenced rejection 
efficiency o f the membrane. Experiments conducted at a low ng/L concentration range
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resulted in lower rejection efficiency as compared to experiments conducted at a pg/L 
range, suggesting the need to conduct experiments at the relevant concentration of 
interest.
Snyder et al. (2007) investigated the removal of a broad range of representative 
PhACs during RO membranes processes in dynamic flow-through pilot skids or in 
operational full-scale treatment plants. In this work, findings indicated that RO 
membranes were capable of removing nearly all compounds that were investigated to 
levels less than method reporting limits. However, trace levels o f some contaminants like 
antibiotics (Sedlak et al., 2005) were still detectable in RO permeates. The compounds 
that breached RO membranes were not consistent, and no clear relationship between 
molecular structure and membrane breaching could be established.
Just as discussed above, current waste-/drinking water treatment technologies 
neither conventional wastewater/water treatment processes nor advanced treatment 
techniques can achieve ideal or complete removal o f PhACs in water systems. Due to 
some kinds o f affect factors like compound structure and aquatic pH value as mentioned 
previously as well as the treatment process employed, activated sludge (type and age), 
environmental temperature, light and matrix effect (O'Brien and Dietrich 2004, Carballa 
et al. 2004), there are always certain PhACs present in the treated water after the 
corresponding treatment processes. For example, the pharmaceutical removal rate of 
NSAIDs is rather low (Petrovic et al. 2003), because their high water solubility and poor 
degradability. Consequently sewage effluents are one of the main sources of NSAIDs and 
their secondary products, and they can reach groundwater as well as drinking water 
(Temes 2002, Reddersen et al. 2002).
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Membrane filtration seems a better technique compared to other currently 
technologies. However, there are still some problems, for example, certain concentrated 
products would field during filtration processing, and there are not any technologies to 
further treat these condensates. Additionally, MF/UF is commonly used technique at 
present in water industries. As mentioned previously, MF/UF has little value to remove 
PhACs in wastewater or water. Therefore, the novel advanced treatment technologies for 
elimination of drug residues are desired to be developed. In next chapter, freeze 
concentration as a lately developed technology will be primarily introdued.
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Chapter 6 FREEZE CONCENTRATION
When ice is crystallized from an aqueous solution, the ice crystal is essentially 
built up by pure water, leaving the solutes in the remaining liquid phase. This process of 
separation o f the dissolved impurities is named the freeze concentration (Rodriguez et al. 
2000)
6.1 Freezing of Water
At the standard conditions of temperature (0°C) and pressure (101.32 kPa), three 
phases o f water stay in the stable equilibrium. Generally, temperature and pressure 
determine the phases of water: liquid, ice or vapor phase. During phase change processes, 
water must give off heat in order to pass it from the liquid to the solid state. The heat is 
the internal energy o f water and is called the latent heat of fusion. Homogeneous, 
heterogeneous, or a combination of them is comprised of the mechanism of ice nucléation 
(Franks 1982). Homogeneous nucléation is the self-nucleation of water under deeply 
supercooled (water is cooled to a temperature below the freezing point without freezing). 
Hobbs (1974) reported that homogeneous nucléation can not occur for extremely pure 
water until it is supercooled to near -40°C. Conversely, heterogeneous nucléation must 
depend on a foreign particle, which is larger then 10 nm (Franks 1982), making an ice 
embryo grow clinging to it. The heat o f fusion is extracted by conduction through the ice 
that has already formed on the foreign particle. The unfrozen water possesses high 
cooling efficiency than any region of convex curvature, and a smooth interface is restored 
prior to freezing of the convex region, thus the water-ice interface tends to remain flat 
(Chalmers 1959).
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Irrespective o f the nucléation process, an ice embryo firstly forms and grows step 
by step till it reaches a critical size, when the freezing process predominates; the ice 
crystal will continue to grow by adding water molecules to its crystal structure, as bricks 
are filled into the construction o f walls (Chalmers 1959). In short, ice is a solid consisting 
o f a crystallographic arrangement o f water molecules (Glen 1974). Moreover, the purely 
electrostatic attraction between counter charged molecules strongly bonded these water 
molecules, which results in the great regular and symmetrical structure of an ice crystal 
(Glen 1974).
6.2 Impurity Separation during Freezing
Freeze concentration totally is a physical process, and ice formed during this 
process has highly organized structure as previously mentioned. Therefore, when freezing 
occurs, if  solute concentration is not very low and the freezing process is enough slow 
(Chalmers 1959), so that the impurities and water molecules separate, each going their 
own way; each ice crystal continues to grow as long as water molecules are available. 
And all other impurities and solid particles, due to the strong attraction between water 
molecules (Glen 1974), carmot incorporate into the ice crystal lattice and are kept ahead 
o f the boundaries o f the ice crystal where they become compressed or dehydrated 
(Chalmers 1959), which resulting in pure water obtained (Halde 1979). Consequently, the 
concentration o f soluble impurities in the liquid phase is higher than in the solid phase 
(ice). If the ice front advances at a rate too rapid for the solute diffusion process, a 
concentration gradient will be created.
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In fact, impurity separation process during freezing is complicated, especially for 
diversiform solutes and solution in practice. In sections to follow, different impurity 
separations during freezing are discussed based on various solutes (inorganic or organic) 
and different conditions (simple or complex solution).
6.2,1 Rejection of Inorganic Impurities in a Simple Solution
Traditionally, most o f the earth and the universe are inorganic (free o f C-H 
containing species). When considering inorganic chemistry and life, it is useful to recall 
that many species in nature are not compounds but are ions. Sodium, chloride, and 
phosphate are essential for life as are some inorganic molecules such as carbonic acid, 
nitrogen, carbon dioxide, water and oxygen (Internet-10, 2007). In this section, the 
behavior of inorganic impurities in a simple solution (i.e. synthetic water, non-mixing 
solution o f inorganic and organic) during freeze concentration will be firstly discussed.
Trace inorganic impurities cause specific changes in the physical and chemical 
properties o f the phase boundary o f growing ice during freezing process (Gross 1967). 
The populations o f ion and valence defects play the role in most o f these effects. For salts, 
during freezing of slightly impure water, the charge separation during the phase charge at 
the ice/water phase boundary resulting into some preferential ions are incorporated into 
the ice; for certain salts, the ice attains negative charge, for others, positive. When a very 
dilute solution o f certain salts freezes rapidly, a strong potential difference is established 
between the solid and liquid phases (lntemet-11, 2007). This mechanism was defined 
Workman-Reynolds effect. Gross (1967) using an apparatus achieving constant freezing 
rates systematically observed Workman-Reynolds effect of various simple inorganic
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solutions. According to the characteristics of the ion and charge transfer reactions. Gross 
(1967) divided all inorganic ionic solutes into three groups listed in Table 6-1.
Table 6-1 Different behavior o f various inorganic solutes in a simple solution
Group Inorganic Behavior at Ice/Water interface
1 Alkali halides and ammonium 
fluoride
Negative ions are preferentially 
incorporated into the ice; the 
solution electrode shows a positive 
potential; freezing potentials are 
strongly depended on concentration 
and freezing rate
11 Ammonium salt (except the 
fluoride) and lead salts
Positive ions are preferentially 
incorporated into the ice, but their 
number is always small; freezing 
potentials are high; charge transfer is 
always small
111 Halogen acids and carbonate-free 
bases o f alkali metals
No charge separation takes place; 
incorporation for the acids decreases 
from the hydrofluoric to the iodic
In the literature review of Gross (1967), the authors presented that Workman and 
Reynolds conceived the phase boundary structure as a double layer formed by ions 
selectively adsorbed at the ice surface, layers o f oriented water dipoles, and a diffuse 
ionic layer in the liquid. The thickness o f this double layer would be of the order of 
hundreds of Angstrom units. Therefore, the freezing potential phenomenon must 
introduce from at least three processes: differential adsorption at the phase boundary, 
differential incorporation into the ice structure, and differential diffusion into the liquid 
away from the ice/water interface, of which differential incorporation plays the dominant 
role. Gross (1967) summarized the experimental results done by many others with such 
Group 111 substances as HF, CsF and KF and found that samples grown from dilute 
fluoride solutions (10*  ̂ M or less) at low freezing raters (5 microns a second or less) 
behave like samples from dilute acid solutions because of differential ion incorporation
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that replace part of the cations by protons in the ice structure. Summary about 
conductivity changes o f doped with miscellaneous impurities o f Group I and II as a 
function of concentration at -10°C indicated that the salts among all solutes including 
LiOH, NaOH, NH4OH, LiF, NaF, LiCl, NaCl, KCl, RbCl, CsCl, and NH4CI did not 
obtain a clear concentration dependence of the conductivity. However, for NH4OH and 
NaOH, it was found that there was significant dependence of conductivity. Additionally, 
through investigation o f Pruppacher (1967) for the effect of miscellaneous inorganic 
compounds, the reduction of the freezing rate increased the concentrations of the 
impurity ions in the liquid phase.
6.2.2 Rejection of Organic Impurities in a Simple Solution
In contrast to inorganic, the mechanism of rejection of organic impurities from a 
simple solution seems different because the organic dissociation potential; molecular size 
or weight; or nature, location and number o f substituent groups did not affect recovery o f 
organic substances during freeze concentration (Baker 1966). Baker (1966, 1967, 1969, 
1970) did a systematic investigation of the process of freeze concentration of organic 
materials in simple aqueous solution. The effect of various factors including physical, 
chemical and mechanical parameters has been determined. All experimental studies 
focused many organic chemicals including phenol and substituted phenols, volatile fatty 
acids and acetophenone. Single-stage and cascades of single-stage freezing steps were 
used to recover quantitatively trace amounts of these solutes. Results indicated that 
physical factors including initial sample volume and mixing rate did not show influence 
on the recovery efficiency. However, geometric mechanical factors limited the final 
volume to which concentration could be made without loss in efficiency. In experiments
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of Baker (1966), if  the final volume is more than a limited final volume (30mL), 
essentially complete recovery of organic material can not be achieved with single-stage 
freezing. In addition. Baker (1967) further pointed out that mixing has no effect in 
distilled water and the absence of inorganic solutes, but when inorganic solutes were 
present, fi-eeze concentration efficiency of organic solutes was increased with increased 
mixing.
Many chemical factors such as pH, inorganic content and ionic strength were also 
investigated for the effect of freeze concentration efficiency of organic solutes. Initial pH 
did not influence organic recovery from distilled water (Baker, 1967). Addition of salts to 
distilled water solutions or increasing of ionic strength resulted in impaired efficiency of 
freeze concentration o f organic solutes, especially when concentrations of total dissolved 
salt content exceeded 10"̂  mg/L (Baker, 1967). Moreover, Baker (1967) explained the 
importance o f ionic strength affecting organic recovery, because ice morphology may be 
changed with formation of dendritic surfaces and incorporation o f solute-rich concentrate 
in the forming ice phase.
According to investigations of Baker (1966, 1967, 1969, 1970), ice washing was 
proven important for even high complete organic solute recovery. For instance, washing 
of ice formed from deionized water solution gave essentially complete organic solute 
recovery over the entire volume concentration range. Although washing of ice formed 
form solutions containing dissolved solids did not achieve complete recovery, it indeed 
improved organic solute recovery (Baker, 1969).
Liu et al. (1997, 1999) proposed and tested progressive freeze concentration of 
liquid foods including glucose, blue dextran and tomato juice. Progressive freeze
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concentration is a method o f freeze concentration based on a concept completely different 
from the conventional method of freeze concentration (suspension crystallization) being 
used for concentration of liquid food. The difference between the two methods is 
discussed in detail in section 6.3. According to their experimental results, a high speed 
stirring at the ice/solution interface and a low ice crystal growth rate resulted in the 
enhanced ice purity and the high concentration ratio between unfrozen liquid and mother 
solution. Moreover, through adding the ice-nucleating protein (0.01-0.1 wt%) into the 
mixture solution of glucose (5 wt%) and/or blue dextran (0.005 wt%), it was proven that 
the ice-nucleating protein can suppress the initial supercooling o f solution and effectively 
improved the concentration efficiency of the organic solutes during freezing (Liu et al. 
1997). Initial concentration o f solutes showed that in the investigation of Liu et al. (1999) 
with aspect to progressive freeze concentration of tomato juice, influence the 
concentration efficiency. A diluted system seems to much suit for progressive freeze 
concentration into high concentrated products. This conclusion also was reported in a 
similar research by Miyawaki et al. (2005).
6.2.3 Rejection of Impurities in a Complex solution
Freeze concentration o f organic solute in complex solution including mineralized 
waters and industrial wastewaters was also studied by Baker (1967, 1970). At the same 
experimental conditions, pH effect on recovery of organic solute in complex solution was 
different compared to simple solution with an example of m-cresol in a mineralized tap 
water. Single-stage freeze concentration efficiency of m-cresol increased as pH was 
decreased from 10 to 3 at initial and final volume ratios exceeding 5:1 but no effect on 
distilled water (Baker 1967, 1970). Additionally, there was no evidence possible o f the
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cation-ligand complex effect on freeze concentration efficiency o f organic solutes 
between pH 3 and 10. The individual components were not selectively separated firom 
complex solution (Baker 1967).
Yang et al. (1992) used freeze concentration to obtain concentrated and stable dye 
solution, because there is neither evaporatiom nor sublimation the solvent out o f the 
solution below dyes’ melting point. Utilizing simple experimental equipment involving a 
beaker and a freezer, the concentration of 500% and 13,000% of dyes solution were 
achieved using one step and three repetitive freezing cycles’ concentration, respectively. 
It is worthy to point out that the recovery of the dye after one freezing cycle can reach 
75% for only the dye in the concentrated solution, and the remaining 25% dye can be 
recuperated by freezing the melted ice from the first freezing, then further increase the 
recovery. Moreover, through comparing dye adsorption and color yield on cotton fabric 
between the dye solutions before (original) and after freeze concentration, no momentous 
difference was found in both of them, thus proved that freeze concentration did not alter 
the visual absorbance characteristics o f the dyes, namely, the dye solution after freeze 
concentration keeps the same dyeing competence as the original solution (Yang et al. 
I992y
Additionally, Yang et al. (1992) found that the solubility o f the dye influenced the 
recovery. Because the attractive forces between dyes and water prohibit the freezing 
process, concentrated abilities of dyes with higher water solubility are not as well as 
lower than the water solubility dyes as shown in Figure 6-1.
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Figure 6-1 Relationship between solubility and efficiency of freeze concentration. The 
numbers in the graph represent ten different dyes (Yang et al., 1992).
Concentration ratio =
concentration after freezing 
initial concentration
Initial concentration = 100 mg/L; initial nonfrozen solution volume = 60 mL. 
After freezing, total nonfrozen solution volume = 5 to 10 mL (Yang et al., 
1992).
Table 6-2 Removal efficiency 
(Lorain et al., 2000)
of freeze concentration for different wastewaters
Wastewater type Initial concentration Purified phase 
Q  (mg/0 Cs (mg/1)
Fretaing ratio Effidency 
*  (%) E  (%)
Urban After primary seitKng 270 49 64 883
After secondary settling « 6 72 93.3
Vinaigrette Raw 2865 834 57 83
After UF 2000 78 48 98
Mayonnaise Raw 955 82.5 70 94
After UF 460 14 58 98
Cutting oil After UF 3000 85 60 98
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Lorain et al. (2000) conducted freeze concentration experiments for complex 
wastewaters using a glycerin solution as cooling medium, and all experiments 
accompanied with rotation speed of 80rpm to achieve a good mixing of the liquid phase. 
Experimental results indicated different removal efficiency o f soluble pollutants in 
different wastewaters (Table 6-2). Additionally, because all soluble impurities were 
removed in the unfrozen liquid phase, it implied non-selectivity o f freeze concentration 
for all impurities.
F " '  ■ ’ '  ^
a. Ice cylinder produced at high freezing rate (11.7 mm/hr)
b. Ice cylinder produced at low freezing rate (2.1 mm/hr)
Figure 6-2 Visual comparison of ice cylinder color and clarity (Martel et al., 2002). 
(Freezing direction is left to right. Original samples are the same)
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A typical Army industrial waste (also called “pinkwater”) was conducted freeze 
concentration processes to remove such hazard substances as TNT (2,4,6-trinitrotoluene), 
RDX (hexahydro - 1,3,- trinitro - 1,3,5 - triazine), HMX (octahydro - 1,3„7 - tetranitro - 
1,3„7 - tetrazocine), TNB (1,3, - trinitrobenzene) and the degradation products 2 - Am - 
DNT (a - amino - 4,6 - dinitrotoluene) and 4 - Am - DNT (4 - amino - 2,6 - 
dinitrotoluene) in pilot-scale by Martel et al. (2002). The effects o f freezing rate (from
2.1 to 11.7 mm/hr) were primarily examined. Generally, either concentrated efficiency of 
impurities or quality o f the melt ice depends on the freezing rate, and freezing rate as low 
as 1.9 mm/hr (got from the liner line of best fit) would be required to high-quality melt 
ice. Even through visual observations (Figure 6-2), it is proven that the slower freezing 
rates products a clearer ice than fast freezing rate. The clear ice suggested the high 
rejection efficiency of impurities from ice crystals during freezing processes. However, 
the author figured out the low freezing rate o f 1.9 mm/hr is hard to achieve using 
conventional freezing equipment; therefore, a multi-stage freezing at a higher freezing 
rate was given as an alternative.
6.3Application of Freeze Concentration in Water and Wastewater 
Purification
Shapiro (1961) first applied freeze concentration technique to concentrate organic 
compounds as a potentially useful pre-analytical procedure. In past several decades, 
freeze concentration has been developed and applied in many fields including chemical 
concentration (Yang et al. 1992) and liquid food industry (Deshpande et al. 1984, Van 
Pelt, and Swinkels 1986, Anon 1989). Among these applications, liquid food industry
8 8
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include a variety o f products such as fruits juices (Bayindirli et al. 1993), coffee and tea 
extracts, beer and wine, vinegar, and dairy products (Hartel and Espinel 1993).
Actual implementation of freeze concentration for sea water desalination was 
never implemented on a large scale (Spiegler 1966, Ziering 1973); however, the potential 
of freeze concentration was investigated thoroughly, especially for the wastewater 
treatment. When most o f the wastewater is frozen, a large amount of clean water and 
concentrated wastewater should yield (Heist 1981). Because of the high concentrated rate 
of five to ten times of the residual wastewater. It is rather easy to further treat the 
condensate by certain concomitant methods such as burning upon drying, recovering 
useful components (lammartino 1975) or using other wastewater treatment systems. Test 
applications so far have included remediation of hazardous waste lagoons, concentrations 
of deep mine reject water, recovery of process materials from ammunition plant wastes, 








Figure 6-3 Two methods for freeze concentration (Miyawaki et al., 2005)
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With the development and increasing applications o f this technology, freeze 
concentration includes two practical methods: suspension crystallization and progressive 
freeze concentration as shown in Figure 6-3. Moreover, the differences between the two 
methods are tabulated in Table 6-3. Suspension crystallization for freeze concentration is 
a more commonly used method before the 1990’s.
Table 6-3 The differences o f suspension crystallization processes and progressive 
freeze concentration (Wynn, 1992)
Suspension crystallization Progressive freeze concentration
Crystal growth
Crystals freely suspended in melt.
Crystals grown as a layer on heat-transfer 
surface.
Crystals and melt at the same temperature. Crystals are colder than melt.
Driving force is super saturation. Driving force is temperature gradient.
Large inter facial area. Moderate interfacial area.
Poor interfacial turbulence. High interfacial turbulence.
Low mass-transfer rates. Moderate mass-transfer rates.
Phase separation
Large interfacial area. Moderate interfacial area.
Separation by filters, centrifuges, or decanters. Separation by gravity draining.
Driving force is the solid/liquid density 
difference.
Driving force is the liquid/gas density 
difference.
Solid/liquid separation is difficult. Solid/liquid separation is easy.
Product can be washed to improve purity. Product can be washed or sweated to improve 
purity.
Product is in solid form. Product is in liquid form.
During suspension crystallization processing as shown in Figure 6-3(a), the 
crystals are freely suspended in a melt. Such processes depend on density difference to 
promote countercurrent transport of crystals and melt. Ice crystals can grow large by 
Ostwald Ripening, an observed phenomenon in solid solutions which describes the
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evolution of an inhomogenous structure over time (Internet-12, 2007). In the Ostwald 
ripening mechanism (Huige and Thijssen, 1972), larger crystals grow from those of 
smaller size which have a higher solubility than the larger ones. In the process, many 
small crystals were formed initially but slowly disappeared, except for a few that grew 
larger, at the expense o f small crystals. The smaller crystals act as fuel for the growth of 
bigger crystals. Based on Ostwald Ripening, the freeze concentration began to be applied 
to concentrate coffee extract, fruits juice (Braddock & Marcy 1985, Deshpande et al. 
1982), dairy products (Hartel & Espinel 1993), and so on, and has been lately adopted in 
hazardous wastewater treatment (Holt 1999, Lemmer et al. 2001). However, the 
complicated freeze concentration system is required due to the size limitation o f ice 
crystals, which is composed of surface-scraper heat-exchanger for generation of seed ice, 
recrystallization vessel for ice crystal growth, and washing tower for separation o f ice 
crystals. Certainly, all o f the equipment made freeze concentration process more 
expensive than the other conventional methods of concentration such as reverse osmosis 
and evaporation (Rodriguez et al. 2000). Such factors as high expense and complicated 
operational systems have limited the applications of freeze concentration.
In order to improve the practical application of freeze concentration, the 
progressive freeze concentration as shown in Figure 6-3 (b) is developed in which a 
crystal layer is grown on a heat-transfer surface (Bae et al. 1994 and Liu et al. 1997). It is 
one method of melt crystallization (Atwood 1973, Gilbert 1991), which has been 
employed mainly to purify organic materials. Historically, the progressive freeze 
concentration was proposed as a small-scale concentration technique for a pre-analytical 
purposes, which is applicable to both aqueous and organic solutions (Matthews and
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Coggeshall 1959, Shapiro 1961, Baker 1963). Impurities in organic solvent were 
effectively concentrated by this method (Matthews and Coggeshall 1959). In this method, 
phase separation to facilitate countercurrent contacting is accomplished by gravity 
draining and functions irrespective o f density differences. In other words, since a single 
large ice crystal, instead o f many small ice crystals in the suspension crystallization 
method, is formed and grow on the cooling surface in a crystallization vessel. It easily 
achieves the separation between the ice crystal and the mother solution, which leads to 
the simple freeze concentration system which is distinctly lower in cost than the 
suspension crystallization.
Halde (1979) had frozen different kinds of sludges and found that separation is 
difficult and depends on many experimental factors such as the mixing rate, the size, and 
the ability o f the impurities to settle. The limiting factor is particle diffusion, which is 
often slower than the speed o f the advancing solid interface. In this case impurity 
entrapment tends to occur. Halde (1979) also suggested that non-soluble compound 
treatment is difficult. On the other hand, the freeze concentration seems to be more 
efficient for soluble compound separation.
Radial freezing with stirring was introduced to treat wastewater by Gay et al. 
(2003). The sky-scraping purification rates of up to 99.97% were attained due to the 
application o f stirring. Moreover, the qualities of treated water can reach drinking water 
standards.
Gao et al. (2003, 2004) used two spray freezing operations; partial and complete 
freezing, equipment similar to an irrigation system (spray guns or sprinklers), to treat 
industrial wastewaters such as pulp mill effluent and oil sands tailings pond water.
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Although the reduction efficiencies o f organic and inorganic contaminants were different 
and usually greater than 60% impurity removal in the spray ice was achieved when the 
freezing degree is 70% of the total volume of the sprayed water. And, during spray ice 
production, partially frozen wastewater obtained higher impurity removal efficiency 
compared with the completely frozen wastewater. Therefore, partially freezing is 
necessary to get higher quality recovered water from spray wastewater. Moreover, due to 
the simple operation as well as the economical and technical feasibility, freeze 
concentration became an alternative wastewater treatment technology in cold regions.
Corapttx
latlm atoi
Figure 6-4 Freeze concentration/incineration flow diagram (Niro Ltd., 1999)
Except to the aforementioned laboratory-scale investigations, two full-scale 
wastewater treatment plants have adopted freeze concentration processes. The first one 
founded in 1997 is an Asian chemical plant with almost a 2 MW load. A combination of 
freeze concentration followed by incineration is used by the plant. Figure 6-4 illustrates 
the freeze concentration/incineration processes. The freezing process takes place in 
surface-scraped heat exchangers with some ice seed in the recrystallizer vessels. Because 
of the ice crystal shape and counter current washing with by-product water, 100% pure 
spherical crystals grow in the recrystallizers which are separated from the concentrated
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liquid in wash columns. Finally, ultra pure water can be attained from the melted ice and 
the non-diluted concentrated to be incinerated (Niro Ltd. 1999).
In 1999, another unit with 3.5 MW load was started up in Europe. As for 
treatment processes, the two plants have no significant differences, but the European 
complex uses more recrystallization units (five in series) and wash columns (seven in 
parallel) than that o f the Asian plant (Niro Ltd. 1999).
According to practical operation of the two plants, for caustic wash water, Asian 
and European plant can achieve 18 and 34 million ton per hour water recovery, 
respectively, with <50 part per million total dissolved solids in recovered water (Niro Ltd. 
1999). Additionally, through comparing the total operational costs for the various 
systems at the Asian plant (Table 6-4), freeze concentration/incineration was proven to be 
viable economic approach compared to incineration especially in the presence of volatile 
organic compounds.
Table 6-4 Estimates o f the total operating costs for the various systems at the Asian 
plant (Niro Ltd., 1999)
Approximate cost 
per m^ feed
Thermal wet air oxidation & bio-treatment (both types) $30-45
Catalytic wet air oxidation & bio-treatment $35-50
Direct incineration $90-125
Evaporation & incineration (total stream) $70-95
Freeze concentration & incineration $35-50
As shown in Table 6-4, the freeze concentration and incineration costs are 
significantly lower than direct incineration and evaporation/incineration, and similar to 
any of the feasible oxidation steps and bio-treatment. However, the freeze concentration 
and incineration demonstrate three noteworthy advantages over the bio-treatment systems
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the drug concentration in water sample. So far, there are no standard methods to detect 
drug residues in water and it is still in the research stage. Some popular analytical 
methods for drug residues are summarized in Chapter 7.
95
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Chapter 7 ANALYTICAL METHODS
It is a real challenge to analyze PhACs in the environment, especially the 
low-concentration drug residues in aquatic environment. Although recently several 
methods have been developed for the determination of pharmaceuticals and their 
metabolites in the lower nanogram per liter range, the amounts of accepted method for 
analysis of these residual drugs are still limited in their available (Boyd et al. 2003). 
Certain approaches such as gas chromatography mass spectrometry (GC-MS), high 
performance liquid chromatography (HPLC) and liquid chromatography-mass 
spectrometry (LC-MS) were frequently adopted by many researchers: Koutsouba et al. 
(2003), Rodriguez et al. (2004), Lin et al. (2005), Sedlak et al. (2005), Bendetta et al. 
(1995) Blanchflowe et al. (1997), Zwiener and Frimmel (2004), Marchese et al. (2003), 
Gômez et al. (2006), Lee et al. (2007), Hamscher et al. (2002), Hilton and Thomas (2003), 
and Cahill et al. (2004).
Ail approaches are based on two primary chromatography (GC and LC) 
accompanying with different detectors such as MS and tandem MS. The choice of GC 
and LC is usually relied on the physicochemical characteristics of the target PhACs 
(Boyd et al. 2003). For example, most GC methods must incorporate a derivatization step 
to overcome the thermolabile property of many polar pharmaceuticals and their 
metabolites, but no this problem if using LC due to it does not need a derivatization step 
(Cha et al. 2005).
Detection limits achieved by these analytical methods such as GC-MS, HPLC and 
LC-MS vary depending on sample origin and the objectives of a specific application. 
They cover a wide range from ng/L to pg/L (Sacher et al. 2001, Metcalfe et al. 2003, Lee
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et al. 2003, 2005, Lindqvist et al. 2005, Chia and Huang 2005). The complexity of a 
sample matrix may complicate the sample preparation procedure and cause high levels of 
interference in the final extract, which can make the proper identification and 
quantification of target parameters difficult. A traditional way to reduce the effects of 
both background and potential interferences on the accuracy o f the quantification process 
of target analytes is to use in tandem or some times even triple mass spectrometry 
techniques. The advantages of these methods, in comparison to single MS, are increased 
sensitivity and greater selectivity. This approach also allows method detection limits 
(MDLs) to be achieved in the range from 0.1 to 1 g/L even for such samples as municipal 
wastewater or solid matrices (Verenitch et al. 2006). Therefore, numerous experimental 
batches extended from three foundation methods (GC-MS, HPLC and LC-MS) are 
prevailing in pharmaceuticals analysis works, i.e., GC-MS/MS, HPLC-MS, 
HPLC-MS/MS and LC-MS/MS.
In the present study, the most advanced aspects of current GC-MS, HPLC and 
LC-MS as well as their expansion methodologies for PhACs analysis are summarized in 
the following sections.
7.1 Extraction Processes
Because most PhACs are usually present at very low concentrations (<pg/L as 
described in Chapter 3) in samples for complex aquatic environmental, nearly all 
techniques of analysis o f PhACs in environmental matrices are applied after clean-up and 
enrichment steps except for PhACs to be persistent in the environment for them to be 
detected (Robinson et al. 2007). Owing to the development of new generations o f sorbent 
materials, solid-phase extraction (SPE) or solid-phase microextraction (SPME) other than
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liquid extraction (LE) have became popular extraction processes in water studies 
(Robinson et al. 2007).
The use o f different sorbents in the extraction cartridge ensures more complete 
retention and better reproducibility of PhACs than liquid/liquid extraction. And the other 
the problems associated with liquid/liquid extraction, such as use o f expensive, breakable 
specialty glassware, and disposal of large quantities o f organic solvents can be prevented 
with SPE. In summary, SPE is more efficient than liquid/liquid extraction, yields 
quantitative extractions that are easy to perform, is rapid, and can be automated. Solvent 
use and lab time are reduced using SPE to pre-treat target PhACs solutions (Internet-13 
2007).
On the other hand, such advantages as less required sample volume, solvent-free, 
and easily automated, which allows high enrichment factors in the concentration of 
organic compounds in aqueous matrices (Huppert et al. 1998, Rodriguez et al. 2004), 
demonstrate the distinctly predominance of SPME over SPE during gas chromatography 
mass spectrometry (GC-MS) analysis of PhACs .
Certainly, SPE can be coupled on-line with the LC-MS systems, allowing the 
transfer o f the whole extract into the chromatographic system, thus either reducing the 
sample volume that has to be extracted or increasing the method sensitivity. Recently 
Quintana et al. (2006) presented an automated, on-line renewable, solid-phase 
extraction-liquid chromatography method and achieved recoveries o f >8 8 % of certain 
NSAlDs including ketoprofen. Such automated online SPE-LC-MS systems are highly 
attractive due to their high sensitivity and high reproducibility with almost complete 
elimination o f the risk o f contamination.
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7.2 Gas Chromatography-Mass Spectrometry (GC-MS)
7.2.1 Description
Gas chromatography-mass spectroscopy (GC-MS) is a method that combines the 
features o f gas-liquid chromatography and mass spectrometry to identity different 
substances within a test sample. Gas chromatography uses the difference in the chemical 
properties between different molecules in a mixture to separate the components of a 
mixture, and mass spectroscopy characterizes each of the components individually by 
breaking each molecule into ionized fragments and detecting these specific fragments for 










Figure 7-1 Scheme of typical GC-MS instruments. (Internet-14,2007)
The primary goal of chemical analysis of GC-MS is to identify a substance by 
comparing the relative concentrations among the atomic masses in the generated 
spectrum to a spectrum library to see if its characteristics are present for some sample in
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the library. Another analysis application is to measure the peaks in relation to one another, 
with the tallest peak receiving 1 0 0 % of the value, and the others receiving proportionate 
values, with all values above 3% being accounted for. The parent peak normally indicates 
the total mass o f the unknown compound. This value can then be used to fit a chemical 
formula containing the various elements assumed to be present in the compound. The 
isotope pattern in the spectrum, which is imique for elements having many isotopes, can 
also be used to identify the presence of various elements. Once a chemical formula has 
been matched to the spectrum, the molecular structure and bonding can be identified, and 
needs to be consistent with a substance of the characteristics recorded by GC/MS. The 
fitting is normally done automatically by programmers which come with the machine, 
given a list o f the elements which could be present in the sample.
A “full spectrum” analysis considers all the “peaks” within a spectrum. However, 
selective ion monitoring (SIM) which looks only at a few characteristic peaks associated 
with a candidate substance, can also be done. This is done on the assumption that at a 
given retention time, a set o f ions is characteristic of a certain compound. This is a fast 
and efficient analysis, especially if one has some prior information about a sample or are 
looking for a specific compound. When the amount of information collected about the 
ions in a given gas chromatographic peak is reduced, the sensitivity o f the analysis goes 
up. So, SIM analysis allows a smaller quantity of a compound to be detected and 
measured, but the degree of certainty about the identity of that compound is reduced.
7.2.2 Application in Detecting PhACs
Among the existing literatures cited in this chapter, the main applications of 
GC-MS are determination of acidic drugs on aquatic environment. Medicinal-class drugs
1 0 0
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including NSAIDs and lipid regulators are also called acidic drugs due to their specific 
chemical characteristics such as polarity, hydrophilicity and pKa around 4.0 (Verenitch et 
al. 2006, Farré et al. 2007) based on their chemical structures containing carboxylic 
moieties and one or two phenolic hydroxyl groups (Temes 2001). These acidic drugs can 
be determined at low-ng/L concentrations means of GC-MS or GC-MS/MS after 
pre-treatments like extraction (Chia and Huang 200, Verenitch et al. 2006). However, a 
derivatization step must be performed before gas chromatography analysis o f acidic 
drugs in order to increase the volatility, decrease the polarity o f these analytes, and in 
some cases to improve their detection e.g., pentafluorobenzyl bromide (PFBBr) permits 
analytes to be determined by electron-capture detection or electron-capture MS 
(Koutsouba et al. 2003).
In addition, according to different derivatization methodologies and matrices of 
acidic pharmaceuticals, the limits o f quantification (LOQs) of GC-MS or GC-MS/MS 
varied from ~I ng/L to high ng/L (Temes et al. 1998, Buser et al. 1998, 1999, Koutsouba 
et al. 2003, Rodriguez et al. 2004, Lin et al. 2005). For instance, as listed in Table 7-1, 
LOQs down to 10 ng/L were achieved in sewage treatment plant effluents as well as in 
surface water using GC-MS, and ~1 ng/L using GC-MS/MS (Temes et al. 1998). 
Moreover, some examples of derivatization pathways used in acidic dmgs analysis are 
shown in Figure 7-2.
1 0 1
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Table 7-1 LOQ for different matrices (Temes et al. 1998)
Analytes LOQ in STP" GC-MS (ng/L)
LOQ in SW” 
GC-MS (ng/L)
LOQ in DW" 
GC-MS/ MS (ng/L)
Acetylsalicylic acid (A.S.A) 50 10 10
Clofibric acid 50 5 1
Ibuprofen 50 5 1
Gemfibrozil 50 5 5
Fenoprofen 50 5 5
Ketoprofen 50 5 5
Diclofenac 50 5 1
Fenofibric acid 50 5 5
Bezafibrate 250 5 25
Indometacine 50 5 5
Naproxen 50 10 n .a “
Tolfenamic acid 50 2 0 n .a “
Meclofenamic acid 50 2 0 N.A"
“ Sewage treatment plant (STP) effluent. ° 
’’ Surface water. *
Drinking water. 
Not analyzed.
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Figure 7-2 Examples o f derivatization pathways for GC-MS analyst of NSAIDs.
TMSH: trimethylsulfonium hydroxide;
BSTFA: bis (trimethylsilyl)trifluoroacetamide;
MSTFA:N-methyl-N-(trimethylsilyl)trifluoroacetamide (Farré et al. 2007).
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Among the available alkylating reagents, diazomethane poses high reactivity 
toward most acidic groups, thus became the most common derivatization reagent for 
analysis o f acidic pharmaceuticals (Buser et al. 1998, Oilers et al. 2001, Tixier et al. 
2003). SPE-GC/MS achieved detection limits o f 0.1-10 ng/L for various NSAIDs and 
lipid regulators analysis in different matrices (i.e., drinking water, surface water and 
wastewater) (Buser et al. 1999, Oilers et al. 2001). However, the toxicity, carcinogenicity 
and explosiveness o f diazomethane made alternative derivatization procedures must be 
developed like alkyl halides. Pentafluorobenzyl bromide (PFBBr) is a good example. 
Many authors, for instance Reddersen et al. (2002) and Koutsouba et al. (2003), 
derivatized polar pharmaceuticals using PFBBr coupling with other reagents such as 
triethylamine and N-(tert-butyldimethylsilyl)-N-methyltrifluoroacetamide (MTBSTFA) 
as catalyst and followed by GC-MS with limits of detection of 1 to 10 ng/L.
On-column or in-port alkylation can be accomplished by tétraméthylammonium 
hydroxide (TMAH) or trimethylsulfonium hydroxide (TMSH) and other alkyl analogs, 
which undergo pyrolytic decomposition at the GC injection temperature, donating alkyl 
groups (methyl groups in these cases) and yielding trimethylamine or dimethylsulfide, 
respectively, as decomposition by-products (Zapf and Stan 1999). While TMAH may 
damage the analytical column, TMSH is less reactive. On-column derivatizations of 
NSAIDs were reported by Jux et al. (2002) using both trimethylsulfonium hydroxide 
(TMSH) and trimethylanilinium hydroxide (TMAH) in methanol; however, with TMSH 
small molecular by-products are not detected as they remain in the solvent peak of the 
chromatogram. TMAH produces aniline as a by-product which can interfere with the
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analysis. Methyl chloromethanoate is another derivatization agent worthy o f mentioning 
(Weigel et al. 2002, Bendz et al. 2005).
On-line derivatization in the injection port and using a large volume sample 
injection with tetrabutylammonium (TBA) salts has been reported to be a rapid and 
simple alternative to conventional derivatization methods for pharmaceutical residues 
(Lin et al. 2005). Nevertheless, the most widely used alternatives to diazomethane are 
silylating agents. There are two main classes o f silylating agents: those producing 
trimethylsilyl (TMS) derivatives and those producing tert-butyldimethylsilyl (TBDMS) 
derivatives. TMS derivatives can be produced by a wide variety o f reagents, like N,0-bis 
(trimethylsilyl)trifluoroacetamide (BSTFA) and N-methyl-N-(trimethylsilyl) 
trifluoroacetamide (MSTFA). TBDMSderivatives are prepared by reaction with 
N-methyl-N- (tert-butyldimethysilyl)trifluoroacetamide (MTBSTFA). At present, the 
majority o f derivatizations applied in NSAID analysis are based on alkylsilyl reagents 
such as MTBSTFA and MSTFA (Kosjek et al. 2005). The resulting TBDMS derivatives 
have greater thermal and hydrolytic stability (e.g., they can tolerate about 1% water 
(Rodriguez et al. 2005)) compared to TMS derivatives; furthermore, EI-MS spectra of 
TBDMS derivatives are normally characterized by a base peak corresponding to the loss 
of the tert-butyl group from the molecular ion, which when added to their higher 
molecular mass improves chromatographic separation and MS detection (Woo and Kim 
1999). However, the drawback of TBDMS reagents compared to TMS reagents is their 
lower reactivity. Rodriguez et al. (2003) described the determination o f five NSAIDs 
(ibuprofen, naproxen, ketoprofen, tolfenamic and diclofenac) in sewage using MTBSTFA 
as derivatization agent followed by GC-MS with quantification limits for sewage water
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ranging from 20 to 50 ng/L. Recently, Lee et al. (2005) reported the determination of 
phenols and acidic pharmaceuticals including salicylic acid, ibuprofen, naproxen and 
diclofenac using derivatization by MTBSTFA with 1% tert-butyldimethylsilyl (TBDMS).
GC-MS also can used to detect P-blockers and p-sympathomimetics, but similar 
to acidic drugs, an efficient derivatization is essential, because both P-blockers and 
P-sympathomimetics contain a secondary aminoethanol structure as well as several 
hydroxyl groups, and these functional groups lead to their relatively high polarity. 
Additionally, due to their structures of multiple-function groups, the derivatization 
processes commonly consist of two steps in order to get the complete and stable 
derivatives of both aminoethanol and hydroxyl groups (Temes et al. 1998).
Temes et al. (1998) adopted a method including SPE and derivatization coupling 
with GC-MS detection and achieved detection down to 5 ng/L o f 11 betablockers and 
P-sympathomimetics, at the same time; they got exceeding 70% recovery. The use o f an 
acidic pH would be appropriate for the protonation of acidic phenolic hydroxyl groups, 
but is disadvantageous for the desired deprotonation of the secondary amino moieties. 
Because of enhanced sorption effects o f the betablockers, presumably caused by the 
secondary amino group, losses by sorption on active glass surfaces as soon as they are 
dissolved in aqueous matrices should be avoided. For instance, the usage o f glass vials 
for the final phosphate buffer extraction volume leads to reduced recoveries o f the 
betablockers, while in PTFE vials or in organic solvents no sorption losses were observed 
(Temes et al. 1998).
Neutral pharmaceuticals such as the most used antiepileptic carbamazepine are 
referred to some different compounds from distinct medicinal classes which contain no
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acidic functional groups and, hence, can be enriched at neutral pH in the reversed phase 
and sorbents can usually be analyzed by GC-MS without derivatization. Temes et al. 
(1998) also observed many neutral dmgs and got in excess of 70% recovery as well as 
LOQs of 20-50 n/L and 100-250 ng/1 in drinking water and STP effluents, respectively. 
However, the determination of certain neutral drugs such as phenazon, carbamazepine, 
cyclophosphamide, ifosfamide and pentoxifylline was frequently subject to interference 
by organic co-extractants in real samples of rivers and sewage effluents.
7.3 High Performance Liquid Chromatography (HPLC)
High-Performance Liquid Chromatography (HPLC)
Continuous flow of solvents 







Sample preliminary clean-up and 
injected into qfstem
Figure 7-3 Scheme of typical HPLC instmments (lntemet-16, 2007)
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In contrast to GC, HPLC is a form of liquid chromatography to separate 
compounds that are dissolved in solution. The work flow line of HPLC is similar with 
GC-MS and includes separating components, analyzing molecules and finally printing to 
a spectrum. Typical HPLC instruments consist o f a reservoir of mobile phase, a pump, an 
injector, a separation column, and a detector as shown in Figure 7-3.
Compounds are separated by injecting the analyte onto the column under the high 
pressure pump. The different components in the mixture pass through the column and are 
retarded by specific chemical or physical interactions with the stationary phase as they 
traverse the length o f the column. The amount of retardation depends on the nature of the 
analyte, stationary phase and mobile phase composition. The retention time at which a 
specific analyte elutes (comes out o f the end of the column) is considered a reasonably 
unique identifying characteristic of a given analyte. The detector serves as the "eyes" o f 
the HPLC system to attain the analysis results. Finally, these analytial results are 
transmitted to the computer and are recorded in the form of chromatogram. (Internet-15, 
2007).
As discussed previously, GC-MS is one of the most common techniques (Weigel 
et al. 2004, Quintana et al. 2004). However, some of drug compounds cannot be 
determined by GC without derivatization, because they are thermally unstable, polar or 
ionic (Gdrdg 2007). In our experimental processes, derivatization step makes the sample 
preparation laborious and time-consuming, increases the possibility o f contamination and 
errors, and may lead to degradation o f labile compounds. Therefore, the introduction and 
rapid spread of HPLC undoubtedly demonstrate importance for the determination of 
involatile PhACs such as antibiotics (Meyer et al. 2000) and distinct advantages for those
107
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
polar compounds over GC-MS (Weigel et al. 2004, Nikolai et al. 2006). In HPLC 
technique, the common detectors companying with LC techniques include MS and 
ultraviolet (UV)-detector. Application of HPLC system with UV detection and 
appropriate preconcentration step allows developing simple and sensitive procedure for 
the analysis o f pharmaceuticals (Gordg 2007). However, the detect limits of HPLC-UV 
for PhACs are at the pg/L-level (Anna et al. 2007).
During the past decade, LC-MS via atmospheric pressure ionisation (API) 
interfaces, especially electrospray ionization (ESI), have become the analytical 
techniques o f choice for the determination of polar environmental pollutants including 
PhACs (Reemtsma 2003, Zwiener and Frimmel 2004). However, one drawback o f the 
electrospray MS technique during measurements of environmental samples is the signal 
suppression effect, which has a negative influence on the reproducibility and accuracy of 
the analyses (Temes 2001). Since matrix components can be rather variable between 
samples— in nature and in amount—their effects are difficult to predict. The mechanism 
of interference during the electrospray ionization process is still not clear (King et al. 
2000).
The use o f internal standards may compensate matrix effects. However, these 
effects can strongly depend upon the chromatographic retention time and more than one 
internal standard may be needed (King et al. 2000). Therefore, the pretreatments like SPE 
are usually essential prior to the LC-MS analysis in order to reduce the matrix effects in 
complex samples.
Chromatographic separation is another important process in reducing ion 
suppression. Although separation is not necessary using MS/MS detection, a complete
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chromatographic separation improves detectability and reproducibility. LC-MS/MS 
detection including time-of-flight (TOP) and quadrupole time-of-flight (Q-TOF) have 
showed many advantages in practice. For instance, for more polar compounds, the 
ubiquitous betablockers atenolol or sotalol could only be termined by LC-ES/MS/MS, 
and for the detection of neutral drugs, the detect limits o f LC-ES/MS/MS were improved 
to 10 ng/L from hundreds o f ng/L o f GC-MS, and independent from the water matrics 
(Temes et al. 1998).
The main advantages of Q-TOF-MS are the availability o f full-scan mass spectra 
throughout each chromatogram (Marchese et al. 2003). However, one of the most 
important drawbacks o f LC-TOF/MS for quantitative measurements of environmental 
contaminants is the effective linear dynamic range (typically two to three orders of 
magnitude) which is significantly lower than the quadrupole instruments dynamic rpige 
(typically >4 orders o f magnitude). Marchese et al. (2003) compared QqQ instrument and 
a hybrid Q-TOF-MS for the determination of analgesics in water. The quantity limits 
obtained for the TOF experiment were approximately three to five times greater than 
those obtained using a QqQ-MS operating in MRM mode. Limits of quantification 
(LOQs) estimated were less than 3 ng/L for each analyte. The between-day precision and 
linear dynamic range results o f the method with the QTOF analyzer were similar to those 
obtained using QqQ (MRM) analysis. Petrovic et al. (2003) developed a new 
multiresidue method using ultra-performance liquid chromatography (UPLC) Q-TOF-MS 
for screening and confirmation of 29 pharmaceutical including NSAIDS. UPLC uses 
columns packed with 1.7-pm particles and enables elution o f sample components in 
much narrower, more concentrated bands, thus permitting very good separation of all
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compounds in 10 min. The detection limits (MDLs) reported by Petrovic et al. (2003) 
ranged from 10 to 500 ng/L for wastewater samples.
Table 7-2 summarizes the main applications of liquid chromatography coupled to 
the different mass spectrometric techniques. In general, although LC-based methods can 
achieve lower detection limits than GC-based methods, LC-based methods belong to 
lately developing techniques thus they still cannot completely instead of GC-MS or 
GC-MS/MS in drugs analysis.
Table 7-2 LC-based methods used for the quantitative determination o f NSAIDs in 
water samples (Farré et al. 2007)
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Chapter 8 MATERIALS AND METHODS
8.1 Materials
8.1.1 Drugs Selected for Experimentation
Acidic drugs including NSAIDs and lipid regulators are mainly medicinal classes, 
and are frequently found at high concentrations in water systems as discussed in Chapter 
2 and 3. In this study, we selected three acidic drugs including acetylsalicylic acid, 
ibuprofen and gemfibrozil, as well as one beta-blocker metoprolol and one antibiotic 
sulfamethoxazole as our primary objects. All drugs studied in this thesis are listed in 
Table 8-1 and were purchased from Sigma-Aldrich Chemicals Canada.
Each individual stock solution of each drug at lOOpg/mL was prepared in 
acetonitrile for the preparation of calibration standards and freezing original samples. But 
for a mixture of multiple drugs (each at 50pg/mL), acetone was used as a solvent. Mthyl 
tert-butylether (MTBE) was used to extract the drug in the solution. Sodium sulfate 
removed any residual water in MTBE extract. These solution, acetonitrile, acetone, 
MTBE and sodium sulfate, were obtained from Sigma-Aldrich Chemicals Canada. The 
silylating agent, N,0-èA(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% 
trimethylchlorosilane (TMCS), in 0.1-mL ampoules, was obtained from Supelc. A 
solvent, wo-octane, for the derivatives o f GC-MS analysis was also gotten from 
Sigma-Aldrich Chemicals Canada. Solid-phase extraction (SPE) cartridges (Oasis® HLB, 
6 mL, 0.2 g, part no. WAT 106202), were purchased from Waters.
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pKai acid dissociation constant, is an equilibrium constant for the dissociation o f a weak acid. 
Kow: the octanol/water partition coefficient.







8.1.2 Water Sample Preparation
Low concentration (lOng/L, 50 ng/L and 100 ng/L) water samples (single drug 
solution) for freeze concentration were prepared based on following steps.
Step 1: Each individual stock solution of each drug at 100 pg/mL was prepared in 
acetonitrile for the preparation of calibration standards.
Step 2: Based on predicted drug concentration in feed water sample, spiking 100 pg/mL 
stock solution o f needed volumes in distilled water was prepared. For very low 
initial concentration such as 10 ng/L and 50 ng/L, the stock solution was diluted 
a few times in acetonitrile.
Water samples containing high drug concentration (> 5 mg/L) included single 
drug sample and five drugs mixed samples. Individual drug was firstly dissolved in 1 mL 
acetone, and then distilled water was added to preferred sample volume. On the other 
hand, five drugs simultaneously mixed in 5 mL acetone first and finally the 5 mL solution 
was spiked into distilled water to get predicted sample.
8.2 Sample Analysis
8.2.1 pH
pH analyses o f all samples were performed with Thermo Orion Model 710A+ pH 
meter in accordance with the section 4500-H^ B of Standard Methods (1998). The pH 
meter had a relative accuracy of ± 0.001 pH units. All determinations were conducted in 
triplicates.
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8.2.2 Conductivity
Conductivity analysis was determined in accordance with the section 2510 B of 
Standard Methods (1998). The conductivity measurement instrument used was advanced 
conductivity meter (Thermo Orion 162A). All determinations were conducted in 
triplicates.
8.2.3 Total Organic Carbon
Total organic carbon (TOC) samples were analyzed by using Dohrmann TOC 
Analyzer following the method described in section 5310 C of Standard Methods (1998). 
TOC test was done for the samples containing high drug concentration, of which were 
original samples never passed through freeze concentration and other sample prepared in 
two-stage freeze concentration. All determinations were conducted in duplicates.
8.2.4 Gas Chromatography-Mass Spectrometry
The concentration in the feed water, the liquid-phase, and the solid-phase (melted 
ice) concentrations were analyzed in GC-MS, and are denoted as Co, Cl and Cs, 
respectively. The separated efficiency (E) is referred to as the mass of impurity removed, 
and can be considered as the ratio between the quantity of the pollutant entrapped in the 
solid phase (ice) and the total quantity of pollutant as estimated by the equation (8.1). The 
recovery efficiency (R) can be considered as the ratio between the quantity o f the 
pollutant entrapped in the liquid phase and the total quantity of pollutant as estimated by 
the equation (8.2).The freezing ratio R? (freezing degree) is obtained from the equation 
(8.2).
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E = ( i - ^g- ^g.)xlOO% (8- 1)
c . x v /
R = X100% (8-2)
C .x V ,
R , = ^  X100% = (1 -  ̂ )  X100% (8-3)
F V  V
0 0
Where:
E = separated efficiency;
Cs = drug concentration in the solid -phase sample (melted ice);
Vs = volume of the melted ice;
Co = drug concentration in the feed water;
V o = volume of the feed water;
R = recovery efficiency;
Cl = drug concentration in the unfrozen liquid;
Vl = volume of the unfrozen liquid 
Rp = freezing ratio.
8.2.4.1 Sample Preparation
For the three acidic drugs (ASA, IBU and GEM), the method described by Lee et 
al. (2003) was used as a reference in method. Each set of samples which included blank 
and duplicate samples, was prepared in a batch in the lab at Lakehead University. 
Following by solid phase extraction including adjusting the samples pH, passing the 
samples through the extraction columns, drying the samples, resuspending the samples
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and derivatization o f the samples. Finally, the derivatized drugs were analyzed by 
GC-MS.
1) Solid phase extraction
A 6 - mL, 200-mg Oasis® HLB was conditioned by elution with 5 mL of methanol, 
followed by 10 mL of water at pH 2. Via a siphon tube, each sample was applied to the 
extraction cartridge using a 1-L glass separatory funnel. A flow rate of 5 mL/min was 
maintained by adjusting the system vacuum. When the extraction was complete, the 
cartridge was dried under full vacuum for 1 minute. Then, the cartridge was eluted with 
two 2.5-mL aliquots of methanol to remove the adsorbed drugs. The methanol extract 
was evaporated to about 300 pL and was back extracted by 5 mL of methyle 
terf-butylether (MTBE) in 2-, 1-, 1- and 1-mL fractions. After adding much anhydrous 
sodium sulfate to remove any residual water, the MTBE extract was evaporated to 50pL 
and putted into a 1.8 mL GC autosampler vial.
2) Derivatization
The addition o f the trimethylsilyl (TMS) group(s) to selected drugs (polar 
compounds) confers thermal and chemical stability in addition to enhanced volatility 
(Blau and Halket 1993). One hundred microlitres of 
N,0-6A(trimethylsilyl)trifluoroacetamide (BSTFA) with 1% trimethylchlorosilane 
(TMCS) was added to the MTBE extract and maintained at 60 °C for 20 minutes to form 
the trimethylsilyl (TMS) derivatives. Finally, the derivatized sample was adjusted to 1.0 
mL in wo-octane for GC/MS analysis.
116
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3) GC-MS Operation
GC-MS is the primary analysis o f drugs used for human therapy (excluding 
antibiotics) (Sedlak et al., 2005). GC-MS analyses of these pharmaceuticals as their TMS 
derivatives were performed with a CP 3800 gas chromatograph equipped with a 
VARIAN CP-8400 automatic liquid sampler and a VARIAN 1200 Mass Selective 
detector. Separation o f the derivatives was achieved with a 30mx0.25 mm I.D., 0.25 pm 
film thickness, fused silica capillary column (VF-5MS) using the following temperature 
program: initial temperature 50 °C, 1-min hold, oven temperature ramps 30 °C/min from 
50 to 150 °C, and 10 °C/min from 150 to 280 °C. The oven temperature was kept at 280 
°C for 6  minutes. A constant carrier (helium) flow of 1 mL/min was maintained. The 
injector temperature was 250 °C. Samples in 1-pL aliquots were injected in the splitless 
mode with a splitless time o f 1 minute.
For quantitative analyses, selected ion monitoring (SIM) was used and the 
characteristic ions chosen for each derivative are listed in Table 8-1.
8.3 Experimental Procedures (Unidirectional Downward Freezing)
The synthetic water samples were partially frozen, and 80% ice and 20% water 
were produced under different experimental conditions. Unidirectional downward beaker 
freezing experiments were carried out in a cold room at -7°C and -15°C, which were the 
warm and colder temperatures o f the cold room. The dimensions of the cold room are
2,362.2 mm (L), 2,362.2 mm(W) and 2,286.0 mm(H). The temperature fluctuation o f the 
cold room was low according to frequent monitoring of the temperature. As shown in 
Figure 8-1, plastic beakers (lOOOmL) were used for the freezing, because glass beakers
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might break down at low temperatures. Beakers were insulated except the top so that the 










4-  Stir Bar
Figure 8-1 Unidirectional downward freezing equipment
Sample volumes o f 1000 mL were used for 80% partial freezing. Samples were 
pre-cooled to near 0°C in the refrigerator before starting the beaker freezing test. Time 
required for 80% partial freezing o f lOOOmL at -7°C and -15°C were around 35 hours and 
19 hours, respectively. The upper portion of the beaker was the frozen portion (ice) and 
the lower portion of the beaker was the unfrozen portion (unfrozen liquid).
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The partial freezing of the samples was carried out in the beakers with stirring. A 
magnetic Fisher Stirrer (mini stirrer) was used for stirring operations. The stirrer was 
placed inside the cold room. To obtain the same extent of stirring for all the runs, the 
speed (300 imp) dial was fixed at 5 and a same magnetic bar o f 24 mm length.
When the desired volume was frozen (as judged by experience), the freezing was 
stopped, the unfrozen contents were sucked out from the plastic beakers by syringe and 
poured into an appropriate graduated cylinder. The volume of the concentrated solution is 
measured and recorded. The ice was melted and recovered. The partial concentrated 
liquid and the melted ice were subjected to the pH and conductivity analysis immediately 
and others were stored in sample bottles in side a refrigerator waiting for GC-MS sample 
preparation to get quantification o f PhACs.
For low feed water concentration of selected drugs, the first freezing stage began 
with a prepared drug concentration of 10, 50, or 100 ng/L, the second freezing stage used 
only the concentrated drug solution from the first cycle. Therefore, we can evaluate the 
recovery of drugs by twice freezing cycles. However, for high initial concentration of 
selected drugs, the second cycle freezing is different with that of the low initial 
concentration o f selected drugs. The melted ice from the first cycle was used to perform 
the second cycle in order to examine the remove efficiency of drugs by freeze 
concentration.
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Chapter 9 RESULTS AND DISCUSSIONS
Synthetic water was used for unidirectional downward freezing experiments. The 
results from these experiments are presented and discussed in this chapter.
9.1 GC-MS Results
Because GC-MS is very sensitive analytical equipment, at least three calibration 
standards containing different drug concentrations had been simultaneously analyzed 
with the samples. Because GC-MS cannot stand water, each individual standard for each 
drug was prepared in acetonitrile. All standards also went through the same preparation 
processes as water samples. According to the standard curve, the concentration of water 
samples can be calculated. An example for each drug is presented in sections to follow.
9.1.1 Acetylsalicylic Acid Responses of GC-MS
As introduced in Section 7.2, GC-MS using full scan MS can determine unknown 
compounds/impurities in a sample. However, in SIM certain specific ion fragments are 
entered into the instrument method and only those mass fragments will be detected by the 
mass spectrometer. The benefits of using SIM analysis is that the typical detection limit 
can be lowered since the instrument is only looking at a handful of fragments (e.g., three 
fragments) during each scan and therefore more scans can take place each second. In this 
study, a high concentration (>0 .2  ppm) drug calibration standard solution was first 
analyzed in full scan mode to determine the retention time and the mass fragment 
fingerprint before detecting relatively low-concentration experimental sample by SIM
1 2 0
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instrument method. As shown in Figure 9-1, a full-scan chromatogram plot o f 1 mg/L of 
A.S.A, a huge peak was displayed at the retention time of 7.9 minutes in a typical broad 
range of mass fragments (m/z 40 to m/z 400) to monitor. The peak was confirmed as 
TMS derivative o f aspirin (Figure 9-2) by comparing the mass fragment to the data 
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Figure 9-1 Full-scan chromatogram plot of Ippm A.S.A. standard
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Figure 9-2 Derivatization of A.S.A.
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Figure 9-3 Chromatogram plots o f typical A.S.A. external calibration standards and 
unfrozen liquid from two-stage freezing
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Through full scan for a high-concentration test solution, a retention time o f A.S.A. 
was known around 7.9 mins. Therefore, the area of peaks shown at the retention time can 
be read from SIM chromatogram plots. For instance, the responses o f GC-MS four 
external calibration standards and a typical experimental sample were demonstrated in 
Figure 9-3. The four standards were prepared at the gradient concentrations of about 10, 
50, 100 and 250 ng/L. The experimental sample is a two-stage unfrozen liquid from feed 
water containing A.S.A of lOOng/L. M/z ratios 195.0 and 210.0 were selected to 
quantification o f each A.S.A test solution. At around 7.9 mins on the abscissa, except for 
the water sample, a series of area-increasing peaks appeared with the standard 
concentrations; therefore, peak area can be plotted with the correspondingly known 
A.S.A concentration in the standards. The trendlines for different m/z ratios were 
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Figure 9-4 A.S.A standard curves from GC-MS responses
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For the water sample shown in Figure 9-3, there was no significant peak shown at 
around 7.9 mins, which suggested no A.S.A in the sample, even the prepared feed water 
acetylsalicylic acid (A.S.A) concentration was as high as 100 ng/L, which was higher 
than that of the other drugs (ibuprofen and gemfibrozil) tested. Throughout experiments, 
hundreds of A.S.A solutions, including different concentrations o f A.S.A in feed water as 
well as their corresponding unfrozen liquid and the ice after first-stage freezing and 
second-stage freezing were analyzed. In addition, the volume of samples was also 
increased from 400mL to lOOOmL, but there is still no response shown in the 
chromatograph plot. Figure 9-3 (i) and (j) only showed a typical example of A.S.A 
solution which has theoretically highest concentration in all tested water samples. These 
results indicated that A.S.A easily degradation in aquatic environment and it is the 
primary reason leading to A.S.A water sample under detection limits in this study, which 
agreed with findings of other researchers. For instance, Verenitch et al. (2006) found the 
instability o f A.S.A in aqueous matrices, especially, during the méthylation process at 
high temperature in GC-MS analysis. Stable responses of the GC-MS for the external 
standards tested during the same time period indicated that the equipment was 
functioning well.
9.1.2 Ibuprofen Responses of GC-MS
Full spectrum of 1 mg/L of ibuprofen was shown in Figiue 9-5, a peak was 
displayed at the retention time o f 8 .8  minutes in a typical broad range of mass fragments 
(m/z 40 to m/z 400). The peak was confirmed to be TMS derivative of ibuprofen (Figure 
9-6) by comparing the mass fragment to the data library in the computer program.
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Figure 9-6 Derivatization of ibuprofen
Through full scan for a high-concentration test solution, a retention time of IBP 
was known around 8.8  mins. The responses of GC-MS to three external calibration 
standards are demonstrated in Figure 9-7. The three standards were prepared at the 
gradient concentrations o f 10, 50 and 250 ng/L. M/z ratios 263.0 and 278.0 was selected 
for IBP quantification. Additionally, the standard curves for IBP are illustrated in Figure 
9-8.
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Figure 9-8 IBP standard curves from GC-MS responses
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Figure 9-9 GC-MS responses of IBP samples
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Figure 9-9 showed a set of responses of ibuprofen samples at two m/z ratios in 
SIM method. These samples from freeze concentration experiments included feed water, 
first stage freezing unfrozen liquid and ice, and second stage freezing unfrozen liquid and 
ice. One sample from each group was used as an example for presentation in this section. 
According to the responses shown in Figure 9-9 and equation: y=275946x for m/z 263.0 
presented in Figure 9-8, the corresponding concentrations of these samples were 
calculated and the results were listed in Table 9-1.






























100 3.162E+06 1.145E+6 114.59 119.14 116.86
liquid
2"“ stage 
freezing ice 300 737825 309648 8.91 10.74 9.83
The first column in Table 9-1 is the name of water sample. The detected sample 
volume was listed in Column 2. Because the responses of GC-MS demonstrate impurities 
abundance in ImL concentrated sample from 1-L feed water, when the feed volume is 
not one liter, a volume ratio (1000 mL / real used volume in mL) must be taken account 
into the calculation o f concentration. For example, based on the GC-MS responses in
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Column 3, the concentration o f 11.39 ng/L of stage of freezing unfrozen liquid in 
default 1-L feed water was determined by using Eq. 9-2. However, the actual detected 
sample volume is 350mL, after given the volume ratio 1000mL/350mL, the real 
concentration o f the unfrozen liquid is 32.54 ng/L. The same as the calculation of 
concentration at m/z 263.0, the concentration at m/z 278.0 is shown in the sixth column. 
Finally, the average concentration was calculated from values o f two m/z ratios and was 
stated in final column.
9.1.3 Gemfibrozil Responses of GC-MS
Full spectrum of 0.2 mg/L of gemfibrozil is shown as Figure 9-10; a peak 
displayed at the retention time of 11.8  mins in a typical broad range o f mass fragments 
(m/z 40 to m/z 400).
'I'sts
Figure 9-10 GC-MS full spectrum of 0.2 ppm GEM external standard
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TMS Derivative of GemfibrozilGemfibrozil
Figure 9-11 Derivatization of GEM
The peak shown in Figure 9-10 was confirmed as the TMS derivative of 
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Figure 9-12 Chromatogram plots of typical GEM external calibration standards
The responses of GC-MS to three external calibration standards (10, 50 and 250 
ng/L) are demonstrated in Figure 9-12. The selected m/z for quantification o f each 
gemfibrozil tested solution was 194.0, 210.0 and 322.0. As shown in Figure 9-13, the 
values of the trendlines were 0.9759 and 0.9774, respectively.
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Figure 9-13 Gemfibrozil standard curves from GC-MS responses
As an example, Figure 9-14 and Figiue 9-15 show a set of responses of 
gemfibrozil samples from freeze concentration experiments at three m/z ratios. These 
samples included feed water, first stage freezing unfrozen liquid and ice (Figure 9-14), 
second stage freezing unfrozen liquid and ice (Figui e 9-15).
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Figure 9-14 GC-MS responses of gemfibrozil feed water and samples after 1st stage 
freeze concentration
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Figure 9-15 GC-MS responses of gemfibrozil samples after 2nd stage freeze 
concentration
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According to the responses shown in Figure 9-14, Figure 9-15 and the standard 
curve in Figure 9-13, the corresponding concentrations of these samples were calculated 
and tabulated in Table 9-2. Similar calculation method for ibuprofen was used to 
determine the concentrations in various samples.





















550 1.608E+7 9.397+7 2.148E+6 232.99 230.92 229.44 231.12
liquid
f  stage 
freezing ice








330 5.965E+6 3.521E+7 898262 144.05 144.20 159.91 149.39
9.1.4 Detection Limits of GC-MS
In the early testing of this study, the detection limits of GC-MS could reach 10 
ng/L for the three acidic drugs. However, after some repair work of the broken parts of 
the instrument in February, 2007, the detection sensitivity of instrument was significant 
lowered, it was no longer able to detect concentrations of the drug at the 10 ng/L level or 
even much higher concentrations as illustrated in Figure 9-16.
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Figure 9-16 Chromatograph plots o f 10 ng/L ibuprofen and gemfibrozil mixed external 
standard
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Figure 9-17 Full spectrum of 20 mg/L ibuprofen and gemfibrozil mixed external 
standard
There are some possible causes including the interference of the mixed drugs, and 
the instrument problem leading to the high detection limits. Firstly, a 20 mg/L 
mixed-drug standard was prepared for GC-MS analysis to find out the influence of 
ibuprofen on the analysis of gemfibrozil or vice versa. This result is shown in Figure 9-17 
and it indicates the close responses for two drugs at the same concentration. For example, 
20 ppm ibuprofen got an area o f 1.271 E-f-09, and the 20 ppm gemfibrozil attained the area 
o f 1.267E4-9 which have identical quantity dimension with area value of 20 ppm 
ibuprofen. In addition, the peaks o f the two drugs were obviously found to be lower than 
that of individual drug shown in Figure 9-5 and Figure 9-10. For example, Ippm
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ibuprofen standard (Figure 9-5) and 0.2 ppm gemfibrozil standard (Figure 9-10) show a 
peak greater than 150 GCounts (Giga counts: 10^) and 0.9 GCounts, respectively; 
however, the peaks shown in Figure 9-17 was only about 1 GCounts for each drug in 20 
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Figure 9-18 Chromatograph plots of ca. 250±8.2 ng/L individual ibuprofen and 
gemfibrozil as well as two drugs mixed external standards
A group o f parallel tests was done to further investigate the influence direction 
(increasing or decreasing) of mixed drugs on individual drugs. Figure 9-18 shows the 
experimental results at two m/z ratios for each drug. No matter in single drug solution or 
the standard for the mixed drugs, selected drugs were prepared at around 250±8.2 ng/L 
concentration within one hour on the same day before the analysis o f GC-MS.
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Figure 9-19 Comparison of GC-MS responses for individual ibuprofen, gemfibrozil and 
two drugs mixed standards at the same concentration of 250±8.2 ng/L.
Figure 9-19 illustrate obviously the increasing ibuprofen responses from the 
GC-MS, but for gemfibrozil looks a little bit increasing which may be leaded by the 
differences between prepared concentrations, because 246.0 ng/L gemfibrozil was in 
single gemfibrozil standard compared 258.0 ppt gemfibrozil in drug-mixed standard. The 
increasing responses o f ibuprofen in matrix are hard to explain and were never mentioned 
by other studies.
Another reason for different response of the GC-MS can be attributed to the 
replacement o f the part and contamination o f GC-MS column (VF-5MS) by the samples, 
which consequently could have lowered the precision of the equipment. It is noted that 
equipment has not been functioning at the levels before the repair.
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Figure 9-20 Response changes for 250 ±3.1 ng/L individual ibuprofen and gemfibrozil 
using fixed GC-MS compared to the old instrument used in the early 
studies.
Figure 9-20 shows the lower responses for individual ibuprofen and gemfibrozil 
o f closed concentration from repaired machine compared to the old instrument.
Additionally, there are many other reasons for lowering the precision o f the 
equipment. The plot of peak area with test date in
Figure 9-21 clearly demonstrates decreasing GC-MS responses o f each drug in 
the sequential testing. Two possible explanations may lead to the decreases. One is that 
the derivatization reagent, BSTFA, as mentioned previously is a contamination for 
GC-MS and easily makes the deviant working of the instrument. Because the instrument
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used in this study is public at Lakehead University, the GC-MS running o f different 
samples from other researches perhaps introduce unknown chemicals then influence the 
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Figure 9-21 Inconsistent GC-MS responses for 10 ng/L individual ibuprofen and 
gemfibrozil solutions obtained
In an effort to get more accurate analytical results and quality control, in addition 
to the external calibration standards, an internal standard of 2,3-D o f 10 mg/L for sample 
analysis was invoked. A typical SIM spectrum of drug-mixed standard solution with 10 
mg/L internal standard is shown in Figure 9-22. In the figure, (a) and (b) shows the 
results o f 20 ng/L drug-mixed standard at two m/z ratios (c) and (d) presents that o f 200 
ppb drug-mixed standard at two m/z ratios.
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Figure 9-22 A typical SIM spectrum of drug-mixed standard added 10 ppm 2,3-D
The difficulties experienced in this study and those reported by other researchers 
mentioned previously (in Chapter 7, PhACs Analytical Methods) suggest the inherent 
challenges o f using GC-MS for analyzing PhACs. Although the process o f whole 
research is really hard, lots of valuable results are still obtained and presented in the 
following sections.
9.2 Freeze Concentration Results
9.2.1 Ibuprofen
The experimental results indicated that ibuprofen was the most stable drug 
compared to A.S.A and gemfibrozil; therefore, more experimental results were attained.
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Based on single-stage freezing and two-stage freezing, the effect of different parameters 
on the freeze concentration of the drugs was presented in the following sections.
9.2.1.1 Single-stage Freezing of Ibuprofen
1) Effect of Initial Drug Concentration in Feed Water on Impurity Removal on 
Single-Stage Freezing
In this study, pH and conductivity as two typical parameters were firstly measured 
for each water sample. Additionally, slight impurities in distilled water as the main 
solvent for each group o f experiment were also taken account into the experimental 
results. Therefore, the counterparts o f the corresponding blanks were tested at the same 
time of analyzing water samples.
pH Change (Ibuprofen, single stage)
x-7°C 0 -15°C
o
i .  0.8 
0.6  -  
0.4 - 
0.2  -
20 40 800 60 1 0 0
Co (ng/L)
Figure 9-23 pH change in unfrozen liquid after single-stage freeze concentration for 
different ibuprofen concentrations in feed water
pH of unfrozen liquid
pH ratio =  -------- —--------- ------
pH of feed water
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Change o f pH in the unfrozen liquid samples versus the feed water sample is 
depicted in Figure 9-23. There is no obvious change in pH values with increasing 
impurity concentration. This phenomenon may be explained by the factor that the 
ibuprofen is a weak acidic and has pKa value of around 5.0 (Carballa et al. 2005). For a 
given acid, pKa values will vary depending on solvent other than impurity concentration 
solution (Intemet-20, 2007). In this study, distilled water is the main solvent to prepare 
synthetic water samples. The distilled water pH was in the range of 5.1 to 6.4 as shown in 
Figure 9-24, and pH value o f feed water was ranged from 5.0 to 6.2. The samples did not 















10 100 1000 10000 100000 1E+06 1E+07
Log Co (ng/L)
Figure 9-24 Comparison of pH between blank and ibuprofen feed water 
Blank is distilled water used to prepare the corresponding feed water.
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In contrast to pH, conductivity is a measure of the ability of an aqueous solution 
to carry an electric current. This ability depends on the presence of ions; on their total 
concentration, mobility, and valence; and on the temperature o f measurement (Clesceri et 
al. 1998). Consequently, the comparison of the conductivity values of blank and feed 
water for each group of freeze concentration was done, and the corresponding results are 
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Figure 9-25 Comparison of conductivity between blank and ibuprofen feed water 
Blank is distilled water used to prepare the corresponding feed water.
According to Figure 9-25, the conductivity of the distilled water used to repair the 
synthetic water samples varied. When the concentration of the drug was low, there was a 
slight decrease o f the sample conductivity. The small decrease o f the sample conductivity
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might be caused by bounding of the some impurities in the distilled water with ibuprofen 
molecules. With further increase o f the drug concentration, the sample conductivity 
increased accordingly. As a result, conductivity of a sample is an important impurity 
concentration indictor. Consequently, the conductivity ratios with corresponding 
concentration ratios are also taken account o f the presentation of the experimental results 
as follows.









Figure 9-26 Concentration ratio and conductivity ratio against ibuprofen concentrations 
in feed water (-7°C).
Rc = Concentration ratio :
Drug concentration in unfrozen liquid (C^) 
Drug concentration in feed water (Co)
^ , Conductivity of unfrozen liquidRd -1 = Conductivity ratio -1 = --------------- --------------------------
Conductivity o f feed water
^ _ Conductivity of unfrozen liquid
Rd - 2 = Conductivity ratio - 2 = ------------------- ------------------------------
Conductivity of blank (distilled water)
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Figure 9-26 and Figure 9-27 show that the ibuprofen concentration ratio in the 
liquid phase to the feed water at -7°C and -15°C, respectively. At the warmer temperature 
(-7°C), the recovery o f ibuprofen from feed water with high initial concentration is 
greater than that with lower initial concentration in feed water. However, results from 
-15°C freezing experiments (Figure 9-27) present that lower recovery efficiency was 
obtained from the more concentrated feed water.










Figure 9-27 C J  Co after single-stage freezing against ibuprofen concentrations in feed 
water (-15°C).
_ „   ̂ Drug concentration in unfrozen liquid (C, )Rc = Concentration ratio  ------------------------------------------ ------
Rd -1 = Conductivity ratio -1 = ■
Drug concentration in feed water (Co) 
Conductivity o f  unfrozen liquid
Conductivity of feed water 
Rd ■ 2 = Conductivity ratio - 2 = _ C « a 4E!.iY&'..of™Ao2e't liquid
Conductivity o f blank (distilled water)
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Results o f -15°C freezing experiments seems to agree with findings o f other 
researches, i.e., as feed water impurity concentration increases, the separation efficiency 
would decrease as the chances to capture of impurities within ice structure is enhanced 
when there are more impurities in the solutions. The possible reasons that might cause the 
discrepancy at -7°C are sample preparation and analytical errors.
Additionally, Figure 9-26 and Figure 9-27 also illustrate that at low concentration 
solutions, the conductivity ratios are significantly higher than the concentration ratios, 
with an example o f experiments at warmer temperature (-7°C), for the group of samples 
of 6.94±3.10 ng/L ibuprofen in feed water, Cl/Co o f Lestage unfrozen liquid to feed 
water is only about 1.3, but the conductivity of unfrozen liquid is around 2.2 folds o f that 
of the feed water. The significant differences between conductivity ratios and 
concentration ratios thus prove that the operation errors during sample preparation 
processing and the low precision o f GC-MS at low concentration. For feed water with 
initial ibuprofen high drug concentration (76.57±16.90 ng/L), the Cl/Cq value was 
greater than the corresponding conductivity ratio. The possible explanation is that the 
sample preparation errors leaded to GC-MS responded the no enough high concentrations 
accordingly to actual concentration in the feed water with really low initial drug 
concentration; but after freezing cycle, the impurity content in the unfrozen liquid was 
much higher, which was perhaps ranged into the good response range of the GC-MS, and 
the sampe preparation errors can be neglected compared to the enough high 
concentrations. As a result, the calculated Cl/Cq value became higher than the 
conductivity ratios. Contamination of the distilled water during sample preparation for 
the low drug concentration samples could be another reason that causes low conductivity
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ratios at high impurity concentration. In general, for analyzing the low concentration 
sample, although conductivity may not directly reflect the actual drug concentration like 
GC-MS, it seems more consistent in measuring the strength o f the ionic species in the 
water samples.
Comparing the conductivity ratios between unfrozen liquid and feed water in 
Figure 9-26, the freeze concentration at -7°C was not affected by the initial impurity 
concentration in feed water. For the experiments at -15°C, the conductivity ratios 
between unfrozen liquid and feed water in Figure 9-27 show that the dilute solution is 
easily concentrated by freeze concentration as mentioned previously. The differences 
between experimental results at the two freezing temperatures are produced by two 
primary factors including freezing temperature and solvent used to prepare the 
corresponding water samples.
According to Rd-2, the conductivity ratios in Figure 9-26 and Figure 9-27, the 
experimental results are consistent with findings o f other researches such as Yang et al. 
(1990) and Liu et al. (1999), i.e., when impurity concentration was low, most o f the 
impurities could be separated by freeze concentration.
2) Effect o f Freezing Temperature on Ibuprofen single-stage Freeze Concentration
Figure 9-28 compares the impurity concentration ratios o f the water samples to 
the feed water and to the blanks at temperature of -7°C and -I5°C freeze concentration. 
As shown in the figure, there were little difference in pH ratios differences between the 
two freezing temperatures while some differences were observed for the drug 
concentration and conductivity.
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pH ratio Rc Rd-1 Rd-2
Figure 9-28 Effect o f freezing temperature on single-stage freeze concentration of 
ibuprofen solution
pH of unfrozen liquid
pH ratio = ^ ---------——  -----------
pH o f feed water
Rc = Concentration ratio =
Drug concentration in unfrozen liquid (C^)
Drug concentration in feed water (Co)
„  , , „  , . . , Conductivity o f unfrozen liquid
Rd -1 = Conductivity ratio -1 = --------------- --------------------------
Conductivity of feed water
„ .  - „ , . . _ Conductivity of unfrozen liquidRd - 2 = Conductivity ratio - 2 = ----------- —----- ------------ — — 3---------
Conductivity of blank (distilled water)
As for drug concentration ratios, the results were mixed as mentioned earlier. At 
high initial feed water impurity concentration (-77 ng/L), freezing at the warmer 
temperature had higher concentration efficiency than that at -15°C. Combining 
concentration ratios and conductivity ratios, freeze concentration at -7°C is more
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effective than that at -15°C. That is because a lower freezing temperature produces a 
slower moving freezing front which allows impurities to be dissipated away, not trapped 
in the ice structure. Similar results were reported by other researchers, for example, Liu et 
al. (1997,1998), Martel et al. (2002), and Gao et al. (2004), and others.
9.2.1.2 Second-Stage Freeze Concentration of Ibuprofen
1) Effect o f Initial Drug Concentration in Feed Water on Impurity Removal on 
Second-Stage Freezing
High impurity separation efficiency can be achieved by using two stages or 
multi-stage freeze concentration as demonstrated in Baker (1967) and other researchers. 
In this experimental study, two stage freeze concentration was used for the unfrozen 
liquid from stage freezing to find out the capacity of the freeze concentration o f 
impurity and volume reduction.
Figure 9-29 show the results obtained the results obtained from testing at -7°C, 
pH changes are still small. Concentration and conductivity of unfrozen liquid to the feed 
water (unfrozen liquid collected from E‘-stage freeze concentration) followed the similar 
trends as the feed water concentration to the E'-stage freezing. It is obviously that the 
lower original impurity concentration attained higher concentration factor.
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Figure 9-29 Effect o f feed water concentration on ibuprofen 2"‘̂ -stage freeze 
concentration (-7°C).
pH ratio = -
pH of unfrozen liquid
pH of feed water to second stage freezing
Drug concentration in unfrozen liquid (C, ) R'c = Concentration ratio = ------------------=------------------------------------
R'd -1 = Conductivity ratio -1 =
Drug concentration in feed water to second stage freezing (C o) 
Conductivity of unfrozen liquid
Conductivity of feed water to second stage freezing
R'd - 2 = Conductivity ratio - 2 = -  CSSliducIrvigLof unAozen Uquid
Conductivity of blank (distilled water)
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Figure 9-30 Effect o f feed water concentration on ibuprofen 2"‘*-stage freeze 
concentration (-15°C).
pH ratio =
pH o f unfrozen liquid
pH of feed water to second stage freezing
R'c = Concentration ratio = -
R'd-1 = Conductivity ratio -1 =
Drug concentration in unfrozen liquid (C^)
Drug concentration in feed water to second stage freezing (C o) 
Conductivity of unfrozen liquid
R'd-2 = Conductivity ratio - 2 =
Conductivity of feed water to second stage freezing 
Conductivity of unfrozen liquid
Conductivity of blank (distilled water)
Figure 9-30 shows the results from -15°C freeze concentration tests. The results 
were close to those o f -7°C. The trends of impurity concentration ratios also suggested 
that dilute solution was more effectively separated.
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2) Freezing Temperature Effect on Second-Stage Freeze Concentration
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Figure 9-31 Effect of freezing temperature on ibuprofen two-stage freeze concentration
 ̂ ^ Drug concentration in unfrozen liquid (C, )R'c = Concentration ratio - ---------------------------------------------- — ^--------- ^ tv
R'd-1 = Conductivity ratio -1 = 
R'd-2  = Conductivity ratio - 2 =
Drug concentration in feed water to second stage freezing (Co) 
Conductivity of unfrozen liquid
Conductivity of feed water to second stage freezing
Conductivity of unfrozen liquid 
Conductivity of blank (distilled water)
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Figure 9-31 shows the comparison of experimental results at two freezing rates. 
Higher drug concentration ratios o f unfrozen liquid obtained during the 2"‘̂ -stage freezing 
to the feed water of 2 '“' stage freezing (unfrozen liquid from 1®‘ stage freezing) were 
observed for the freezing at the warmer temperature (-7°C).
9.2.2 Gemfibrozil
9.2.2.1 Effect o f Initial Drug Concentration in Feed Water on Impurity Removal on 
Single-stage Freeze Concentration
Similar to ibuprofen, gemfibrozil has a pKa value of 4.7 which means its chemical 
characteristic such as a weak acid closed to ibuprofen. Therefore, pH of gemfibrozil 
solution does not clearly vary with gemfibrozil concentration, even when the 
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Figure 9-32 Comparison of pH between distilled water and gemfibrozil feed water 
Blank is distilled water used to prepare the corresponding feed water.
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Figure 9-33 Comparison of conductivity between distilled water and gemfibrozil feed 
water
Blank is distilled water used to prepare the corresponding feed water.
Comparison of conductivity of blank and the gemfibrozil feed water suggests the 
behavior of gemfibrozil in distilled water is more like that of ibuprofen. Also, the 
fluctuation o f conductivity o f the distilled water used to prepare the synthetic water 
samples was observed. Again, the decrease of sample conductivity occurred after 
addition of the drug. The sample conductivity did increase with increase in drug 
concentration (Figure 9-33), The corresponding conductivity ratios of the feed water to 
blank samples are presented in Figure 9-34.
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Figure 9-34 Effect o f gemfibrozil concentrations in feed water on 1st stage freeze 
concentration (-15°C).
_  ̂ Drug concentration in unfrozen liquid (C, )
Rc = Concentration ratio = ----------------------- ;------------------ ------
Drug concentration in feed water (Co)
„  , , _ j  1 Conductivity of unfrozen liquidRd -1 = Conductivity ratio -1 = --------------- ---------- ---------------
Conductivity of feed water
„  j - ^  _ Conductivity of unfrozen liquidRd - 2 = Conductivity ratio - 2 = -------------------   ^---------
Conductivity of blank (distilled water)
According to Figure 9-34, the conductivity changes of unfrozen liquid based on 
distilled water indicate that the dilute solution has achieved effective concentration. 
However, drug concentration ratios were in contradiction with the results of conductivity 
ratios. Considering the operation errors in low drug concentration sample preparation 
processing, these errors significantly influence the concentration values of the original 
samples and unfrozen liquid after 1®‘ stage freeze concentration at initial concentration of 
about 14 ng/L but the influences from operation errors became very low for those feed
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water samples o f around 71 ng/L, therefore, higher drug concentration ratios were 
obtained.
9 2 2 2  Effect o f Initial Drug Concentration in Feed Water on Impurity Removal on 
Second-Stage Freeze Concentration
Figure 9-35 shows the changes in concentration and conductivity o f gemfibrozil 
solution after 2"** stage freeze concentration. The concentration ratios of the the second 
stage freezing was slightly lower than those of the first stage freezing. Increase in 
impurity concentration might be the reason.











Figure 9-35 Effect o f feed water concentration on gemfibrozil 2nd stage freeze 
concentration (-15°C).
R'c = Concentration ratio :
R 'd-1 = Conductivity ratio -1 =
Drug concentration in unfrozen liquid (C^)
Drug concentration in feed water to second stage freezing (C o) 
Conductivity of unfrozen liquid
Conductivity o f feed water to second stage freezing
R'd - 2 = Conductivity ratio - 2 = Conductivity o f unfrozen liquid
Conductivity of blank (distilled water)
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9.2.3 Comparison of Ibuprofen and Gemfibrozil
9.2.3.1 Single Stage Freeze Concentration
Figure 9-36 shows the comparative results o f the two drugs passed through single 
stage freezing. Generally, no obvious differences are apparent in pH ratio and 
conductivity ratios based feed water and blank. The concentration ratio of gemfibrozil 
was slightly higher than that of ibuprofen when the feed water had higher initial drug 
concentration.
First stage freeze concentration (-15°C)
y .3 .5
% 3
2  2.5  
c  2
I  1.5 
^  1














Figure 9-36 Comparison of different drugs in single-stage freezing (-15°C). 
pH o f unfrozen liquid
pH ratio =
Rc = Concentration ratio =
pH of feed water
Drug concentration in unfrozen liquid (C^ )
Rd -1 = Conductivity ratio -1 = 
Rd - 2 = Conductivity ratio - 2 =
Drug concentration in feed water (Co) 
Conductivity of unfrozen liquid
Conductivity of feed water 
Conductivity of unfrozen liquid 
Conductivity o f blank (distilled water)
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9.2.3.2 Two Stages Freeze Concentration
The concentration ratios of the two drugs (for the freezing at -15°C) are plotted in 
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Figure 9-37 Comparison of different drugs in two stages freezing (-15°C). 
pH o f unfrozen liquid from second stage freezing
pH ratio = -
R'c = Concentration ratio =
R'd-1 = Conductivity ratio -1 =
pH of feed water to first stage freezing
Drug concentration in unfrozen liquid from second stage freezing (C^)
R'd - 2 = Conductivity ratio - 2 =
Drug concentration in feed water to first stage freezing (Co) 
Conductivity of unfrozen liquid from second stage freezing 
Conductivity of feed water to first stage freezing 
Conductivity of unfrozen liquid from second stage freezing
Conductivity of blank (distilled water)
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In general, the results are close; there is no significant difference between the 
removal efficiency of ibuprofen and gemfibrozil. The only discrepancy was the drug 
concentration ratio of gemfibrozil at initial feed water concentration o f 74±4.2 ng/L. The 
experimental error (s) related to chemical analysis might have been the cause in addition 
to the difference in freeze separation/concentration efficiency.
9.2.4 Association of Drug Concentration with Total Organic Carbon (TOC)
For water/wastewater treatment plants, it is impractical, if  not possible, to identify 
and to monitor of all o f PhACs in their effluents. For organic contaminants, the effluent 
quality is practically measured by gloss parameters such as BOD, COD and TOC. 
Effluent quality control in terms of the organic contaminants is also accomplished by 
controlling the concentrations of TOC, BOD, or COD. Therefore, it is important to find 
out the association o f PhACs concentrations with the gross organic parameters as no such 
studies have been conducted.
In this study, the TOC concentrations of five drugs (A.S.A, ibuprofen, gemfibrozil, 
metoprolol and sulfamethoxazole) were measured and freeze concentration efficiency of 
ibuprofen and gemfibrozil and mixed drugs in one stage and two stage processes was also 
investigated at -7 °C. Ice samples fi-om both Ist-stage and 2"^-stage freezing were also 
collected in addition to the unfrozen liquid and the feed water samples (see the schematic 
illustration o f freeze concentration tests in Figure 9-38).
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Figure 9-38 Schematic of two-step cascade freeze concentration o f high concentration 
drug solution
FW = Feed water to first stage freeze concentration;
UF = FW-2 = Unfrozen liquid from first stage freeze concentration;
ICE = FW-3 = Ice formed in first stage freezing (melted ice is collected as feed water of 
melted ice refreezing);
UF-UF = Unfrozen liquid from refreezing of unfrozen liquid from first stage freeze 
concentration;
UF-ICE= Ice from refreezing of unfrozen liquid from first stage freeze concentration; 
ICE-UF= Unfrozen liquid from refreezing of melted ice obtained in first stage freezing; 
ICE-ICE=Ice from refreezing of melted ice obtained in first stage freezing.
9.2.4.1 Drug Concentration versus TOC
TOC concentration of the samples was determined by subtracting the TOC in the 
blank and the small volume of solvent. The plot of TOC versus selected drug 
concentrations in the water samples was shown in Figure 9-39.
160



















Figure 9-39 TOC vs. drug concentration 
Point #1 : Single drug solution (IBP of 4.98 mg/L);
Point #2: Single drug solution (GEM of 5.03 mg/L);
Point #3: Five drugs mixed solution (1.05±0.03 mg/L for each drug of A.S.A., IBP, GEM, 
MET and SUL)
Point #4: Five drugs mixed solution (1.47±0.03 mg/L for each acidic drug of A.S.A., IBP 
and GEM; 2.52±0.01 mg/L of MET and SUL, respectively)
Point #5: Five drugs mixed solution (1.49±0.03mg/L for each acidic drug of A.S.A., IBP 
and GEM; 4.52±0.01 mg/L of MET and SUL, respectively)
According to Figure 9-39, TOC concentration generally increased with increasing 
drug concentrations, and the increase trend presents like logarithmic curve. For example, 
when total drug concentration increased from around 5 mg/L to about 9.5 mg/L (the 
section from points #1,2,3 to point #4 in Figure 9-39), the corresponding TOC increased 
about 200 units. However, there is not significantly difference between Point#4 and 5 
with total drug concentration of about 9.5 mg/L and 13.5 mg/L, respectively. 
Additionally, there are probably some equipment errors, especially for high drug 
concentration samples. Because the accurate range of TOC analyzer is limited, sometime 
the TOC values o f high drug concentration samples maybe out off the range. In this study.
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TOC concentrations of the water samples were surprisingly high, and could not be 
explained by experimental errors. The TOC analysis was carried out on different days 
and blank samples were measured each time with the samples, and duplicate samples 
were also taken. The TOC of distilled water sample (3.24 mg/L) and distilled water plus 
solvent (TOC changed with the solvent volume) were reasonable and confirmed that no 
contamination of samples or malfunction of TOC analyzer occurred. The TOC analyzer 
was calibrated each time before each sample analysis. It seems that the drugs (which are 
not 100% pure) and the additives have high TOC concentrations. In fact, effluents from 
wastewater treatment plants may contain hundreds or even thousands of different drugs, 
it is impossible to control the concentration of every drug in wastewater during practical 
water industry. Based on the finds of this study, overall, the residue drugs may contribute 
to significantly increase of TOC concentration. TOC concentration is thus critical for 
drug residue control.
9.2.4.2 TOC of Frozen Ibuprofen, Gemfibrozil and Mixed Drugs
Different concentration ratios of unfrozen liquid or ice from different freezing 
cycle to the corresponding feed water are shown in Figure 9-40. For example, the first 
field in Figure 9-40 is the C/Co ratios of unfrozen liquid and ice to the feed water. With 
freezing about 84% (volume) of the feed water whose initial ibuprofen concentration was 
4.98 mg/L, the ice obtained from the first freezing contained only ca. 21% of the drug 
concentration in the feed water and the unfrozen liquid (UF) drug concentration was 
1.64±0.42 times that of in the feed water. Refreezing of the unfrozen liquid and the ice 
obtained from the U' stage freeze concentration helped of to achieve further concentration 
of the drug or purification of the ice was achieved. During the second stage freezing.
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77±1% volume of the feed water (i.e., the unfrozen liquid from the first stage freezing) 
was frozen. As indicated in the Figure 9-40, the concentration ratios for the unfrozen 
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Figure 9-40 Freeze concentration results of 4.98 mg/L ibuprofen single solution
T O C  n r T O C
R -1 = TOC concentration ratio -1 = ------------  —  (T O C fw -i -  4.98 mg/L)
TOC F W - I
T O C  n r  T O C
R - 2  -  TOC concentration ratio - 2  =   E m m  (TOCfw-2 = TOCuf)
T O C F W - 2
R - 3 = TOC concentration ratio - 3 = 'TOC,(;g.,CT
TOC (T O C fw-3 ~  T O C ice)F W - 3
those obtained from the first stage freezing. UF-UF and UF-ICE were 1.08±0.01 and 
0.54±0.06, respectively. Freezing of the melted ice obtained from the first stage, resulted 
in higher impurity concentration ratios, the liquid (ICE-UF) contained 3.90±0.09 times of
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drug concentration and the ice (ICE-ICE) only 6±1% of compared to the feed water (i.e. 
melted ice). Overall, in terms of mass of TOC causing materials, the removal efficiency 























Figure 9-41 Final products of two stages freeze concentration of 4.98 mg/L ibuprofen 
single solution
TOCfw-1 = 4.98 mg/L
Rf -1 = final product TOC concentration -1 =
TOC UF-UF






Figure 9-41 presents two final products during two stages freeze concentration of 
about 5mg/L ibuprofen single solution. After the second stage freezing, around 64% of
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the total feed water (volume) reached close to 99% reduction of TOC concentration and 
approximately 99% for ca 64% of the total feed water after two stages fi'eeze 
concentration.


















































The detailed removal efficiency for each stage is listed in Table 9-3. Column 1 
figures out which freezing stage the water samples are collected from. The second 
column explains the comparative objectives which the corresponding TOC concentration 
ratios are presented in Column 3. Additionally, volume reduction and removal efficiency 
are listed the last two columns, respectively.
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Figure 9-42 Actual volume changes during ibuprofen freeze concentration experiment
FW = Feed water to first stage freeze concentration;
UF = FW-2 = Unfrozen liquid from first stage freeze concentration;
ICE = FW-3 = Ice formed in first stage freezing (melted ice is collected as feed water of 
melted ice refreezing);
UF-UF -  Unfrozen liquid from refreezing o f unfrozen liquid from first stage freeze 
concentration;
UF-ICE= Ice from refreezing of unfrozen liquid from first stage freeze concentration; 
ICE-UF- Unfrozen liquid from refreezing of melted ice obtained in first stage freezing; 
ICE-ICE=Ice from refreezing of melted ice obtained in first stage freezing.
Figure 9-42 illustrates the actual volumes of various samples obtained or used for 
the first and the second stage freezing of ibuprofen, which have been mentioned many 
times in previously sections. From this figure, 80±5% freezing degree is kept for each 
freezing stage. Reference to Table 9-3, after two stages freeze concentration, about 960 
mL high quantity melted ice (UF-ICE and ICE-ICE) may be obtained from 1600 mL feed 
water contained, which means at least around 60% wastewater reuse. If remaining high 
drug concentration liquids are further treated, much water will be recovered.
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Figure 9-43 Freeze concentration results of 5.03 mg/L gemfibrozil single solution
(TOCpw-i ~ 5.03 mg/L)R -1 = TOC concentration ratio -1 = ^
TOC FW-t
R - 2  = TOC concentration ratio - 2 = -9^uF.uF TOC^p.,c£  ̂= TOCuf)
TOC




TOC (T O C fw-3 -  T O C ice)FW-3
Results o f freezing o f gemfibrozil were similar to those of ibuprofen, as shown in 
Figure 9-43. A TOC concentration ratio of 1.3 was obtained for the unfrozen liquid after 
freezing about 78 % of the total volume of the feed water which had a 5.03 mg/L o f 
gemfibrozil, and the concentration ratio for the ice o f the first stage freezing was 0 .1 2 , i.e., 
the ice contained 12% o f the TOC as compared to the feed water. The ice made from the 
gemfibrozil solution was purer than that of the ibuprofen. Refreezing of the melted ice
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formed in the first stage freezing further reduced gemfibrozil TOC concentration in the 
ice, i.e., the final product which contained only 1% of the initial TOC concentration in 

























Figure 9-44 Final products o f two stage freeze concentration o f 5.03 mg/L gemfibrozil 
single solution
TOCpw-i ~ 5.03 mg/L
R f -1 = final product TOC concentration -1 =
TOC UF-UF
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Table 9-4 listed concentration ratios of all gemfibrozil samples and corresponding 
drug removal efficiency to each stage freeze concentration. Column 1 figures out which 
freezing stage the water samples are collected from. The second column explains the 
comparative objectives which the corresponding TOC concentration ratios are presented 
in Column 3. Additionally, volume reduction and removal efficiency are listed the last 
two columns, respectively.
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Chapter 10 SUMMARY AND CONCLUSIONS
This study was carried out to get a better understanding o f the occurrence of 
pharmaceutically active compounds (PhACs) in the aquatic environment and water 
systems, and to evaluate the potential of freeze concentration technique for the removal 
of PhACs from water systems. The following is a summary and the conclusions drawn 
from the study:
• Occurrence o f residual drugs in municipal wastewater treatment plant effluent 
(WWTP) and the aquatic environment is the reality; various drugs were detected 
in municipal wastewater treatment plant effluents, surface, ground water, and in 
some cases, treated drinking water in difference countries. According to the 
published literatures the concentration of the drug residues in WWTP effluents 
and the environment are expected to increase with increased consumption o f the 
drugs, if  effective treatment processes are not employed.
• The analytical methodology for the determination o f drug residues in complex 
environmental matrices is still evolving and it may takes years before the 
universally accepted methods are developed. The GC-MS method used by many 
researchers requires complex sample preparation, which could influence the 
accuracy o f the analysis.
• Freezing o f ibuprofen and gemfibrozil in one stage freeze concentration, about 
84% and 92% removal efficiency is for TOC, about 81% and 83% removal 
efficiency for the two drugs based on the GC-MS analysis. High TOC
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concentrations were observed in the water samples prepared with individual or 
mixed drugs. The removal efficiency of TOC for ibuprofen was around 84% in 
the first stage freezing and approximately 99% in the second stage freezing, for 
gemfibrozil circa 92% and 99.5%, respectively.
In general, freeze concentration was effective and not sensitive to the nature o f the 
impurities in the feed water.
Recommendations for Future Research
• Future research is needed to investigate the removal efficiency o f PhACs in 
municipal wastewater treatment plant effluents by the progressive freeze 
concentration process.
• More types o f drugs should be selected to observe their behaviors during the 
freeze concentration
• Investigations of large scale experiments should be carried out to evaluate the 
potential o f the progressive freeze concentration processes.
• Analytical method researches must be kept to do till simple and high effective 
standard method(s) occurrence.
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